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Abstract
The general subject area of research considered in this thesis is population level
epidemic modelling of infectious diseases, with specific application to the prob-
lems of model indeterminacy and systems that include processes associated with
maternally acquired immunity. The work presents the derivation and analysis of
a lumped systems model framework to study the influence of maternal antibod-
ies on the population dynamics of infection among neonate and young infant age
classes. The proposed models are defined by sets of ordinary and partial differen-
tial equations that describe the variation of distinct states in the natural history
of infection with respect to time and/or age.
The model framework is extended to explore the potential population level out-
comes and consequences of mass maternal immunisation: an emerging targeted
vaccine strategy that utilises the active transfer of neutralising antibodies during
pregnancy in order to supplement neonatal immunity during the first few months
of life. A qualitative analysis of these models has highlighted the importance of
interaction with early childhood targeted vaccination campaigns, the potential to
invoke transient epidemic behaviour and the prospective advantages of seasonal
administration.
The work considers the implications of structural identifiability, indistinguishabil-
ity and formal sensitivity analyses on a number of fundamental model structures
within the proposed framework. These methods are used to establish whether a
postulated model structure, or the individual parameters within a known struc-
ture, are uniquely determinable from a given set of empirical observations. The
main epidemiological measures available for the validation of epidemic models are
inherently based on records of clinical disease or age serological surveys, which are
not explicitly representative of infection and provide a very limited observation
of the full system state. The analyses suggest that these issues give rise to prob-
lems of indeterminacy even in the most simple models, such that certain system
characteristics cannot be uniquely estimated from available data.
xv
Chapter 1
Introduction
The implementation of mass immunisation campaigns has long been recognised
as an effective strategy for preventing severe morbidity and mortality inflicted by
a variety of infectious diseases. Neonatal and young infant age classes however,
remain vulnerable to many of these infections [Englund et al., 1998]. Immunising
vaccines are generally unsuccessful in individuals with immature immune systems
and their safety in newborns is of ongoing concern. An accumulation of evidence
suggesting that passive protection during the first few months of life may be con-
veyed in the form of maternal antibodies (MAb) could therefore have a significant
impact on future health care effort within this context [Munoz and Englund, 2000].
The potential to augment passively acquired immunity in the newborn by stimu-
lating a complementary active immune response in the mother has presented an
emerging public health opportunity in the form of maternal immunisation [Glezen
and Alpers, 1999]. Interventions of this nature have already been successfully
applied in several developing regions with the aim of reducing young infant mor-
tality due to tetanus [WHO, 2002]. Candidate vaccines are currently also being
considered for a number of other highly prevalent viral infections, such as human
respiratory syncytial virus (hRSV), influenza and pertussis, which are found to
1
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cause a significant burden of disease among neonatal and young infant age classes
[Healy and Baker, 2006].
The inherent complexity of host-pathogen interactions at both individual and pop-
ulation levels, and the necessarily stringent processes by which new large scale
healthcare intervention strategies are approved, prescribe the use for methods of
theoretical analysis [Nokes and Anderson, 1988]. Mathematical modelling provides
an abstract framework with which to explore the observed behaviour of real world
systems and their potential responses to various environmental conditions, without
the constraints typically imposed by real world risk or cost of experimentation. In
the context of communicable diseases, these efforts are motivated by a requirement
for more accurate predictions regarding the outcome of infection, a greater under-
standing of the principal biological mechanisms at work and to inform decisions
concerned with the governance of public health policy.
Mathematical models are generally classed as either process driven or data driven,
depending on whether they represent an analytic description of the underlying
physical processes or simply some empirical record of real world system behaviour.
The adoption of both approaches is evident throughout the study of mathemati-
cal epidemiology, however, process driven modelling methods are generally more
favourable since they allow more elemental inferences to be made regarding the
fundamental operation of the system. A general procedure for generating and ap-
plying mathematical models of this nature to a particular real world problem may
be described in the following stages:
• Problem Definition - Specify the scope of the problem and capture the
requirements of the model.
• Model Derivation - Collate relevant hypotheses and prior knowledge of the
real world system in order to identify the key physical processes of interest
and describe critical interactions between them in an appropriate mathemat-
ical form.
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• General System Analysis - Investigate relations within the fundamen-
tal operation of the model using mathematical techniques such as steady
state analysis, stability criterion, and bifurcation theory, in order to further
understand the characteristic behaviour of the system.
• Validation - First, ensure that the model sufficiently describes any qual-
itative characteristics of the real system using the aforementioned general
system analysis. Second, calibrate the model by quantitatively comparing
its output with empirical observations and estimating unknown parameters.
Validation is performed in order to ensure that the model may be used to ac-
curately infer characteristics of a specific real world system and make mean-
ingful predictions about its future behaviour.
• Simulation - Explore the predicted behaviour of the system by simulating
the model with a series of input conditions and perturbations that may be
representative of critical and interesting scenarios.
It is the application of this modelling methodology to epidemic systems, including
those that describe characteristics associated with maternally acquired immunity
and intervention, that is the subject of this work.
Problem Statement
The benefits of maternally acquired immunity and maternal immunisation to the
individual are becoming increasingly well established through studies such as those
described by Vandelaer et al. [2003], Puck et al. [1980], and Mulholland [1998].
However, the influence of these processes on population level infection character-
istics remains largely unknown.
The epidemiology of infectious diseases is markedly different to that of noninfec-
tious diseases. Since each infective individual is a potential source of infection to
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others, the risk of disease to any one member of a host population is inherently
dependent on the status of all those with whom they may potentially come into
contact [Medley and Nokes, 2005]. The spread of an infectious agent throughout
a large population of hosts is therefore principally driven by community-wide pat-
terns of susceptibility/immunity and the prevalence of infection. Epidemiological
characteristics and interventions that may influence these variables subsequently
have indirect population level consequences beyond those of the individual to which
they directly relate. Furthermore, heterogeneous interactions between these fac-
tors, such as seasonal, demographic and immunological dependencies, often lead
to highly complex system behaviour.
Population dynamics of communicable diseases are frequently explored using lumped
system models, where individuals within a population are grouped according to
some common epidemiological characteristic and considered as a single homoge-
neous unit [Jacquez, 1996]. Individual level complexities may be reduced according
to risk factors such as immunological experience, age or spatial distribution, in or-
der to make analysis of the resulting model more tractable. In this instance, the
appropriate selection of model structure and the identification of essential system
processes are crucial and have a significant impact on the applicability of the model
to a specific problem.
In order for mathematical models to accurately describe particular real world sys-
tems, they must first be rigorously validated. However, the validation of complex
population level infection based models is often a markedly non-trivial task. The
main epidemiological measures available are typically based on records of clinical
disease or age serological surveys, which are not necessarily representative of in-
fection and provide only a very limited observation of the full system state [White
et al., 2005]. The notification of many infectious agents is also incomplete and
heavily biased depending on awareness, severity of symptoms and social stigma
[Thacker et al., 1983]. These issues give rise to the problem of indeterminacy,
where certain system characteristics may not be uniquely determined from the
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available set of empirical observations.
It is the objective of this work to derive and consider the validation of a series of
population level epidemic model structures that may be used to estimate the influ-
ence of processes and interventions associated with maternally acquired immunity
on the epidemiology of infectious disease. Significant and original contributions in
both these subject areas are presented, where it is hoped that the resulting frame-
work will ultimately contribute to the assessment and optimal implementation of
future public health policies within this context.
Thesis Structure
The thesis is structured into two chapters that describe the derivation of both
existing and novel epidemic model structures, three chapters of analysis and a
brief overall discussion that includes suggestions for future research. Each technical
chapter contains an introduction, a review of relevant literature and a discussion
of the key findings and implications of the work.
Chapter 2 provides a pedagogical review of current epidemic compartmental
systems and the basic modelling principles required by the reader. A number
of fundamental model structures are described in detail since they are applicable
to the derivation of new models in Chapter 3 and their subsequent analysis in
Chapters 4 and 5 is novel. Chapter 3 presents the development and preliminary
analysis of models that incorporate processes associated with maternally acquired
immunity and maternal immunisation.
Chapters 4 and 5 describe the application of techniques used to address issues
of indeterminacy that arise during the validation of the discussed models. These
methods are namely structural identifiability/indistinguishability and sensitivity
analysis, which aim to establish, first, whether it is even theoretically possible
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to ascertain unique parameter estimates from a particular set of measurements
(structural identifiability), and second, how well a particular estimation is deter-
mined or supported by an experimental observation (numerical identifiability and
sensitivity analysis). The results from these analyses are also interpreted to give
an indication of the likely influence of maternally acquired immunity over popula-
tion level system behaviour and discussed in the context of model reduction and
future experimental design.
Chapter 6 describes additional qualitative analysis of the models derived in Chap-
ter 3 and presents a series of examples demonstrating their applicability to epi-
demiological problems arising from maternally targeted intervention. Simulation
is performed using nominal characteristic parameter estimates extracted from the
literature in order to establish what the potential static, dynamic and seasonal
implications of these processes might be.
Chapter 2
Mathematical Modelling of
Communicable Diseases
In reality, all epidemic system processes are inherently stochastic in nature since
they are primarily driven by individual-level events and interactions between hosts.
However, the analysis of epidemic models that include probabilistic descriptions
of such random processes can be a complex and challenging task, and often only
considered following a preliminary analysis of more tractable deterministic mod-
els [Andersson, 2000]. At a population level, stochastic variations are generally
most critical when considering the progression of minor outbreaks within small
isolated cohorts or the persistence of pathogens that are close to the threshold of
extinction. As a result, deterministic models provide a useful approximation to the
epidemic evolution of highly infectious agents that appear ubiquitous throughout
large populations [Anderson and May, 1991].
The most common approach to deterministic modelling of population level mi-
croparasite transmission dynamics is through a compartmental representation of
the various stages in the natural history of infection, written as a system of ordinary
differential equations (ODEs). Analogous examples of compartmental analysis are
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also frequently found throughout the literature relating to other scientific contexts,
such as chemical and drug kinetics, where a large base of applicable techniques
have been documented [Godfrey, 1983]. Models of this type comprise a finite num-
ber of interconnected subunits (compartments) that consist of homogeneous and
well-mixed material, where all flow of material between compartments, and to and
from the environment, adheres to the principle of mass balance. For epidemic
systems, the compartmentalised material corresponds to a large population of in-
dividual hosts, through which an infectious agent may be transmitted. In this
instance, compartments in the model structure represent subpopulations of hosts
residing in a common state of disease.
Compartmental based epidemic models were first developed by Kermack and McK-
endrick [1927] and have since been extended to incorporate a wide range of complex
epidemiological characteristics such as incomplete immunity [Gomes et al., 2004],
altered secondary infection [Glass and Grenfell, 2004; Greenhalgh et al., 2000] and
multiple-strain variants [White et al., 2005]. For the general application of these
models see the texts by Anderson and May [1991], Capasso [1993] and Jacquez
[1996], and for specific examples see the work by Medley et al. [2001] and Edmunds
et al. [1996] for hepatitis-B virus (HBV), Weber et al. [2001] and White et al. [2007]
for human respiratory syncytial virus (hRSV), and Keeling and Grenfell [2002] for
measles.
2.1 SIR Framework Models
The general SIR model [Kermack and McKendrick, 1927], shown in Figure 2.1,
is used to characterise epidemic systems where the natural history of infection
can be reasonably approximated into three distinct stages. The host population is
therefore divided into three non-overlapping classes that distinguish an individual’s
state of disease as either susceptible, infective or recovered, which are delineated
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by the state variables S(t), I(t) and R(t), respectively.
The susceptible class includes all individuals who are able to contract the dis-
ease and become infectious; the infective class represents only individuals who are
currently infected and infectious to susceptibles; and the recovered class contains
all individuals who have recovered from infection and have consequently acquired
solid lifelong immunity. In this instance, latency incubation periods are neglected,
whereby all infected individuals are immediately considered to be infectious. It
is also assumed that recovered individuals are no longer able to transmit or re-
contract the pathogen, hence, the structure is most appropriate for modelling dis-
eases such as measles, mumps and rubella (MMR), where evidence suggests that
lifelong immunity to the entire pathogen population is induced following recovery
from natural infection [Jansen et al., 2003].
Figure 2.1: General SIR Compartmental Model
Individuals are born into the susceptible class at a net birth rate, µN , where N is
the total population size. It is assumed that the average duration of infection, v−1,
is small with respect to the average life expectancy, µ−1, such that the net mortality
rate, µ(S(t) + I(t) + R(t)), can be assumed to equal µN , hence maintaining a
constant size population.
Transmission of the infectious agent throughout the population is modelled us-
ing a frequency dependent approximation to mass action mixing. This method
is generally accepted for the spread of pathogens among humans, although alter-
native approximations also exist [McCallum et al., 2001]. Assuming a constant
average contact rate, c, per individual, between all individuals within a particular
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population, the rate at which infectives, I(t), make contact with the susceptible
proportion, S(t)/N , is equal to cS(t)I(t)/N . For each of these contacts there is
then a constant probability, ρ, that the infectious agent will be successfully trans-
mitted. Therefore, the incidence of infection, that is the rate at which susceptible
hosts become infected, can be modelled as βS(t)I(t)/N , where β = cρ. The func-
tion λ(t) = βI(t)/N is often used to represent the force of infection [Jacquez,
1996], where the average age at primary infection can be approximated by λ(t)−1.
The resulting transmission dynamics predicted by the SIR model are subsequently
described by the following system of ordinary differential equations:
S˙(t) = µN − λ(t)S(t)− µS(t), S(0) = S0, (2.1)
I˙(t) = λ(t)S(t)− (µ+ v)I(t), I(0) = I0, (2.2)
R˙(t) = vI(t)− µR(t), R(0) = R0, (2.3)
where
λ(t) = βI(t)/N. (2.4)
It should also be noted that the model structure is strictly a two state system,
since any one of the three state variable equations may be trivially found from the
assumption that the population size is constant, i.e. N = R(t)+S(t)+I(t).
2.1.1 The Basic Reproduction Number R0
The basic reproduction number, denoted R0, is often considered to be the most
important quantity in mathematical epidemiology of infectious diseases. It is pri-
marily defined as the average number of secondary cases of infection induced by a
single primary case in a completely susceptible (naive or virgin) population [Dietz,
1993], and is expressed as a product of the transmission parameter, β, and the
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average duration of time an individual remains infectious:
R0 =
β
µ+ v
. (2.5)
This definition gives rise to an invasion threshold at R0 = 1 that determines
whether or not an infectious agent can successfully sustain within a particular
host population. If the average infective case leads to more than one secondary
case, i.e. R0 > 1, then the infection has the ability to invade the host population
and cause an epidemic. Given that transmission is heavily dependent on social
and environmental variables, which differ between demographically and geograph-
ically distinct populations, R0 is unique for both different diseases and different
populations within which it is being considered [Anderson and May, 1991].
2.1.2 Transmission Dynamics & Endemic
Equilibrium
Following the introduction of an infectious agent into a fully naive population, the
initial growth of a resulting invasion is depicted by the basic reproduction num-
ber, R0. However, once an epidemic has become established, the host population
is no longer completely susceptible to infection since a significant proportion of
the population are either infective or recovered. In this instance, the number of
secondary cases per primary case is defined by the effective reproduction number,
RE = XR0, where X = S/N represents the subsequently reduced proportion of
the population susceptible.
The typical time course of a resulting epidemic can be described in terms of four
distinct stages (see Figure 2.2). The first stage corresponds to a rapid initial in-
crease in transmission due to an abundant availability of susceptible hosts present
within an inexperienced population. As the number of available susceptibles di-
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minish with the spread of infection, the growth of the invasion begins to stall. An
epidemic peak in prevalence is reached at the point where X equals a critical value
X∗ = R−10 ; at which point RE = 1 (i.e. only one new infection arises from each
existing case) and there are generally a greater number of individuals recovering
from infection per unit of time than there are new cases emerging. Subsequently,
Figure 2.2: Typical epidemic curve for a closed population SIR-type system.
during the third stage, the number of infective individuals begins to fall at a rate
largely determined by the average duration of infection. This leads to a reduction
in the force of infection and a further decrease in the proportion of the population
infective. Finally, the invading pathogen population will either continue to decline
and become extinct, or, if there is sufficient replenishment of susceptibles, settle
into a stable endemic equilibrium where X is sustained at X∗.
Steady state analysis of the general SIR model may be applied by initially setting
the system equations (2.1)-(2.2) equal to zero:
S˙(t) = µN − β
N
SˆIˆ − µSˆ = 0, (2.6)
I˙(t) =
β
N
SˆIˆ − (µ+ v)Iˆ = 0, (2.7)
and solving explicitly in terms of the model parameters. It is found that two steady
state solutions exist, which correspond to either a disease free or endemic state of
invasion, given respectively by
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 Sˆ
Iˆ
 =
 N
0
 and
 Sˆ
Iˆ
 =
 NR0
µN
µ+v
(1− 1
R0
)
 . (2.8)
Since all state variables must be non-negative, it can be seen that the endemic
equilibrium is only valid for R0 > 1. Therefore, the threshold R0 = 1 gives rise to
a bifurcation point, at which the number of valid steady states and their associated
stability is subject to change. These characteristics may be determined through
an eigenvalue analysis of the system Jacobian matrix, given by: −(µ+ βN I) − βNS
β
N
I β
N
S − (µ+ v)
 . (2.9)
Since all parameter values are also real and non-negative, eigenvalues for the dis-
ease free and endemic steady states are found respectively to be of the form:
λ1,2 = −µ, β−(µ+v), (2.10)
λ1,2 = −1
2
(
µR0 ±
√
µ(µ(R0−2)2 − 4v(R0−1))
)
. (2.11)
It can be seen from (2.10) that the disease free eigenvalues are always real and
that the corresponding steady state is asymptotically stable (i.e. has negative real
parts) for R0 < 1 (that is β < µ+ v) and unstable for R0 > 1 (that is β > µ+ v),
which re-iterates the invasion threshold discussed in Section 2.1.1. The endemic
steady state is stable throughout its valid range of R0 > 1, however, the associated
eigenvalues are seen to become complex for certain values of R0 determined by the
following conditions:
2(µ+ v −√v(µ+ v))
µ
< R0 <
2(µ+ v +
√
v(µ+ v))
µ
. (2.12)
In this instance, the analysis implies that the system will display damped oscilla-
tory behaviour while it converges to endemic equilibrium.
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2.1.3 Recurrent Epidemics & Seasonal Forcing
Many common infections such as measles, mumps and rubella (MMR), influenza
and hRSV tend to display large seasonal oscillations about their endemic equilib-
rium (for example see Figure 2.3). All epidemic behaviour is primarily driven by
susceptibility. Therefore, recurrent epidemics are usually caused by a degree of
antagonism between a relatively slow rate of susceptible supply and a high rate
of recovery from infection, which is sustained by some element of periodic exter-
nal forcing. For the unforced SIR example, where R0 adheres to the conditions
for complex endemic eigenvalues given by (2.12), the natural inter-epidemic time
period may be expressed by the following approximate form:
T ≈ 2pi√
µ(β − v) . (2.13)
In general, it is found that systems with higher net birth rates and more rapid loss
of immunity exhibit shorter inter-epidemic time periods. In contrast, infections
with a carrier state or a large duration of infection with respect to net birth rate
tend not to display significant (underdamped) oscillatory behaviour. Similarly,
infections that induce very limited immunity, such as most sexually transmitted
infections, also do not show recurrent epidemic cycles without significant periodic
forcing.
Recurrent epidemic cycles can in theory be sustained purely by stochastic vari-
ation [Alonso et al., 2007], although most recurrent epidemic systems are found
to oscillate in clear annual or biennial cycles [Hawker et al., 2005]. This strongly
suggests the influence of external seasonal forcing given that the natural frequency
of oscillation is highly parameter dependent and it is unlikely that these values will
coincidently combine to give a consistent time period corresponding to a natural
number [White et al., 2005].
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Figure 2.3: Weekly case notifications of measles in England and Wales for the
period 1948 to 1968, prior to the introduction of mass vaccination [Anderson and
May, 1991]
The most commonly considered mechanisms for seasonal forcing are associated
with the transmission parameter, β(t), since both the effects of human behaviour,
c(t), and the contagiousness of the infectious agent, ρ(t), are potentially governed
by recurring seasonal trends. For example, seasonality in measles is primarily
driven by the annual school term-time pattern of increased contact between indi-
viduals in the classroom (see Keeling et al. [2001], and Fine and Clarkson [1982]),
and the prolonged survival of pathogens such as rotavirus, norovirus and influenza
(see Cook et al. [1990], Mounts et al. [2000], and Hemmes et al. [1960]) outside
the host can be affected by a number of climatic conditions such as temperature,
humidity and exposure to sunlight (see also the reviews by Altizer et al. [2006],
and Grassly and Fraser [2006]). Temporal variation is typically included in basic
SIR type models as a simple sinusoidal function of time of the form:
β(t) = β0
(
1 + β1 cos
[
2pi(t− φ)]), (2.14)
where β1 defines the magnitude of the annual variation and φ corresponds to the
phase (annual timing).
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2.1.4 Models With Incomplete Immunity
In reality, most pathogens are able to evade natural immunity and re-infect their
hosts through either static antigenic variability or antigenic evolution over time.
The consequence of significant antigenic variability within a pathogen population is
that natural immunity acquired through experience of infection serves only to pro-
tect an individual against a proportion of the circulating infectious agents, leading
to only partial immune protection within the host population [Gomes et al., 2004].
Similarly, if the pathogen population experiences a rapid rate of antigenic evolu-
tion then any acquired immunity following infection will appear only temporarily
effective. It should be noted that the extreme case of incomplete immunity is the
SIS (Susceptible, Infected, Susceptible) model structure, in which all individual
hosts recover directly back into the fully susceptible state and are immediately
able to re-contract the infection. SIS type structures are most appropriate for
diseases such as gonorrhoea, which does not produce sufficient immunity against
reinfection [Capasso, 1993].
In order to model an epidemic system where immune hosts experience waning
of acquired immunity with time since previous infection, the general SIR model
is extended to include an additional transfer of individuals from compartment R
to compartment S, with rate coefficient ωR. This describes the rate at which
Figure 2.4: SIRS Temporary Immunity Model
recovered (immune) hosts return to being fully susceptible (note that the average
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duration of immunity is then ω−1R ) where they are able to re-contract the infection
upon contact with an infective individual. It is assumed that before waning off,
acquired immunity is solid and provides protection against all current variants of
the infectious agent. The model connectivity diagram is shown in Figure 2.4, from
which the system equations can be stated as follows:
S˙(t) = µN − λ(t)S(t)− µS(t) + ωRR(t), S(0) = S0, (2.15)
I˙(t) = λ(t)S(t)− (µ+ v)I(t), I(0) = I0, (2.16)
R˙(t) = vI(t)− (µ+ ωR)R(t), R(0) = R0, (2.17)
where
λ(t) = βI(t)/N. (2.18)
A partial immunity model describes the situation when immunity serves only to
protect the individual against a proportion of the current pathogen population,
and an element of susceptibility to some antigenic variants is always retained. The
Figure 2.5: SIRp Partial Immunity Model
model can be considered as a combination of an SIR submodel (primary infection)
and an SIS submodel (secondary infection), hence the recovered class now acts as
a second susceptible class where hosts have a reduced susceptibility to the force
of infection governed by the parameter σ ∈ [0, 1]. The model structure is shown
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diagrammatically in Figure 2.5 and is defined by the following system equations:
S˙(t) = µN − λ(t)S(t)− µS(t), S(0) = S0, (2.19)
I˙(t) = λ(t)(S(t) + σR(t))− (µ+ v)I(t), I(0) = I0, (2.20)
R˙(t) = vI(t)− σλ(t)R(t)− µR(t), R(0) = R0, (2.21)
where
λ(t) = βI(t)/N. (2.22)
It is assumed that any acquired immune protection does not wane with time and
is not altered by subsequent re-infections. The dynamic behaviour and endemicity
of the system is dually dependent on the contributing characteristics of the SIR
and SIS components of the system. The skewing of this dependence towards either
primary or secondary infection is governed by the re-infection threshold [Gomes
et al., 2004], which describes a limit for R0 with respect to the partial immu-
nity parameter σ, beyond which re-infection becomes dominant and a significant
increase in transmission can occur.
2.2 Vaccination Models
Vaccination strategies are employed to protect susceptible hosts, both at individ-
ual and population level, against parasite infection and subsequently reduce the
prevalence or burden of disease [Anderson and May, 1991]. Vaccines work by
presenting a foreign antigen to the immune system in order to evoke a specific
immune response with less morbidity than the naturally occurring infection. At
a population level, immunisation can be considered as a process of fast-tracking
a proportion of all susceptible hosts to a state of immunity without experiencing
infection and hence a period of time during which they are infectious to others.
The work documented in this study focuses on the analysis of models where vac-
Chapter 2 2.2 Vaccination Models 19
cination is assumed to induce identical properties of immunity to that of natural
infection, such that vaccinated hosts are included within the recovered population
class, R(t). In this instance, mechanisms such as antigenic variability and evolu-
tion that allow the infectious agent to evade natural immune protection also apply
to vaccine induced immunity. In cases where vaccine induced immunity character-
istics differ significantly from those produced by natural infection, an additional
state variable is typically included to represent individuals protected by the vac-
cine (for a useful introduction to models of mass vaccination see the review by
Scherer and McLean [2002]).
The simplest form of immunisation program is that of an untargeted blanket vac-
cination of a proportion of the total population. In this instance the vaccination is
applied to a random selection of individuals in the population regardless of which
state (experience of infection) they reside in. This is a particularly inefficient strat-
egy given that some individuals who have already attained a degree of immune
protection through natural infection, or who are currently infected, will receive
the vaccine to no effect. This approach can often be the only applicable strategy
given the frequent difficulties that arise with identifying an individual vaccinee’s
prior experience of infection (for example in cases of wild animal vaccination).
Figure 2.6: SIR Model With Birth Targeted Vaccination
One of the most common examples of a targeted vaccination strategy is to admin-
ister immunisation to a proportion of individuals at a particular age. This type of
program, typically employed for childhood immunisations such as the MMR, can
be easily implemented and monitored within a typical healthcare infrastructure.
The most simple realisation of this strategy for an SIR-type epidemic model is
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to assume that a proportion of all newborn individuals are vaccinated at birth.
Although in reality, vaccination is very rarely administered to neonates due to
complications associated with a highly immature immune system, this assumption
provides a useful approximation to situations where vaccination is targeted below
the average age of primary infection, without the otherwise necessary inclusion
of age dependency within the model. A strictly time domain description of this
strategy can therefore be implemented within the SIR framework structure (2.1)-
(2.4) by replacing the inflow of births, µN , into the susceptible compartment (2.1),
by an inflow of susceptibles, µN(1− Pv), and an inflow of vaccinated individuals,
µNPv, to the recovered compartment (2.3) (see Figure 2.6), where the parameter
Pv is the actual proportion of newborns that successfully take the vaccine and
develop immunity to infection.
Following either the introduction of an infectious agent (discussed in Section 2.1.2),
or the implementation of a birth targeted vaccination campaign, the corresponding
population is no longer completely susceptible, and the number of secondary cases
per primary case is subsequently described by RE = XR0. Considering the case
of a disease free population where I(t) = 0 and S(t) = N , vaccination serves to
reduce the proportion susceptible from X = 1 to X = 1− Pv (provided immunity
is solid and lifelong, for example in the case of the general SIR). Hence the effective
reproduction number becomes RE = (1− Pv)R0. Given that RE is required to be
greater than unity for an epidemic to occur, a potential pathogen invasion can be
prevented through vaccination provided the following inequality is achieved:
Pv ≥ 1− 1
R0
. (2.23)
The expression also provides a threshold for the eradication of an established
endemic infection and illustrates how diseases with a relatively low R0 such as
smallpox can be eradicated much more easily than those with a high R0 such as
measles. This concept is often referred to as herd immunity [Anderson, 1992] and
shows how population level protection against an infection can be achieved without
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necessarily vaccinating all individual hosts within it (see also the comprehensive
article by Nokes and Anderson [1988]).
2.2.1 Vaccination & Eradication Thresholds
The invasion threshold, which determines the basic reproduction number R0, and
the minimum vaccination threshold can both be derived from an eigenvalue anal-
ysis of the stability of the disease free equilibrium. Given that Pv ∈ [0, 1] is
a proportion, it can be seen from the expression for herd immunity (2.23) that
eradication of an SIR type infection is always possible provided 100% vaccination
coverage can be achieved. For the general SIR model with birth targeted vaccina-
tion (Figure 2.6), the disease free steady state of the reduced two state system is
found to be of the form:
 S
I
 =
 N(1− Pv)
0
 . (2.24)
The influence of vaccination on the stability of the disease free equilibrium can be
determined from the corresponding eigenvalues of the system Jacobian matrix:
Jacobian =
 −(µN + βI)/N −βS/N
βI/N βS/N − (µ+ v)
 , (2.25)
where the corresponding eigenvalues for the disease free equilibrium are: λ1 = −µ
and λ2 = β(1− Pv)− (µ+ v). It can then be seen that λ1 and λ2 are always real,
and from rearranging λ2, that the disease free steady state can be forced stable
(i.e. negative) if Pv ≥ 1− 1/R0, hence reiterating the condition for herd immunity
(2.23).
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SIRS Temporary/Waning Immunity
For the SIRS model (Figure 2.4), where acquired immunity serves only to pro-
tect individuals for a limited period of time, the system Jacobian matrix, when
evaluated at the corresponding disease free equilibrium, gives rise to the following
eigenvalues:
λ1 = −ωR − µ and λ2 = β [µ(1− Pv) + ωR]
ωR + µ
− (µ+ v). (2.26)
It can be seen that λ1 is always negative and real. However, the stability of λ2
is also dependent on the waning immunity parameter, ωR. Given that Pv = 1
indicates ideal 100% vaccination coverage, a new threshold term can be derived
that determines the maximum rate of loss of immunity before eradication of the
infection through vaccination becomes impossible. For the eradication of endemic
or potentially endemic infections (where R0 > 1) to be possible:
ωR <
µ
R0 − 1 . (2.27)
Provided the temporary immunity parameter, ωR, satisfies this condition, the crit-
ical vaccination coverage required to force the disease free steady state to be stable
and hence successfully eradicate the infection is found to be:
Pv >
(R0 − 1)(ωR + µ)
R0µ
. (2.28)
SIRp Partial Immunity
For the partial immunity model (Figure 2.5), when Pv = 1 the model structure can
be reduced to that of an SIS given that only secondary infections can occur. This
implies that for eradication to be possible, the corresponding basic reproduction
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number for the SIS submodel, σR0, must be less than unity, hence:
σ <
1
R0
. (2.29)
Provided σ does not exceed this threshold, the critical vaccination coverage re-
quired to eradicate the infection can be derived from the following eigenvalues,
evaluated again at the disease free equilibrium:
λ1 = −µ and λ2 = β [1− Pv(1− σ)]− (µ+ v). (2.30)
The critical vaccination coverage is therefore given by,
Pv >
(1−R0)
R0(σ − 1) . (2.31)
2.2.2 Consequences of Vaccination
It can be seen from an endemic steady state analysis of the discussed models that
the implementation of a mass vaccination campaign can have a significant effect on
the average age of infection [Nokes and Anderson, 1988]. A reduction in endemic
prevalence, Iˆ, and hence the force of infection, λ, will result in an increase in the
average time taken for newborn individuals to become exposed to and infected with
the disease, and therefore a rise in the average age at infection. The approximate
average age of infection for the general SIR model with birth targeted vaccination,
shown in Figure 2.6, can be derived as follows:
Av = λ
−1 =
N
βIˆ
=
L
R0(1− Pv)− 1 , (2.32)
where L = µ−1 is the average life expectancy at birth. The individual and pop-
ulation level implications of increasing the average age of infection can be varied
depending on the age-related nature of the clinical disease and any heterogeneity
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within the transmission function, β [Anderson and May, 1985]. If the severity of
clinical disease, or the primary route of transmission changes significantly within
this region, the resulting shift in the age distribution of infective individuals can
be both beneficial or detrimental to the success of the intervention. For example,
the risk of intrauterine infection in cases of congenital rubella increases signifi-
cantly with fertility. In this instance any notable benefit from reducing the overall
incidence of infection may be severely undermined by the increased risk of severe
disease arising from a greater distribution of cases among child bearing age classes
[Anderson and Grenfell, 1985; Knox, 1980].
It should also be noted that the implementation of public health campaigns with
the capability to significantly and rapidly reduce the proportion susceptible can
also result in significant rebound epidemics prior to a new endemic equilibrium
being reached [Scherer and McLean, 2002]. This occurs due to an initial period of
reduced incidence driven by the intervention, which allows for an unsustainable ac-
cumulation of susceptibles in excess of the epidemic threshold [Medley and Nokes,
2005]. The magnitude of the resulting epidemic behaviour may be particularly
pronounced if the perturbed system is highly oscillatory in nature.
2.3 Age Structure
In Section 2.1.3 it was discussed how transmission function properties associated
with human behaviour, c(t), and the probability of transmission, ρ(t), have been
frequently found to vary as a result of some seasonal forcing with respect to time.
However, significant heterogeneity in the transmission of infection can also occur
in the form of an age dependency of structured social and intimate mixing pat-
terns, and individual susceptibility/infectivity to circulating infection. The work
by Anderson and May [1983] argues for the better representation of heterogeneous
transmission patterns in epidemiological models, where the importance of this
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structure on transmission dynamics and vaccination design has since been illus-
trated in a number of high profile examples (see the work by Anderson and May
[1985] for measles and rubella, and Gupta et al. [1989] and Sattenspiel et al. [1990]
for HIV).
Age dependency may be included in epidemic model structures in one of two ways:
either discretely, as additional SIR type compartments that represent key age/risk
groups (see the worked example by Jacquez [1996]), or continuously as a system
of partial differential equations (PDE) (see Anderson and May [1985; 1991]). The
fundamental SIR model (2.1)-(2.4) is therefore extended to give the following set
of system equations:
∂S(t, a)
∂t
+
∂S(t, a)
∂a
= −[λ(t, a)+µd(a)]S(t, a), (2.33)
∂I(t, a)
∂t
+
∂I(t, a)
∂a
= λ(t, a)S(t, a)− [v(a) + µd(a)]I(t, a), (2.34)
∂R(t, a)
∂t
+
∂R(t, a)
∂a
= v(a)I(t, a)− µd(a)R(t, a), (2.35)
where
λ(t, as) =
1
N(as)
∫ ∞
0
β(t, as, ai) I(t, ai) dai, (2.36)
with boundary conditions given by:
S(t, 0) =
∫ ∞
0
µb(a)N(a) da, I(t, 0) = 0, R(t, 0) = 0. (2.37)
In this instance, the state variables correspond to (time dependent) age distribu-
tions of individuals within a given state of disease, where age dependent mortality is
described by µd(a) and the (age dependent) duration of infection is D(a) = 1/v(a).
The function β(t, as, ai) describes the transmission rate of infection from infectives
of age ai to susceptibles of age as, incorporating heterogeneous mixing and sus-
ceptibility/infectivity patterns among individuals of different ages, as well as a
potential dependency on time. It is assumed that the population as a whole is of
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constant size N (i.e constant net birth and mortality rates), and has a constant
age distribution with respect to time of the form:
N(a) =
N
L
e
−
∫ a
0
µd(z) dz
, (2.38)
where the average life expectancy is given by L = NS(t, 0)−1.
If the number of susceptible individuals becoming infective at age a (and time t) is
given by λ(t, a)S(t, a), then the average age of infection can be calculated from the
first moment of this distribution [Anderson and May, 1991], using the following
integral equation:
Av(t) =
∫ ∞
0
a λ(t, a)S(t, a) da∫ ∞
0
λ(t, a)S(t, a)da
. (2.39)
2.3.1 Heterogeneity & Basic Reproduction
In most applied situations the value of R0 is estimated as an average value taken
over an integer number of annual cycles, discounting any seasonal fluctuations in
contact patterns. Therefore, the transmission function β(as, ai) is a matrix that
represents average annual (age dependent) transmission rates. In cases with a long
duration of infection (i.e. if contact properties or mortality changes significantly
during the infectious period), the average number of individuals of age as that
contract the infection from a single individual infected at age ai, where S(a) =
N(a), during the interval [ai, ai + δai] is given by:
β∗(as, ai) = N(as)
∫ ∞
0
β(as, ai + u){1−Dai(u)}e
−
∫ ai+u
ai
µs(z) dz
du, (2.40)
where Dai(u) corresponds to the cumulative distribution function of the infectious
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period for an infective at age ai [Farrington et al., 2001]. Hence, if an infected
individual is introduced into a non-homogeneously mixing susceptible population,
the number of resulting cases (i.e. the initial growth of the invasion) will depend
on the age of the initial individual. It should also be noted that for cases with a
relatively short infectious period, β∗(as, ai) ≈ N(as)Dβ(as, ai).
According to the work by Diekmann et al. [1990], R0, now the number of expected
cases in a naive population arising from a single typical infective introduction, can
be defined as the dominant eigenvalue of β∗(as, ai). For details on the definition
of the effective reproduction number, R, in heterogeneous systems see the work by
Farrington and Whitaker [2003].
2.4 Model Validation and Empirical Data
As previously discussed, prospective mathematical model structures must be ap-
propriately validated in order to accurately relate to specific real world systems.
One key aspect of this process is often referred to as the ‘inverse problem’ [Jacquez,
1982], where internal model parameters are assigned numerical values correspond-
ing to an output that best correlates with experimental data. Epidemic models
such as those described in this work are based on processes of infection and are
regularly fitted to time series data collected from records of clinical disease, or
with respect to age in the form of age-stratified serological surveys. The main
epidemiological measures considered in this study are:
• Prevalence - the number of individuals within the population currently
presenting the infection, defined by y(t, a) = I(t, a).
• Incidence - current rate of emerging cases, for example, recorded as the
number of new cases within a given 4 week period, y(t, a) = λ(t, a)S(t, a).
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• Serology - a qualitative serological survey is used to determine prior ex-
perience of infection, implemented as y(t, a) = Ab+(t, a), where Ab+(t, a)
corresponds to all seropositive individuals, i.e. R(t, a).
It should be noted that all of these measures can, in principle, be recorded with
respect to both time and age. However, for infections that exhibit strong seasonal
epidemic patterns, steps must be taken to ensure the correction of any subsequent
distortion in the average age distribution resulting from inconsistent sampling
throughout the inter-epidemic period [Whitaker and Farrington, 2004]. The work
by Keeling and Grenfell [2000] suggests that ignoring the temporal variation in
these cases serves to underestimate values for R0.
2.4.1 Model Indeterminacy
An immediate problem concerning parameter estimation for infection based epi-
demic models arises from an inherently limited and often biased observation of
the full system state, where the main epidemiological measures typically allow
access to only the (clinically) infective and/or seropositive populations. Notifica-
tion of communicable diseases is often found to be incomplete and its bias due to
awareness, disease severity, perceived public health importance and social stigma
is notoriously difficult to quantify [Harpaz, 2004; Thacker et al., 1983].
In addition, the metrics of infection, disease and serology, although strongly in-
terdependent, are not necessarily concordant, and may depend incongruously on
risk factors such as age. This implies that observations arising from the detec-
tion of severe clinical symptoms or from the presence of disease specific antibodies
are often not accurately representative of circulating infection, and may therefore
distort any deductions that might be made from fitting the model to data.
Chapter 2 2.4 Model Validation and Empirical Data 29
In the study of hRSV it is found that the risk of severe lower respiratory tract
infections (LRTI) such as bronchiolitis and pneumonia, and resulting hospitali-
sation (typical source of time series data) decreases significantly with increasing
age. However, it is not known whether this susceptibility to disease is governed
by continuous physiological development (e.g. larger airways) or accumulative
immunological experience, or if this dependency correlates with that of suscepti-
bility to infection [White et al., 2005]. The vast majority of observable cases occur
in children under 12 months of age, but a potentially significant yet unknown
amount of subclinical reinfection is likely to circulate unobserved throughout the
wider population as well [Cane, 2001].
For simplicity it is typically assumed that observable disease is directly propor-
tional to infection, or at least infectivity, where, for example, the transmission
of many airborne respiratory infections are aided by the nature of their clinical
symptoms (e.g. coughing and sneezing). In these cases it is common to include
an unknown observation gain k (i.e. y(t, a) = kI(t, a)) that acts as a constant
scalar between predicted infection and real data. For hRSV it is often assumed
that susceptibility to disease decreases with prior experience of infection, whereby
hospital data is considered as a proportion of all primary infection (see examples
by Weber et al. [2001] and White et al. [2007]).
Further indeterminacy arises in age structured models when attempting to esti-
mate heterogeneous transmission characteristics and basic reproduction from sero-
logical survey data [Anderson and May, 1991]. The problem derives from the de-
pendency of R0 on the potentially infectious contact patterns represented by the
transmission function β(t, as, ai), whereby the rate of increase in seropositive in-
dividuals with age is indicative of the force of infection (i.e. rate that susceptibles
become infected, see equation (2.36)), but does not provide information relating to
which age classes the transmission of infection originates. This issue is addressed
in the work by Farrington et al. [2001] where relationships between the contact
patterns of different infections with similar routes of transmission are assumed thus
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allowing further elicitation of information regarding β(t, as, ai). Alternatively, the
work by Edmunds et al. [1997] documents the analysis of a questionnaire for the
direct determination of adult contact patterns associated with the spread of air-
borne infections. However, estimates such as this are unlikely to be sensitive to
many casual social interactions such as those in crowded public spaces. It should
also be noted that the indeterminacy issue becomes more intractable if the depen-
dency of individual susceptibility and infectivity is additionally considered with
respect to age.
2.5 Conclusions
Mathematical models of epidemiological systems are developed in order to inves-
tigate potential responses to critical input conditions and to gain a better under-
standing of the underlying physical processes that characterise observed system
behaviour. Population dynamics of infectious diseases are often explored through
the use of lumped compartmental models, where complex host-pathogen interac-
tions are generalised into common stages within the natural history of infection.
It has been shown throughout this chapter that a wide range of epidemiological
characteristics may be described and analysed within this framework, with varying
levels of complexity and application.
In order for postulated model structures to accurately describe the behaviour of
specific real world systems, they must be parameterised with respect to empirical
measurements under a known set of experimental conditions. Numerous examples
of epidemiological measures may be found throughout the literature, however,
these are typically based on records of clinical disease or serological surveys and
often provide only a very limited observation of the full system state. As a result,
issues of indeterminacy frequently arise in epidemic modelling, leading to poor
characterisation during data fitting. Formal methods to identify model indetermi-
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nacy are an essential prerequisite to parameter estimation and future experimental
design and are discussed in later chapters of this work.
Chapter 3
Models for Maternal & Early
Childhood Immunisation
The models presented in this chapter have been developed to investigate the pop-
ulation level influences of maternally acquired immunity on epidemic systems with
contrasting epidemiological characteristics and their potential response to pertur-
bation from mass maternal immunisation. It is intended that this work encourage a
more panoptic consideration of how prospective maternal and potentially conflict-
ing childhood vaccines might be optimally implemented within different dynamic
populations, and what the resulting impact of the intervention on broader system
behaviour might be.
Models are derived to study the potential outcomes and consequences of maternally
targeted intervention strategies, both in terms of their potential to reduce neonatal
morbidity and mortality from infection, and their effects on the static, dynamic
and seasonal characteristics of the system. The models are discussed in three
main structural forms: homogeneous time and age domain ordinary differential
equation (ODE) models (Sections 3.2 and 3.3.2), discrete age (continuous time)
structured ODE models (Section 3.4.1) and decoupled continuous age-time partial
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differential equation (PDE) models (Section 3.4.2), which are derived successively
from an encompassing general model framework described in (Section 3.2).
3.1 Background Biology
The human immune system is an extremely complex collection of biological mech-
anisms that continually acts to protect the individual against infection from ex-
ternal pathogens capable of causing damage and disease to the body [Janeway
and Travers, 2005]. Molecules that are found to induce a response in the immune
system are called antigens (antibody generators) and comprise of either (non-self)
foreign substances (such as bacteria, viruses and other microorganisms etc.) or
(self) cells belonging to the individual. The success of the immune system relies
heavily on its ability to distinguish between self and non-self elements; an abnor-
mal breakdown in this process can often lead to various autoimmune type disorders
where the immune system mounts an aberrant response on the individual’s own
cells and tissues. The system is generally divided into two staged components:
• Innate immune system - provides an immediate, but non-specific response
to infection. This includes anatomical barriers such as the desquamation of
epithelial surfaces, and mucosal secretions in the respiratory and gastroin-
testinal tracts.
• Adaptive immune system - antigen specific response that adapts to im-
prove the recognition and removal of a particular pathogen, resulting in
immunological memory.
The innate and adaptive components of the immune system are also both highly
dependent on a combination of cell-mediated and humoral reactions to infection.
The cell-mediated response involves the migration of white blood cells such as
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macrophages and natural killer cells around the body, and the activation of antigen-
specific cytotoxic T-lymphocytes (T-cells). In contrast, the humoral immune re-
sponse emanates from the secretion of antibodies (immunoglobulin) into the blood
and tissue fluids [Davies, 1997].
Antibodies (Ab) contribute to the immune function by binding to a specific anti-
gen, either tagging it for removal by the complement system, or neutralising its
ability to bind with target cells and cause infection. Antibodies also occur on the
surface of B-cell lymphocytes forming a B-cell receptor (BCR). When activated
by the presence of a corresponding antigen, these BCRs differentiate into either
plasma cells that produce large quantities of specific free antibodies, or memory
cells that survive for long periods of time and allow the system to respond more
rapidly to repeat exposures.
3.1.1 Maternally Acquired Immunity
During early life the neonatal immune function is highly immature, naive to infec-
tion and largely deficient in its ability to protect the individual against circulat-
ing pathogens. Adaptive components of the immune system are yet to be primed
through exposure to foreign antigens (which includes the absence of memory cells),
inhibiting its ability to react with the rapid antibody production synonymous with
a typical secondary immune response [Kemp and Campbell, 1996]. Newborns are
therefore acutely dependent on the accumulated immunologic experience of the
mother, which is conveyed in the specific form of immunoglobulin isotopes IgA
and IgG [Zinkernagel, 2001].
The majority of maternal IgG transfer occurs during the final four weeks of preg-
nancy, where antibodies actively enter foetal circulation by means of a specific
receptor-mediated mechanism via the placenta [Saji et al., 1999] and exceed ma-
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ternal concentrations by a ratio of around 1.2:1 - 1.8:1 at full term [Pitcher-Wilmott
et al., 1980; Sato et al., 1979]. The bulk of IgA is transferred after birth through
breast feeding and remains predominantly within mucosal secretions in the di-
gestive and respiratory tracts of the infant. Active components of the mother’s
immune system such as specific T-cells are unable to transfer protection to the in-
fant due to differences between maternal (self) and foetal (non-self) tissue antigens,
raising the possibility of an adverse response being mounted on the foetus.
Given that the bulk of transplacental maternal IgG is acquired so late in the ges-
tation period, concentrations of maternal antibodies (MAb) in premature infants
are considerably lower than that of full term infants [Costa-Carvalho et al., 1996],
further compromising immunity and significantly increasing the risk of inimical
infection. The work by Ballow et al. [1986] reports an average IgG concentration
for 28 week gestation infants of around 250 mg dL−1 compared to 1500 mg dL−1
for full term infants.
Immunoglobulin proteins are also ultimately short lived and, following birth, neona-
tal concentrations of maternally acquired serum IgG decay exponentially with age.
However, estimates for the rate of this clearance appear to vary enormously; half
lives of between 12 and 100 days are reported in the literature (see Table I in [Sar-
vas et al., 1993]). Several hypotheses exist regarding these inconsistencies such as:
measurement error, perhaps caused by damage to the IgG molecules from iodine-
labelling in work such as that by Waldmann and Strober [1969]; misinterpretation
of seroconversion due to infection [Ochola et al., 2009]; and variability in more
physiological characteristics such as endogenous synthesis, concentration depen-
dency of decay (due to saturatable recycling of antibodies through a finite number
of FcRn receptors), or rapid growth of the infant (increasing apparent volume of
distribution). At a population level, seroepidemiological surveys of common viral
infections such as those by Cox et al. [1998] and Hacimustafaoglu et al. [2004] for
hRSV, Williams et al. [1995] for measles and Nicoara et al. [1999] for MMR, have
shown that most infants become seronegative within 6-9 months of age.
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3.1.2 Maternal Immunisation
Despite the limited duration and inherently passive characteristics of MAb, the
magnitude of their afforded protection against a number of common viral and bac-
terial diseases is frequently reported. Studies such as those by Ogilvie et al. [1981]
and Hacimustafaoglu et al. [2004] for hRSV, and Puck et al. [1980] and Reuman
et al. [1987] for influenza A have demonstrated a strong correlation between high
cord antibody titres (a measure of serum antibody concentration (titre) taken from
the umbilical cord) and a reduced risk of infection among neonates. Similarly, the
administration of hRSV specific immunoglobulin prophylaxis to high-risk infants
and young children has produced a notable decrease in hospitalisation and severity
of disease [Dougherty and Meissner, 2000; Groothuis et al., 1993].
The implementation of a maternally targeted vaccine acts to augment these pro-
tective properties by inducing a complementary active immune response to immu-
nisation in the mother at around 30 weeks gestation. The immediate intention is
to raise maternally acquired serum IgG titres in newborns, hence providing passive
supplementary protection during the first few months of life [Munoz and Englund,
2000]. Additional benefits and demerits of this form of intervention include:
Advantages:
• Pregnant women respond well to vaccination and antibodies (IgG) are readily
transferred across the placenta.
• Intervention directly targets neonatal age classes, which are typically the
most susceptible to infectious diseases and least responsive to vaccines.
• Pregnant women tend to be regularly accessible through existing health care
infrastructure.
• Immunisation has the potential to protect both the infant and the mother.
Chapter 3 3.1 Background Biology 37
Disadvantages:
• Protection is less effectively conveyed to preterm infants who are likely to be
among those most requiring supplementary protection.
• Potentially limited efficacy in areas with high prevalence of infections such as
HIV and malaria, which can suppress the immune system, diminish placental
function and induce prematurity.
• High levels of MAb are likely to inhibit the immune response of young infants
to active childhood vaccines and natural infection.
• Many women are reluctant to accept vaccination during pregnancy due to
concern of associated risk to the foetus.
Maternal immunisation is of primary interest in cases where a significantly high
incidence of disease occurs in particularly young age classes, before immune system
maturation or the successful uptake of an appropriate childhood vaccine [van der
Zeijst et al., 2007]. As a result, intervention strategies of this nature are partic-
ularly applicable in developing contexts where high birth rates and infant trans-
mission skew the incidence age profile towards younger age groups, and neonatal
mortality due to infection is high [Greenwood, 2003]. Mass maternal immunisation
campaigns have already been successfully implemented in a number of developing
regions to reduce young infant mortality due to tetanus [WHO, 2002], where the
contribution of this infection to global neonatal mortality has subsequently been
reduced from 14% in 1993 to around 5% in 2002 [Vandelaer et al., 2003].
Further candidate infections for prospective control by maternal immunisation in-
clude Haemophilus influenzae type b (Hib) [Englund and Glezen, 2003; Mulholland
et al., 1996], pertussis (whooping cough) [Mooi and de Greeff, 2007], influenza [En-
glund, 2003; Sumaya and Gibbs, 1979; Zaman et al., 2008] and hRSV [Englund,
1994; Munoz et al., 2003] (for additional information see also the reviews by Munoz
and Englund [2000], Englund et al. [1998] and Healy and Baker [2006]).
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In cases where maternally acquired IgG has been shown to inhibit the infant re-
sponse to vaccine, work such as that by Williams et al. [1995] and Nicoara et al.
[1999] carefully target childhood immunisation at the peak age of susceptibility
(nadir in seropositivity) where as much exposure to natural infection is avoided as
possible, whilst also minimising ineffective interaction with maternally derived im-
munity. For example, with measles the (natural) average age at primary infection
is around 5-6 years and vaccination is therefore not routinely administered until
12-23 months of age [Williams et al., 1995].
However, in more developing settings where transmission rates among pre-school
children are often much higher, and with more virulent infections such as hRSV,
selection of an optimal age for vaccination is more difficult, often requiring strate-
gies that include multiple dosing. Studies such as those by Siegrist [2003] and
Crowe [2001] suggest that immunisation induced MAb can also inhibit childhood
targeted intervention, therefore increasing maternally derived immunity through
maternal immunisation may prove detrimental to this challenge.
3.2 General MSIR Model Framework
The structure of the general model framework is based on that of an MSIR com-
partmental system, where the natural history of infection includes an additional
state variable that corresponds to neonates and young infants protected by passive,
maternally acquired immunity [Anderson and May, 1991]. It is intended that the
complete model structure describe as much of our prior knowledge or hypotheses of
the underlying biological processes as possible, including the following significant
properties:
• Neonatal MAb protection - a degree of passively acquired (temporary)
immune protection is afforded to newborn infants, depending on the mother’s
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prior experience of infection and immunisation.
• Intervention - implementation of maternal and young infant targeted im-
munisation invokes an active immune response in the recipient.
• Age structure - complete model must be supportive of age dependency in
all parameters and state variables.
• Transmission - inclusive of separable mixing and varying susceptibility with
respect to age, and periodic seasonal forcing.
• Incomplete immunity - a range of outcomes following infection encom-
passing complete/incomplete immunity and potentially altered secondary
infection.
In reality, protective immunity z ∈ [0, 1] is a continuous property that tends to
increase with experience of infection or vaccination, and decrease with respect to
time since recovery. The work by White [2000] discusses the capture of these
characteristics in a PDE model framework where time, age and immunity are all
implemented as continuous independent variables. A possible, though highly in-
tractable implementation of this approach to the MAb problem can be illustrated
by the following expression for a subpopulation of newborns prior to natural in-
fection or vaccination:
∂S(t, a, z)
∂t
+
∂S(t, a, z)
∂a
− ∂ωM(z)S(t, a, z)
∂z
=
δ(a)
∫ ∞
0
µb(a)N(a, z)da− µd(a)S(t, a, z) (3.1)
− [σ(a, z)λ(t, a) + ϑ(a, z)V (t, a)]S(t, a, z),
where
λ(t, as) =
∫ ∞
0
β(t, as, ai)
∫ 1
0
γ(ai, z) I(t, ai, z) dz dai. (3.2)
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The protective effects of MAb and physiological development against circulating
infection are described by a reduced susceptibility parameter σ(a, z), which is de-
pendent on both age and passively acquired immunity. The subsequent attenuation
of vaccine uptake (from a vaccination programme V (t, a)) is included through the
function ϑ(a, z), and the waning of acquired immunity is governed by the param-
eter ωM(z). The distribution of acquired protection at birth is governed by that
of wider population immunity, N(t, a, z), and the application of an age dependent
fertility function µb(a), where the Dirac delta function, δ(a), ensures all newborns
are born at age zero. The force of infection λ(t, a) is representative of heteroge-
neous contact patterns determined by β(t, as, ai), an infectivity variable, γ(ai, z),
and the corresponding distribution of the infective population I(t, ai, z).
The solution to each state variable of the resulting system is therefore a two-
dimensional surface, characteristically an age serological profile, that is continu-
ously evolving with respect to time. Rigorous validation or even numerical evalu-
ation of such a system is found to be largely unmanageable and extremely compu-
tationally intensive [White, 2000]. Therefore in this work the continuous nature
of immunity is discretised according to distinct (compartmentalised) events in the
natural history of infection, i.e. maternally protected, susceptible, recovered etc.,
whereby fixed degrees of immunity are afforded to individuals depending on their
current state. A number of other common assumptions are made in order to con-
strain the scope and complexity of the problems addressed in this work. These
include:
• Constant population size and age distribution.
• No disease induced mortality.
• No vector or vertical routes of transmission.
• No latent incubation prior to becoming infectious.
• Maternally acquired immunity provides complete protection.
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These assumptions are considered to be appropriate since many of the infectious
agents currently being considered for maternal immunisation tend to evolve over
relative short time frames, are largely non-fatal and are not contracted before
birth or via non-human vectors. The inclusion of a latent incubation period prior
to becoming infectious, and a partial immunity stage due to the progressive waning
of MAb are natural extensions to the proposed model structure and are discussed
in later chapters as a suggestion for future research.
The general model is therefore defined as a continuous age-time PDE type struc-
ture, which is extended from that of the SIR model (2.33)-(2.37) described in
Section 2.3, to support the inclusion of MAb and epidemiological characteristics
associated with incomplete immunity and intervention (discussed separately in
Sections 3.3.1 and 3.3.2 respectively). The model is described by the following
system of partial integro-differential equations:
∂M(t, a)
∂t
+
∂M(t, a)
∂a
= −[ωM(a)+µd(a)]M(t, a), (3.3)
∂S(t, a)
∂t
+
∂S(t, a)
∂a
= ωM(a)M(t, a)−
[
λ(t, a)+µd(a)
]
S(t, a), (3.4)
∂I(t, a)
∂t
+
∂I(t, a)
∂a
= λ(t, a)S(t, a)− [v(a) + µd(a)]I(t, a), (3.5)
∂R(t, a)
∂t
+
∂R(t, a)
∂a
= v(a)I(t, a)− µd(a)R(t, a), (3.6)
where
λ(t, as) =
1
N(as)
∫ ∞
0
β(t, as, ai)I(t, ai) dai. (3.7)
The state variables M(t, a), S(t, a), I(t, a) and R(t, a) correspond to the distri-
bution with age of subpopulations classified as protected by maternally acquired
immunity, susceptible to circulating infection, currently infective and recovered at
time t, respectively.
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Age dependent functions for birth, µb(a), and mortality, µd(a), rates, average du-
ration of infection, v(a)−1, heterogeneous and potentially seasonal transmission,
β(t, as, ai), and population age distribution, N(a), are all congruent with those
described in Section 2.3. However, the boundary conditions for M(t, 0) and S(t, 0)
are subsequently amended in order to reflect the coupled dependency of mater-
nally acquired protection on the levels of immunity in the adult population. The
conditions are therefore given by:
M(t, 0) =
∫ ∞
0
µb(a)Ab
+(t, a) da, S(t, 0) =
∫ ∞
0
µb(a)Ab
−(t, a) da, (3.8)
where the variables Ab+(t, a) and Ab−(t, a) correspond to subpopulations of indi-
viduals grouped as either seropositive or seronegative, depending on their current
state of immunity. Given that M(t, a) and R(t, a) represent those protected by
high levels of maternal and post-infection acquired antibody, it is intuitive that
Ab+(t) = M(t) + R(t), where an appropriate age dependent fertility function,
µb(a), prevents the birth of newborns to infants protected by MAb. It is therefore
assumed that active immunity is acquired upon recovery from the infective state,
whereby mothers ‘currently infected’ at the time of giving birth do not transfer
protective levels of MAb to their offspring. This is a reasonable assumption to
make since adult IgG levels are typically found to peak at around 20 to 30 days
after the onset of clinical symptoms [Ogra, 2004]. Hence, the variables S(t) and
I(t) are considered seronegative, where Ab−(t) = S(t) + I(t).
A series of reduced model structures can then be derived from successive simpli-
fications of the general model, in order to aid analytical tractability of specific
system attributes with respect to the problem statement:
• Dynamics - seasonal and other time dynamic characteristics of the system
may be isolated by removing or compartmentalising age specific processes
within the system.
Chapter 3 3.3 Homogeneous MSIR Models 43
• Statics - age profile characteristics may be studied without the complexities
of time dependency by considering the system at a stable endemic equilib-
rium, and, if necessary, averaging across complete recurrent epidemic cycles.
• Decoupling - simplification through decoupling the dependency of passive
neonatal protection on adult infection dynamics allows the inclusion of a
more empirical model for the rate at which neonates lose maternally acquired
protection.
3.3 Homogeneous MSIR Models
The most fundamental realisation of the general MSIR framework can be derived
by neglecting the inclusion of age dependency in the model parameters and only
considering the system behaviour with respect to either time or age. In this in-
stance homogeneous and non-separable mixing is assumed regarding the transmis-
sion function β(t), and other epidemiological characteristics such as susceptibility
to infection are dependent entirely on immunological experience (i.e. history of in-
fection). Physiological properties attributed to varying age are therefore excluded
from the model.
Figure 3.1: MSIR Compartmental Model
Integrating the system equations (3.3)-(3.6) with respect to age (i.e. finding the
total number of individuals residing in each state of disease for time t):
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dM(t)
dt
= µb
∫ ∞
0
δ(a)Ab+(t, a) da− (ωM+µd)∫ ∞
0
M(t, a) da, (3.9)
dS(t)
dt
= µb
∫ ∞
0
δ(a)Ab−(t, a) da− (λ(t)+µd)∫ ∞
0
S(t, a) da, (3.10)
dI(t)
dt
= λ(t)
∫ ∞
0
S(t, a) da− (v+µd)∫ ∞
0
I(t, a) da, (3.11)
dR(t)
dt
= v
∫ ∞
0
I(t, a) da− µd
∫ ∞
0
R(t, a) da, (3.12)
where
λ(t) =
β(t)
N
∫ ∞
0
I(t, ai) dai, (3.13)
and the Dirac delta function, δ(a), terms replace the boundary conditions (3.8),
yields a more concise, single domain, time dynamic ODE model analogous to
that of a fundamental SIR given by (2.1)-(2.4) in Section 2.1. The fundamental
MSIR, shown in Figure 3.1, is therefore described by the following set of ordinary
differential equations:
M˙(t) = µAb+(t)− [ωM + µ]M(t), M(0) = M0, (3.14)
S˙(t) = µAb−(t) + ωMM(t)− β(t)
N
S(t)I(t)− µS(t), S(0) = S0, (3.15)
I˙(t) =
β(t)
N
S(t)I(t)− (µ+ v)I(t), I(0) = I0, (3.16)
R˙(t) = vI(t)− µR(t), R(0) = R0, (3.17)
where ωM depicts the rate at which maternally protected newborns lose passive
immunity through natural antibody clearance and become fully susceptible to
infection.
Overall net birth and death rates are equal, i.e. µb = µd = µ, hence a constant
size population is maintained. As before, individuals are born either maternally
protected or fully susceptible, at rates µAb+(t) and µAb−(t), respectively, depend-
ing on the previous infection experience of the mother. It should be noted that in
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the general model (3.3)-(3.8) the inclusion of age dependent fertility prevents the
unlikely event of babies born to maternally protected mothers. However, in the
homogeneous model, where the fertility function, µ, is a constant, this becomes a
consequential characteristic of the reduced system.
In the most simple case, where total net birth/death rate is µN and Ab+(t) =
M(t) + R(t), the inflow of passively protected newborns from mothers with high
levels of MAb is cancelled by neonatal mortality. Therefore if both fertility and
mortality from the maternally protected population M(t) are neglected, where
the net birth/death rate becomes µ(N −M(t)), the time domain model remains
structurally equivalent.
Alternatively, if neonatal mortality is included and births from MAb protected
mothers is removed, the seropositive/seronegative variables can be proportioned
such that:
Ab+(t) =
R(t)
N −M(t)N and Ab
−(t) =
S(t) + I(t)
N −M(t) N, (3.18)
where Ab+(t) + Ab−(t) = N , hence maintaining balanced inflows (µAb+(t) +
µAb−(t)) and outflows (µN), and a constant population size N .
Choice of input structure is therefore determined by the characteristics of the stud-
ied population; in developed countries it is found that infant mortality (under 1
year of age) is typically below 1%, making the neglection of µM(t) a more reason-
able description. However, in developing regions where death rates among young
infants is often much higher, the proportioned fertility model may be more appro-
priate. In both cases the coupled nature of MAb dependence on adult immunity is
preserved, however analytic analysis of the latter (inclusive of neonatal mortality)
can become considerably more complex.
The acquisition of MAb serves to protect seropositive newborns for an average du-
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ration given by ω−1M , whereby the average age at primary infection is dependent on
both the force of infection and the number of infants born with passively acquired
immunity. For an MSIR system residing at a fixed point endemic equilibrium, the
average age at primary infection can be approximated by the expression:
Av ≈ Ab
+
N
(ω−1M + λ
−1) +
Ab−
N
(λ−1), (3.19)
which is derived from a weighted average corresponding to the respective propor-
tions of seropositive/seronegative newborns. The expression (3.19) is an approx-
imation to the actual value predicted by this model as it does not account for
the effects of mortality and the resulting (exponentially decaying) age distribu-
tion assumed by its structure. It can be seen that increased population immunity,
due to a high force of infection, acts antagonistically against a low average age of
contraction synonymous with high levels of exposure.
3.3.1 Incomplete Immunity
Candidate cases for maternal immunisation generally correspond to systems where
there is a significant prevalence of infection among neonates in the first few months
of life, close to the average duration of MAb. A particularly low average age at
primary infection is likely to be driven by a high force of infection, suggesting either
very high infant transmission or sub-optimal immunity and significant reinfection
throughout the wider population. Intuitively, the corresponding influence of MAb
over wider system dynamics is likely to crucially depend on the age distribution of
population level infectivity, i.e. the relative contributions of primary (potentially
influenced by MAb) and secondary (all subsequent) infection, in addition to the
average age of primary challenge.
However, recalling the issues of indeterminacy with hRSV (see Section 2.4.1), it is
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not always clear whether primary or subsequent reinfection dominate the behaviour
of the system. It is known that a significant level of subclinical reinfection exists
throughout the wider population [Falsey et al., 2006], but its likely contribution
to the total force of infection (or that acting on the neonatal age group) is yet to
be confidently established. As a result, two limiting hypotheses exist regarding
the relationship between observed (disease) dynamics of hRSV and maternally
acquired immunity:
• Neonatal MAb levels may be an insignificant consequence of dominant adult
infection dynamics, whereby they provide protection to only a negligible
proportion of the total population and are therefore unlikely to influence the
system as a whole.
• Conversely, if the majority of secondary subclinical infection does not result
in high infectivity and frequent antibody boosting occurs largely as a result of
exposure to primary infected infants, then MAb may be a significant driving
force in the availability/supply of susceptibles and therefore the time course
of the infection.
The MSIRS2 model structure, shown by the connectivity diagram in Figure 3.2,
has been derived in order to delineate the continuum of system characteristics
between these two extremes and to examine the potential influence of MAb as the
dominance of infectivity is varied within this domain. This approach is similar to
that described by White et al. [2007], and Greenhalgh et al. [2000], who explore
the consequences of altered secondary infection on the transmission dynamics and
equilibrium characteristics of human and bovine RSV. The MSIRS2 model is also
structurally similar to the more expansive MSEIRS4 model proposed in the work
by Weber et al. [2001] (see Appendix A), where the objective was to include
additional realism relating to processes of temporary and accumulating immunity
consistent with observations from a number of longitudinal studies.
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Figure 3.2: MSIRS2 Incomplete Immunity Model
In accordance with clinical observation [Falsey et al., 2006; Hacimustafaoglu et al.,
2004], passive and actively acquired immunity are assumed to wane at different
rates, where the average duration of protection is given by ω−1M and ω
−1
R , respec-
tively. In an analogous manner to the work by Weber et al. [2001], maternally pro-
tected neonates lose immunity and become fully susceptible, S1(t), to circulating
infection, whereas recently recovered individuals become only partially susceptible,
S2(t), due to a degree of immunological memory. This subsequent reduction in the
risk of infection is governed by the parameter σ ∈ [0, 1], by means of a similar
process to that of the SIRp example described in Section 2.1.4.
Secondary infection, I2(t), is assumed to be less severe than primary infection,
I1(t) [Ogra, 2004], with a shorter duration v
−1
2 < v
−1
1 and reduced infectivity
(viral shedding) γ ∈ [0, 1] [Hall et al., 1991]. Therefore the parameters σ and γ
can be varied in order to govern the dominance of primary and repeat infectivity
within the population. The model is defined by the following system of ordinary
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differential equations:
M˙(t) = µAb+(t)− [ωM + µ]M(t), M(0) = M0, (3.20)
S˙1(t) = µAb
−(t) + ωMM(t)−
[
λ(t) + µ
]
S1(t), S1(0) = S
0
1 , (3.21)
I˙1(t) = λ(t)S1(t)−
[
µ+ v1
]
I1(t), I1(0) = I
0
1 , (3.22)
R˙1(t) = v1I1(t) + v2I2(t)−
[
µ+ ωR
]
R1(t), R1(0) = R
0
1, (3.23)
S˙2(t) = ωRR1(t)−
[
µ+ σλ(t)
]
S2(t), S2(0) = S
0
2 , (3.24)
I˙2(t) = σλ(t)S2(t)−
[
µ+ v2
]
I2(t), I2(0) = I
0
2 , (3.25)
where
λ(t) =
β(t)
N
[
I1(t) + γI2(t)
]
. (3.26)
The seropositive variable Ab+(t) = M(t) + R1(t) includes individuals who have
recently recovered from an immunising infection and those protected by high levels
of MAb. Individuals considered to be seronegative, where Ab−(t) = S1(t)+I1(t)+
I2(t)+S2(t) (i.e. N = Ab
−(t)+Ab+(t)), include those fully or partially susceptible
and currently infective. It can also be noted that the incomplete immunity model
is a generalisation of the fundamental MSIR, whereby setting ωR = 0, i.e. fully
protective immunity from experience of infection no longer wanes with time, the
model becomes equivalent to that given by (3.14)-(3.17).
3.3.2 Maternal Immunisation Models
In accordance with the biological description of the intervention in Section 3.1.2,
mass maternal immunisation is applied to a proportion, Pm, of the total net birth
rate, µN , whereby an additional influx of newborns from low immunity mothers,
given by µPmAb
−(t), are born maternally protected, M(t), instead of fully suscep-
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tible, S1(t) (see Figure 3.3). It is assumed that the mother’s immune response to
the vaccine is actively protective, i.e. the same as that for natural infection, hence
the function µ Pm Ab
−(t) also corresponds to the net rate at which seronegative
pregnant women are immunised and subsequently move into the protected state
R1(t).
Figure 3.3: MSIRS2 Maternal Immunisation Model
However, a degree of ambiguity exists over the exact implementation of the ac-
tive response in the model due to the difference in time at vaccine administration
and duration of full term (around 30 and 37 weeks gestation respectively). To
avoid the introduction of complex delay functions and gender structure, it is in-
tuitive to assume that vaccination is actively applied at the time of birth and is
instantly transferable to the newborn, although this is arguably a contradiction to
the prior assumption that mothers who are infective at this time do not transfer
any subsequent immunity to their offspring. Mathematically this discrepancy is
only significant when considering the application of the vaccine to I1,2(t), where im-
munised infectives (in reality vaccinated several weeks before giving birth) should
not have contracted the infection during that time. Given that the target popu-
lation for the vaccine (i.e number of pregnant woman) is realistically a very small
proportion of N , it is anticipated that this is a reasonable simplification to make.
Therefore the following set of system equations can be extended from those given
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in (3.20)-(3.25):
M˙(t) = µ
[
Ab+(t)+PmAb
−(t)
]− [ωM+µ]M(t), (3.27)
S˙1(t) = µ(1−Pm)Ab−(t) + ωMM(t)−
[
λ(t)+µ(1+Pm)
]
S1(t), (3.28)
I˙1(t) = λ(t)S1(t)−
[
v1 + µ(1+Pm)
]
I1(t), (3.29)
R˙1(t) = µPmAb
−(t) + v1I1(t) + v2I2(t)−
[
ωR+µ
]
R1(t), (3.30)
S˙2(t) = ωRR1(t)−
[
σλ(t) + µ(1+Pm)
]
S2(t), (3.31)
I˙2(t) = σλ(t)S2(t)−
[
v2 + µ(1+Pm)
]
I2(t). (3.32)
It is assumed that maternally immunised newborns incur only the same passive
protection as those born to naturally immune mothers and that no extra immunity
is afforded to those already seropositive. All infants protected by natural and
vaccine induced MAb (except those who succumb to infant mortality) ultimately
become fully susceptible to infection and do not acquire (active) lasting immunity
until they have independently experienced primary infection.
3.3.3 Interacting Childhood Vaccination
Young infant targeted vaccination can be simplified to that of the birth targeted
model described in Section 2.2. A proportion, Pv, of either all newborns, µN (if
the vaccine does not immunologically interact with MAb), or only the offspring
of low immunity mothers, µAb−(t) (if MAb completely inhibits vaccine response),
are born into a protected or partially protected state, bypassing primary infection.
The degree of interaction between the two vaccines is governed by the parameter
ϑ ∈ [0, 1], whereby a proportion (1 − ϑ)Pv of maternally protected newborns
successfully respond to an administered childhood immunisation. The system can
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then be described by the following set of differential equations:
M˙(t) = µ(1−(1−ϑ)Pv)
[
Ab+(t)+PmAb
−(t)
]− [ωM+µ]M(t), (3.33)
S˙1(t) = µ(1−Pv)(1−Pm)Ab−(t) + ωMM(t)−
[
λ(t)+µ(1+Pm)
]
S1(t), (3.34)
I˙1(t) = λ(t)S1(t)−
[
v1 + µ(1+Pm)
]
I1(t), (3.35)
R˙1(t) = V (t) + v1I1(t) + v2I2(t)−
[
ωR+µ
]
R1(t), (3.36)
S˙2(t) = ωRR1(t)−
[
σλ(t) + µ(1+Pm)
]
S2(t), (3.37)
I˙2(t) = σλ(t)S2(t)−
[
v2 + µ(1+Pm)
]
I2(t), (3.38)
where
V (t) = µ (1− ϑ) Pv
[
Ab+(t) + PmAb
−(t)
]
+
µ Pv(1−Pm)Ab−(t) + µ PmAb−(t).
(3.39)
A potential limitation of this model arises again from the omission of age struc-
ture, this time with respect to fertility. It can be seen that vaccinated newborns
immediately contribute to the birth rate of maternally protected babies, where
in reality the peak age of fertility is predominantly in early adulthood. This as-
sumption may lead to an over estimation of the impact of active intervention on
maternally acquired immunity, particularly in cases where the relative duration of
active immunity is short.
3.3.4 Age Domain Models
If instead the reduced (non age-structured) general PDE model is considered at
endemic equilibrium (steady state variables denoted by Xˆ) and integrated with
respect to time, for example over τ complete annual cycles (to find the average
number of individuals residing in each state of disease for a given age a), then the
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following system of age domain integro-differential equations can be derived:
dM(a)
da
=
µδ(a)
τ
∫ τ
0
Ab+(t, a) dt− (ωM+µ)1
τ
∫ τ
0
M(t, a) dt, (3.40)
dS(a)
da
=
µδ(a)
τ
∫ τ
0
Ab−(t, a) dt− 1
τ
∫ τ
0
(
λ(t)+µ
)
S(t, a) dt, (3.41)
dI(a)
da
=
1
τ
∫ τ
0
λ(t)S(t, a) dt− (v + µ)1
τ
∫ τ
0
I(t, a) dt, (3.42)
dR(a)
da
=
v
τ
∫ τ
0
I(t, a) dt− µ
τ
∫ τ
0
R(t, a) dt, (3.43)
where
λ(t) =
β(t)
N
∫ ∞
0
I(t, ai) dai, (3.44)
If the transmission function β does not vary with time, or if some seasonal average
value is assumed, then the equations (3.40)-(3.44) reduce to a linear ODE model
of the form:
dM(a)
da
= −(ωM + µ)M(a), M(0) = µ ˆAb+, (3.45)
dS(a)
da
= ωMM(a)−
( β
N
Iˆ + µ
)
S(a), S(0) = µ ˆAb−, (3.46)
dI(a)
da
=
β
N
IˆS(a)− (µ+ v)I(a), I(0) = 0, (3.47)
dR(a)
da
= vI(a)− µR(a), R(0) = 0, (3.48)
where the following analytic solutions may be found:
M(a) = µ ˆAb+e−a(µ+ωM ), (3.49)
S(a) =
µe−a(µ+λ)
(
ˆAb−(λ− ωM) + ωM ˆAb+(ea(λ−ωM ) − 1)
)
λ− ωM . (3.50)
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However, if the transmission function β(t) is explicitly dependent on time, then
the incidence age profile is calculated to be of the form:
1
τN
∫ τ
0
β(t) S(t, as)
∫ ∞
0
I(t, ai) dai dt, (3.51)
whereby for seasonal systems there is inevitably some residual time dependency
in the age profile, requiring the full PDE system to be solved.
3.3.5 Preliminary Model Analysis
In the following section a general steady state analysis is performed on a number of
the non age-structured MSIR models discussed so far. The models are compared
to the basic SIR framework described in Section 2.1, the vaccination models in
Section 2.2 and to each other, in order to assess the relative implications of their
structural forms.
Standard MSIR
The basic MSIR structure, given by equations (3.14)-(3.17), can be derived from
the encompassing incomplete immunity model (3.20)-(3.25) by setting ωR = 0, i.e.
an infinite duration of immunity following primary infection, and ensuring that the
initial conditions S02 , I
0
2 = 0. Setting these differential equations equal to zero and
through simple algebraic manipulation it can be shown that two equilibrium points
exist, corresponding to either extinction (disease free) or endemic persistence of
the invading pathogen. The disease free steady state, given by:
Mˆ = 0, Sˆ = N, Iˆ = 0, Rˆ = 0, (3.52)
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is equivalent to that of the basic SIR (2.8), and through an eigenvalue analysis of
the resulting Jacobian matrix:
λ1 = −µ, λ2 = −ωM , λ3 = β−(µ+v), (3.53)
is also found to adhere to the same conditions for stability (i.e. the stability condi-
tion R0 < 1 gives rise to an invasion threshold at R0 = 1). The endemic susceptible
population Sˆ is again found to be the same as that for a system without maternally
acquired protection, as shown by the corresponding equilibrium expression:
Mˆ =
Nvµ(β−(µ+v))
β(µωM+v(µ+ωM))
, Sˆ =
N(µ+v)
β
, Iˆ =
ωM
v
Mˆ, Rˆ =
ωM
µ
Mˆ, (3.54)
implying that in an analogous manner to birth targeted vaccination, natural im-
munity attributed to MAb has no static influence over the number of susceptibles
in a population already supporting an endemic infection. The endemic prevalence
Iˆ and the proportion recovered Rˆ are however found to be dependent on ωM , and
subsequently differ from that of the basic SIR. Given that all parameters are pos-
itive and R0 > 1, an increase in the duration of MAb (i.e. a decrease in ωM) can
only result in a greater proportion of the population residing in Mˆ , and hence a
smaller proportion currently infective or recovered.
This is an interesting result as it suggests that maternally acquired immunity has
the capability to reduce population level infection despite the passivity of MAb
(i.e. all maternally protected neonates ultimately become fully susceptible). It can
be deduced that this reduction in prevalence is due to an additional proportion
of the population being immune to circulating pathogens and the subsequent loss
of infants who do not survive the background death rate before contracting an
infection. However, from an eigenvalue analysis at the corresponding system equi-
librium (3.53) it can be seen that there is no possible value of ωM that will give rise
to otherwise unconditional stability of the disease free steady state. This infers
that there is no duration of MAb that can lead to eradication of the pathogen as
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population immunity diminishes with reducing levels of infection.
The number of protected neonates is also strongly dependent on the nature of
population net birth/mortality rates, where an increase in µ leads to a larger Mˆ
and subsequently accentuates the resulting reduction in Iˆ. This reiterates the
hypothesis that MAb may be more influential in developing regions where there
are likely to be higher birth and infant mortality rates, and additionally an age
distribution skewed towards young infant age classes.
The approximate average age at primary infection predicted by the standard time
domain MSIR model can be found explicitly in terms of its parameters by recalling
equation (3.19) and substituting endemic steady state values from (3.54) (note also
λˆ = βIˆ/N):
Av ≈ Mˆ(µ+ωM)
Nµ ωM
+
Nv(v+µ)
Mˆβ2ωM
+
µ ωM + v(µ+ ωM)
βµ ωM
. (3.55)
Taking the first derivative of this function with respect to ω−1M , and providing
[β, ωM , v, N, µ] > 0, R0 > 1, it can be shown that:
d Av
d ω−1M
≥ 0, (3.56)
implying that an increase in the duration of MAb can only result in an increase
in the average age at primary infection.
It should be noted that a more detailed illustration of this characteristic may also
be shown using the age domain realisation (3.45)-(3.48) described in Section 3.3.4.
In this instance the analytic solution for S(a), given by (3.50), is substituted into
the general expression for the average age of infection given by (2.39).
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MSIR with Maternal Immunisation
Setting the parameters ωR, S
0
2 and I
0
2 equal to zero in equations (3.27)-(3.32),
i.e. reducing the model to that of the basic MSIR (3.14)-(3.17) with maternal
immunisation, the following disease free equilibrium can be found:
Mˆ =
2PmµN
θ
, Sˆ =
NωM
θ
, Iˆ = 0, Rˆ =
PmωMN
θ
, (3.57)
with common denominator,
θ = ωM + Pm(2µ+ωM).
It can be seen that the distribution of individuals throughout a naive, disease free
population is governed by the parameters Pm, µ and ωM , where Mˆ + Sˆ + Rˆ = N .
Increasing the amount of maternal immunisation, Pm, reduces the proportion of
individuals susceptible to infection, and consequently increases the proportion of
those both passively and actively protected. An interesting outcome of this analysis
can be found in the numerators of the expressions for Mˆ and Rˆ, where the relative
contributions of neonatal and maternal immunity to the reduction in population
susceptibility is seen to be dependent on the differential magnitudes of µ and ωM .
Inevitably the average duration of MAb is considerably less than life expectancy
(2µ << ωM), hence Mˆ << Rˆ, inferring that lifelong active immunisation is a
considerably more effective population level intervention.
The disease free eigenvalues of the system are found to be expressed by the fol-
lowing parameter combinations:
λ1 = −µ(Pm+1)− v1 + βωM
Pm(2µ+ ωM) + ωM
, (3.58)
λ2,3 = −1
2
(
µ(1 + 2Pm) + ωM ±
√
µ2(1−2Pm)2 − 2µωM + ω2M
)
,
where λ1 indicates that increasing Pm subsequently alters the stability character-
Chapter 3 3.3 Homogeneous MSIR Models 58
istics of the disease free equilibrium (i.e. the effective reproduction number). In
contrast to the standard MSIR model this suggests that it is in some cases theoret-
ically possible to eradicate an infection through mass maternal immunisation. The
condition for possible eradication is calculated in terms of the basic reproduction
number (2.5) by substituting complete vaccination coverage Pm = 1 into λ1, giving
rise to the inequality:
R0 <
2(2µ+ v)(µ+ ωM)
µ+ v
. (3.59)
The second and third eigenvalues can be seen to become complex under certain
parameterisations, leading to oscillatory behaviour. However, given that Pm ∈
[0, 1] and 2µ << ω this is generally not the case.
The endemic equilibrium is found to be given by the following expressions:
Mˆ =
µN
[
(Pm−1)v2 + 2Pmβµ+ v
(
β + (P 2m−1)µ
)]
β
[
v(µ+ωM) + µ
(
ωM + Pm(2µ+ ωM)
)] ,
Sˆ =
N(µ(Pm+1)+v)
β
.
(3.60)
The model predicts that the introduction of maternal immunisation, Pm, will result
in an increase in the proportion of the population protected by MAb and a decrease
in the prevalence of infection. In this instance, the average age at primary infection
can be approximated by the following form:
Av ≈ Mˆ + Rˆ+Pm(Sˆ + Iˆ)
N
(ω−1 + λ−1) +
(1−Pm)(Sˆ + Iˆ)
N
(λ−1), (3.61)
where the average age is seen to increase with greater levels of maternal immuni-
sation.
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MSIRS Temporary/Waning Immunity
The effects of temporary/waning immunity resulting from natural infection can
be explored by setting σ = 1, γ = 1 and v = v1 = v2 in equations (3.20)-(3.26),
whereby secondary infection characteristics are considered to be identical to that
of primary infection. Susceptible and infective states can then be combined such
that: S(t) = S1(t) +S2(t) and I(t) = I1(t) + I2(t), giving rise to a model structure
analogous to that of the SIRS described in Section 2.1.4. The disease free steady
state remains the same as that of the SIR and MSIR systems (3.52), and the
resulting endemic equilibrium is given by:
Mˆ = µNv θ, Sˆ =
N(µ+v)
β
, Iˆ = ωMN(µ+ωR) θ, Rˆ = ωMNv θ, (3.62)
where
θ =
β − (µ+v)
β
(
ωM(µ+ωR) + v(µ+ωM)
) .
Comparing the expressions in (3.62) with those in (3.54) reiterates the result that
waning of active immunity acts to raise endemic prevalence (force of infection)
within a population through a reduction in the number of individuals currently
protected from infection. Consequently the number of newborns protected by MAb
is also reduced, thus through a combination of this and a higher force of infection,
a short duration of immunity can significantly lower the average age at primary
challenge.
3.4 Age Structured MSIR Models
It is the intention of this work to use a continuous PDE type age structured model
(see the book by Anderson and May [1991]) to assess the impact of MAb on the
distribution of primary infection incidence. This is attempted using the general
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MSIR model (3.3)-(3.8) described in Section 3.2. However, models that include
both time and age as continuous independent variables are inherently complex
to rigorously analyse. Therefore an intermediate, discretised age structure is also
proposed in order to ease analytical tractability.
3.4.1 Discrete Age Structure
In discrete age-structured models the key characteristics of heterogeneous mixing
patterns are lumped together in distinct (homogeneously mixed) age classes with
common epidemiological properties associated with infection [Farrington et al.,
2001]. The age classes are divided according to known characteristics of transmis-
sion, such as higher transmissive contact rates of respiratory viruses among school
aged children or of sexually transmitted infections among young adults. This ap-
proach also allows for a more realistic inclusion of birth and mortality functions
and potentially the influence of physiological development on susceptibility and
infectivity.
Figure 3.4: Discrete Age Model Structure
In this instance the transmission function β(t) becomes an n × n matrix, often
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referred to as a ‘who acquires infection from who’ matrix, that describes the trans-
missive interaction of individuals between n discretised age groups. Each element
βij(t) denotes the rate of transmission arising from contacts between susceptibles
residing in age class i and infectives in age class j. The process of progressive
ageing throughout the model structure is included by means of a linear coefficient
decay parameter ki (see Figure 3.4) that describes the rate at which individuals
mature and leave a particular age class i, where k−1i corresponds to the age-span
of the group.
The set of ordinary differential equations describing an MSIR type model with n
discrete age classes can be expressed as follows:
M˙1(t) = UAb+(t)−
(
ωM1 + µd1 + k1
)
M1(t), M1(0) = M
0
1 , (3.63)
S˙1(t) = UAb−(t) + ωM1M1(t)−
(
λ1(t) + µd1 + k1
)
S1(t) S1(0) = S
0
1 , (3.64)
I˙1(t) = λ1(t)S1(t)−
(
v1 + µd1 + k1
)
I1(t), I1(0) = I
0
1 , (3.65)
R˙1(t) = v1I1(t)−
(
µd1 + k1
)
R1(t), R1(0) = R
0
1, (3.66)
M˙i(t) = ki−1Mi−1(t)−
(
ωMi + µdi + ki
)
Mi(t), Mi(0) = M
0
i , (3.67)
S˙i(t) = ki−1Si−1(t) + ωMiMi(t)−
(
λi(t) + µdi + ki
)
Si(t) Si(0) = S
0
i , (3.68)
I˙i(t) = ki−1Ii−1(t) + λi(t)Si(t)−
(
vi + µdi + ki
)
Ii(t), Ii(0) = I
0
i , (3.69)
R˙i(t) = ki−1Ri−1(t) + viIi(t)−
(
µdi + ki
)
Ri(t), Ri(0) = R
0
i , (3.70)
where
i = {2, . . . , n}, kn = 0, λi(t) =
n∑
j=1
βij(t)Ij(t).
In the general case all model parameters are allowed to vary with age, supporting
heterogeneity in transmission, fertility and mortality. The population net birth
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and death rates are balanced to ensure constant population size N and distribution
{Ni, . . . , Nn} with respect to age:
µN =
n∑
i=1
µbiNi =
n∑
i=1
µdiNi, (3.71)
where the population sizes for each age class are found to be:
N1 =
µN
µd1 + k1
, Ni = µN
i−1∏
j=1
kj
i∏
j=1
(
µdj + kj
) for i = {2, . . . , n}. (3.72)
The corresponding influxes for seropositive and seronegative newborns are then
defined according to the number of individuals currently immune such that:
UAb+(t) =
n∑
i=1
µbi
[
Mi(t) +Ri(t)
]
(3.73)
UAb−(t) =
n∑
i=1
µbi
[
Si(t) + Ii(t)
]
, (3.74)
where individuals are born into the youngest age class.
Basic Reproduction Number
As discussed in Section 2.3.1 the average transmission function βij corresponds
to an n× n matrix, where the basic reproduction number is subsequently defined
as the average number of expected cases arising from a single typical infective
introduction into an otherwise naive population. Recalling the expression for R0
(2.5), and neglecting movement of infectives due to ageing, the basic reproductive
growth in age class i emanating from a single infective individual residing in age
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class j can be given by:
R0 =

β11N1D1 β12N1D2 . . . β1nN1Dn
β21N2D1 β22N2D2 . . . β2nN2Dn
...
...
. . .
...
βn1NnD1 βn2NnD2 . . . βnnNnDn
 , (3.75)
where Di = (µdi+vi)
−1 corresponds to the average duration an individual remains
infective.
Unfortunately, the derivation of an appropriate, single value for R0 that describes
the invasion threshold and the initial growth rate for the whole system cannot be
achieved through simple averaging of the individual components in equation (3.75).
Following the method documented by Diekmann et al. [1990], the progression of
an epidemic system may be considered in terms of generations, where each new
generation, φg+1, is found by applying an n × n matrix reproduction function,
K, to the current generation, φg. Each generation of infectives is represented by
an n-dimension vector, φ, showing their distribution throughout the different age
classes in the model:
φg = Kφg−1 = K2φg−2 = . . . = Kgφ0, (3.76)
where in the early stages of an epidemic the reproductive function K can be
assumed to be the matrix R0 (3.75).
If, for example, K = R0 is a 2 × 2 matrix (signifying a model structure with two
discrete age classes), with two distinct real eigenvalues λ1 and λ2, and it is known
that λ1 > 0 is the dominant eigenvalue, i.e. λ1 > |λ2|, then ψ(1) and ψ(2) are
corresponding eigenvectors from which any vector x ∈ R2 can be expressed as a
linear combination:
x = c1ψ
(1) + c2ψ
(2), (3.77)
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where
Kx = c1λ1ψ
(1) + c2λ2ψ
(2), (3.78)
and subsequently
Kgx = c1λ
g
1
[
ψ(1) +
c2
c1
(
λ2
λ1
)g
ψ(2)
]
. (3.79)
Given that |λ2/λ1| < 1 and provided c1 6= 0, then the second term in (3.79) will
tend to zero as the number of generations g →∞, effectively reducing (3.79) to:
Kgx ∼ c1λg1ψ(1). (3.80)
The basic reproduction number for the overall system can therefore be quoted as
the dominant eigenvalue λ1, given that λ1 > 1 results in exponential growth and
λ1 < 1 results in exponential decay, thus describing the invasion threshold for a
completely susceptible population. It can also been noted that the influence of the
initial condition is restricted to the value of c1.
3.4.2 Continuous Age Structure
An alternative approach to modelling the effects of MAb on the average age pro-
file of primary incidence is to consider a more empirical representation of the rate
at which the neonatal population loses passively acquired immunity. The process
is implemented as a simplification to the continuous immunity model (3.1)-(3.2),
proposed in Section 3.2, where the acquisition of protective MAb is decoupled
from wider adult infection/immunity dynamics. This may be appropriate for sys-
tems where high titres of disease specific neutralising antibodies are ubiquitous
throughout the adult (child bearing) population and are relatively unaffected by
‘childhood’ epidemics or seasonality. The model is also extended from that of the
continuous age-time SIR (2.33)-(2.37) discussed in Section 2.3 and defined by the
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following set of equations:
∂M(t, a)
∂t
+
∂M(t, a)
∂a
= −Q(t, a)− µd(a)M(t, a), (3.81)
∂S(t, a)
∂t
+
∂S(t, a)
∂a
= Q(t, a)−[λ(t, a)+µd(a)]S(t, a), (3.82)
∂I(t, a)
∂t
+
∂I(t, a)
∂a
= λ(t, a)S(t, a)− [v(a) + µd(a)]I(t, a), (3.83)
∂R(t, a)
∂t
+
∂R(t, a)
∂a
= v(a)I(t, a)− µd(a)R(t, a), (3.84)
where
λ(t, as) =
1
N
∫ ∞
0
β(t, as, ai) I(t, ai) dai. (3.85)
The boundary conditions (i.e. the number of newborns seropositive and seroneg-
ative) are both determined by C(t, Ab); a function that describes the population
cord log antibody titre distribution at a given point in time, and τ , a parameter
representing a discrete cut-off threshold in Ab that distinguishes between complete
immunity and full susceptibility. Although C(t, Ab) includes some inherent depen-
dency on time, the integral of this function with respect to Ab corresponds to the
current net birth rate and is therefore considered to be constant. Hence:
M(t, 0) =
∫ ∞
τ
C(t, Ab) dAb, S(t, 0) =
∫ τ
0
C(t, Ab) dAb, I(t, 0) = 0. (3.86)
Individual log antibody titres are assumed to decay linearly with respect to age
[Ochola et al., 2009], where the average population decay rate is given by ωM ,
and the rate at which maternally protected infants lose MAb and become fully
susceptible to infection is modelled by the function Q(t, a).
Neglecting infant mortality, if an instantaneous birth cohort (i.e. a = t for all
members) is born at t0 and has a log antibody titre distribution C(t0, Ab), then at
t0, the rate at which individuals cross the immunity threshold and subsequently
lose maternally acquired protection is given by Q(0) = ωMC(t0, τ). For a > 0 this
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rate becomes Q(a) = ωMC(t0, ωMa + τ). Generalising this function beyond that
of a single cohort and including infant mortality yields the expression:
Q(t, a) = ωM C(t−a, ωMa+τ) e−
∫ a
0 µ(α)dα, (3.87)
where all individuals of age a (born at time t−a) have antibody titres according
to the same distribution C(t− a,Ab).
The average duration of protection from MAb is evaluated as the average age of
all individuals becoming susceptible at a given time t. In the general case this
can be found in a similar manner to the average age of infection (2.39) from the
following integral expression:
Av(t) =
∫ ∞
0
a Q(t, a) da∫ ∞
0
Q(t, a)da
. (3.88)
In the more simple case where the effects of infant mortality are omitted from the
model and C(t, Ab) is assumed constant with respect to time, this value can be
expressed more simply as:
Av =
(C¯ − τ)
ωM
, (3.89)
where the average duration is dependent on the difference between the average
cord antibody titre, C¯, and the cut-off threshold for immunity τ , as well as the
average individual MAb decay rate ωM .
3.4.3 Maternal Immunisation
Maternal immunisation can be applied to the model (3.81)-(3.87) by means of
a distorting function VM(Ab), which is applied to the initial cord antibody titre
distribution C(t, Ab). If the average MAb response (scalar increase in log Ab
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titre) to the implemented vaccine is independent of the mother’s initial antibody
level, and VM(Ab) follows some random (Gaussian) distribution, then the resulting
post-vaccine cord antibody function can be generated in the following manner:
Cv(t, Ab) =
∫ Ab
0
C(t, z)VM(Ab/z)
C¯(t)
dz. (3.90)
However, given that only a limited proportion, Pm, of pregnant women will suc-
cessfully take up the vaccine, the actual resulting cord log antibody function is
given by:
Cv(t, Ab) = (1− Pm)C(t, Ab) + Pm
∫ Ab
0
C(t, z)VM(Ab/z)
C¯(t)
dz. (3.91)
If the administered vaccine does immunologically interact with a mother’s response
to prior experience of infection, then the potential efficacy of the vaccine may be
impeded by an initially high antibody titre. At a population level, only those indi-
viduals who would not otherwise already be protected by high MAb would benefit
from the immunisation. Neglecting any change in antibody titre between immuni-
sation at 30 weeks gestation and birth, and assuming Ab titres corresponding to
mother and foetus are equal, if a discrete threshold τm defines both immune pro-
tection and vaccine interaction in the adult population, then the function VM(Ab)
is only applied to the region of C(t, Ab) between 0 and τm. Therefore
Cv(t, Ab) = (1− Pm)C(t, Ab) + Pm
∫ Ab
0
f(t, Ab, z)dz, (3.92)
where
f(t, Ab, z) =

C(t, z)VM(Ab/z)
C¯(t)
for z ≤ τm,
C(t, z) for z > τm.
(3.93)
If AT defines some point in age, then all individuals born with log antibody titres
below ATω + τ will become susceptible and at risk of contracting infection before
they reach age AT . One primary aim of maternal immunisation is then to minimise
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the number of infants with cord titres below this target. However, if the vaccine is
ineffective above the mother’s antibody interaction threshold, τm, then assuming
τ < τm < ATω + τ , there is a proportion of newborns who remain at risk from
the infection and are unaided by the vaccine. This proportion may be described
by the following integral expression:
∫ ATω+τ
τm
C(t, Ab) dAb. (3.94)
In this instance good vaccine response is required in mothers with log antibody
titres up to at least τm ≥ ATω + τ .
3.5 Nominal Parameter Values
Throughout the forthcoming work, realistic estimates of model parameters are re-
quired for numerical and qualitative analysis. Nominal values are not estimated
from fitting the proposed model structures to empirical data, since it is initially
unknown if particular parameters are sufficiently determined by the available in-
put/output behaviour of the system. Alternatively, estimates are based on prior
knowledge extracted from a number of clinical studies, epidemiological observa-
tions and the validation of alternative epidemic models presented in the literature.
The following section is used to collate these results and to provide appropriate
sets of initial parameter values corresponding to the ODE MSIR and MSIRS2
models presented in Sections 3.3 and 3.3.1. The parameterisation of models that
incorporate age dependency is discussed for specific examples in Chapter 6.
The models are considered in the context of two contrasting viral infections, namely
measles and human respiratory syncytial virus (hRSV). These pathogens are both
members of the Paramyxoviridae virus family but show differing degrees of anti-
genic variability. The primary route of transmission is through respiratory secre-
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tions by means of either inhalation of aerosol droplets or contact with contami-
nated fomites. It is likely that both infections may be subject to similar processes
of temporal variation, although their resulting seasonality is markedly different.
These pathogens are adopted as illustrative examples since they subsequently dis-
play contrasting interactions with the host immune system that complement the
varying reinfection models presented throughout this chapter and have also been
the subject of an extensive degree of study.
3.5.1 Measles
The foundation model structure described in this work is the fundamental MSIR
model (3.14)-(3.17), which describes the evolution of pathogens that are seen to
induce solid, lifelong immunity following infection. The epidemiology of measles
is traditionally considered in this manner, where clinical disease is generally only
observed among primary cases [Hawker et al., 2005]. However, the boosting and
waning of adult antibody titres has been observed in studies such as that by Huiss
et al. [1997] and Pedersen et al. [1989], which raises the possibility of persistent
subclinical reinfection throughout the recovered/vaccinated population [Damien
et al., 1998; Glass and Grenfell, 2004]. Although measles is unlikely to be a future
candidate for mass maternal immunisation, the potential interaction of MAb with
infant vaccine response, and relations between passively acquired antibodies in
neonates and population wide immunity are of ongoing interest [Gans et al., 1998;
Pabst et al., 1992; Siegrist, 2003].
The infection is widely reported to have an average duration of infectivity, v−1, of
approximately 5 days (i.e. v = 73 yr−1) [Hawker et al., 2005; Schenzle, 1984], and
a basic reproduction number, R0, of around 18 within the UK [Anderson and May,
1991]. Assuming a constant birth/mortality rate coefficient, µ = 0.014yr−1 [White
et al., 2007] (corresponding to an average life expectancy of 71.4 years), the average
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Table 3.1: Initial estimated values for MSIR model parameters corresponding to
pre-vaccine measles in the UK.
Parameter Description Value Source
µ UK net birthrate coefficient 0.014 yr−1 [White et al., 2007]
N UK population size 5.7×107 [White et al., 2007]
β0 Annual average transmission rate 1314 yr−1 [Anderson and May, 1991]
β1 Seasonal variation in transmission 0.046 [Keeling and Grenfell, 2002]
φ Annual epidemic timing 0.019 [Fine and Clarkson, 1982]
v Rate of recovery 73 yr−1 [Hawker et al., 2005]
ωM Waning MAb rate coefficient 4 yr−1 [Nicoara et al., 1999]
transmission rate, β0, may be calculated from (2.5) to be approximately 1314yr
−1.
Although the duration of maternally acquired immunity does not appear to have
been estimated explicitly, typical values of around 2-4 months (ωM = 4 yr
−1) have
been suggested in a number of sources (such as those by Nicoara et al. [1999] and
Williams et al. [1995]). Table 3.1 provides a complete set of nominal parameter
values for the homogeneous MSIR model derived in Section 3.3.
3.5.2 Respiratory Syncytial Virus
Human respiratory syncytial virus is one of the leading world wide causes of severe
respiratory tract infection among neonate and young infant age classes [Ogra,
2004]. The disease results in hospitalisation rates of 1-3% in infants under 12
months of age, with a peak at 2-3 months and a mortality rate of 1-3% among those
admitted [Munoz et al., 2003]. Age serological surveys such as those described in
the work by Cox et al. [1998] suggest an overall force of infection, λ, in the region
of 0.84 yr−1, where the majority of infants have immunological experience by 3
years of age [White et al., 2007].
In contrast to the measles virus, hRSV is found to display significant antigenic
variability [Cane, 2001], leading to frequent reinfection throughout the wider pop-
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Table 3.2: Fixed nominal MSIRS2 model parameter values corresponding to hRSV
infection in the UK.
Parameter Description Value Source
µ UK net birthrate coefficient 0.014 yr−1 [White et al., 2007]
N UK population size 5.7×107 [White et al., 2007]
λ Average force of infection 0.84 yr−1 [Cox et al., 1998]
v1 Primary infection recovery rate 40.56 yr−1 [White et al., 2005]
v2 Secondary infection recovery rate 107.35 yr−1 [Hall et al., 1991]
ωM Waning MAb rate coefficient 4 yr−1 [Hacimustafaoglu et al., 2004]
ulation [Weber et al., 2001]. As a result, the infection is more appropriately de-
scribed by the MSIRS2 model defined in Section 3.3.1. Adult infection is typically
less severe than that of young children [Falsey and Walsh, 2000]. However, it
is not known whether this is primarily the result of accumulating immunological
experience or some aspect of physiological development [White et al., 2005]. Doc-
umented estimates for the duration of viral shedding are found to vary between
6.7− 10.1 days for infants (corresponding to values of v1 equal to 54.48 yr−1 [Hall
et al., 1976], 40.56 yr−1 [White et al., 2007] and 36 yr−1 [Weber et al., 2001]), and
3.0−4.4 days for adults (corresponding to values of v2 equal to 121.67−91.25yr−1
[Falsey and Walsh, 2000], 107.35 yr−1 [Hall et al., 1991] and 82.95 yr−1 [Lee et al.,
2004]).
The average duration of maternally acquired immunity is reported to be around
1.23-3.75 months (corresponding to values of ωM equal to 9.73 yr
−1 [Brandenburg
et al., 1997], 3.67 yr−1 [Cox et al., 1998] and 3.20 yr−1 [Ochola et al., 2009]). A
representative midrange value of 4 yr−1 (average duration of 3 months) is chosen
since it also corresponds with the observations reported by Hacimustafaoglu et al.
[2004] for hRSV and Nicoara et al. [1999] for measles mumps and rubella.
As previously discussed, the contributions of primary and secondary hRSV trans-
mission to the overall force of infection remains largely unclear. Nominal values
for the duration of secondary immunity are found to be between 6.67− 24 months
Chapter 3 3.6 Nominal Parameter Values 72
Table 3.3: Varying nominal MSIRS2 model parameter values corresponding to
hRSV infection in the UK.
Parameter Description A B C D
β0 Average transmission rate 2490 yr−1 2490 yr−1 152 yr−1 486 yr−1
β1 Seasonal variation in transmission 0.15 0.15 0.21 −
φ Annual epidemic timing 0.51 0.51 0.11 −
σ Susceptibility to secondary infection 0 1 1 0.5
γ Infectivity of secondary infection 0 0 1 0.6
ωR Waning immunity rate coefficient 0 yr−1 1.8 yr−1 1.8 yr−1 0.67 yr−1
(corresponding to values of ωR equal to 1.8 yr
−1 [Weber et al., 2001], 1.0− 0.5 yr−1
[Falsey et al., 2006] and 0.51yr−1 [White et al., 2005]). However, altered secondary
infection parameters, i.e. proportionally reduced susceptibility, σ, and infectivity,
γ, are inherently more difficult to estimate, particularly from clinical studies. In
this instance, these parameters are varied within their valid ranges in order to em-
ulate the continuum of possible reinfection characteristics described by the model.
The average transmission parameter, β, is set such that the average force of infec-
tion, λ, remains constant. Sets of nominal estimates for fixed and varied MSIRS2
model parameter values are given by Tables 3.2 and 3.3, respectively, for hRSV in
the UK.
Parameter sets A and B correspond to cases where the overall force of infection is
dominated by primary infectivity. Set A gives rise to a realisation equivalent to
that of the fundamental MSIR model (3.14)-(3.15), where high levels of maternal
antibodies are sustained through solid and lifelong immunity acquired following
primary infection. In contrast, parameter set B corresponds to a situation where
wider population immunity dynamics are dependent on exposure to primary infec-
tion among infants, but do not contribute to overall transmission. Parameter sets
C and D correspond to cases where secondary infectivity is considered equivalent
to primary infection and partially reduced, respectively.
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3.6 Conclusions
A series of MSIR framework models have been presented that aim to address
questions regarding the population level influence of maternally acquired immunity
and the potential outcomes of mass maternal immunisation. The models have been
derived through successive simplifications of an encompassing general PDE model
structure in order to address specific aspects of the problem statement for systems
with contrasting epidemiological characteristics. Sets of initial parameter estimates
have also been collated from the literature corresponding to two common viral
diseases that provide suitable illustrative examples during forthcoming numerical
analysis of the models.
Chapter 4
Structural Identifiability &
Indistinguishability Analysis
The problems of structural identifiability and indistinguishability (see the work
by Bellman and A˚stro¨m [1970] and Godfrey and DiStefano III [1987]) are purely
theoretical concepts that aim to address the question of uniqueness in the determi-
nation of unknown model parameters and the inference of system structure from
known input-output behaviour of a real system. These analyses are an essential,
yet often overlooked, prerequisite to experiment design and parameter estimation
[Evans et al., 2002]. They are particularly relevant in disciplines such as epidemi-
ology where there is often a significantly limited observation of the full system
state.
In model indistinguishability, the objective is to determine whether or not a series
of competing model structures that represent alternative descriptions of some un-
derlying physical process can be parametrised in such a way as to yield identical
input/output behaviour. If two prospective models are found to be structurally
indistinguishable then it is hence not possible, without the use of additional knowl-
edge of the real system, to determine which structure best corresponds to the col-
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lected data. This analysis is of particular importance when there is a degree of
uncertainty in the elemental function of the real system.
The concept of structural identifiability (a special case of indistinguishability where
competing models have the same structure) describes the problem of whether or
not the unknown parameters of a single postulated model can be uniquely deter-
mined from perfect, noise free and continuous experimental data. Global identifia-
bility indicates that a given parameter (or model structure, should all parameters
be globally identifiable) is uniquely determinable from the considered observation.
Should a model structure prove to be unidentifiable, whereby a number of different
parametrisations exist that give rise to identical measurable behaviour of the sys-
tem, parameter values estimated from fitting to real data should be treated with
extreme caution.
Application to Epidemic Systems
The application of identifiability/indistinguishability techniques to identifying prob-
lems of indeterminacy can provide cogent advocation for the more rigorous valida-
tion of epidemic models used in the assessment of decisions regarding large scale
public health policy. However, the illustrated use of these methods are relatively
sparse in the literature and generally not common practice among the epidemi-
ological community. In reality, the identifiability problem is arguably reduced
through the substitution of ‘known’ parameter values, such as population size,
N , and the duration of infection, v−1, into the model prior to fitting. However,
clear estimation of these attributes is often difficult to obtain, for example defining
geographical bounds around a population supporting an unubiquitous infection,
or measuring the exact duration of viral shedding, and do not necessarily scale
consistently between individual and population level characteristics.
The work by White et al. [2001] describes the use of a structural identifiability
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analysis in the validation of a multispecies model for the spread of major and mi-
nor pathogens causing mastitis in dairy cattle. Despite the size and complexity
of the model, it was found that all model parameters were uniquely determinable
from the available data. However, in this case a very comprehensive longitudinal
data set was available for the study, effectively allowing for simultaneous obser-
vation of all four state variables. In contrast, the work by Evans et al. [2004,
2005] considers, respectively, an identifiability analysis of the seasonally forced
general SIR model (2.1)-(2.4), (2.14), and an indistinguishability analysis of an
SIR model (2.1)-(2.4) and an SIRS model (2.15)-(2.4) with temporary/waning im-
munity. The output structure is limited to a more common prevalence observation
with an unknown scaling factor, and in both cases the models were found to be
unidentifiable/indistinguishable.
It is the objective of this chapter to broaden the application of these techniques
to epidemic models that include characteristics of incomplete immunity and birth
targeted vaccination, as described in Sections 2.1 and 2.2, and to some of the
fundamental MSIR model structures derived in Section 3.3.
4.1 Formal Definitions
In order to provide a more formal definition of structural identifiability the follow-
ing standard form for uncontrolled nonlinear systems is assumed:
Σ(p)

x˙(t, p) = f(x(t, p), p),
y(t, p) = h(x(t, p), p),
x(0, p) = x0(p),
(4.1)
where x(t, p) ∈ Rn≥0 and y(t, p) ∈ Rm≥0 denote the state and output vectors re-
spectively; p ∈ Ω (an open subset of Rq>0 denoting all feasible parameter vectors)
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corresponds to a constant parameter vector, and for all p ∈ Ω, f(·, p) and h(·, p)
are analytic on Rn≥0.
Definition 1. Two particular parameter vectors p, p˜ ∈ Ω are said to be indistin-
guishable (p˜ ∼ p) if they give rise to identical outputs, i.e. y(t, p) = y(t, p˜) for all
t ≥ 0. Hence it is impossible to distinguish between p and p˜ from an ideal noise
free observation via the output.
Definition 2. For generic p ∈ Ω, the ith parameter pi is said to be globally identi-
fiable if p˜ ∼ p and p˜ ∈ Ω imply that p˜i = pi, and locally (non-uniquely) identifiable
if there exists some open neighbourhood N (p) ⊂ Ω (N (p) 6= Ω) such that p˜ ∼ p
for p˜ ∈ N implies that p˜i = pi. If pi is shown not to be at least locally identifiable
then it is said to be unidentifiable.
Definition 3. A model conforming to (4.1) is said to be structurally globally
identifiable if all parameters pi are globally identifiable, and structurally locally
identifiable if any non-globally identifiable parameters are locally identifiable. If
any parameters are found to be unidentifiable then the model is unidentifiable.
For structural indistinguishability, a competing model structure analogous to that
of (4.1) is also defined in standard form:
Σ˜(p˜)

˙˜x(t, p˜) = f˜(x˜(t, p˜), p˜),
y˜(t, p˜) = h˜(x˜(t, p˜), p˜),
x˜(0, p˜) = x˜0(p˜),
(4.2)
where x˜(t, p˜) ∈ Rn˜≥0 and p˜ ∈ Ω˜ (an open subset of Rq˜>0) correspond to state and pa-
rameter vectors respectively, outputs from both competing models y(t, p), y˜(t, p˜) ∈
Rm≥0, and for all p˜ ∈ Ω˜, f˜(·, p˜) and h˜(·, p˜) are analytic on Rn˜≥0.
Chapter 4 4.2 Identifiability Methods for Nonlinear Systems 78
Definition 4. The competing systems Σ(p) and Σ˜(p˜), where p ∈ Ω and p˜ ∈ Ω˜,
are said to be output indistinguishable (Σ(p) ∼ Σ˜(p˜)) if they give rise to identical
outputs, i.e. y(t, p) = y˜(t, p˜) for all t ≥ 0. Hence it is impossible to distinguish
between Σ(p) and Σ˜(p˜) from an ideal noise free observation.
Definition 5. The models Σ and Σ˜ are said to be structurally indistinguishable
(Σ ∼ Σ˜) if for generic p ∈ Ω there exists a p˜ ∈ Ω˜ such that Σ(p) ∼ Σ˜(p˜); and for
generic p˜ ∈ Ω˜ there exists a p ∈ Ω such that Σ(p) ∼ Σ˜(p˜).
4.2 Identifiability Methods for
Nonlinear Systems
Since the early 1970’s, an extensive base of literature has accumulated regarding
the issue of identifiability in compartmental systems, for examples see the review
by Cobelli and DiStefano III [1980], the relevant chapter in Jacquez [1996] and
the book by Godfrey [1983], as well as the papers by Godfrey and Chapman
[1990], Godfrey et al. [1994] and Chappell et al. [1990]. Epidemic models such
as those characterised in this work tend to be uncontrolled (free or autonomous)
and inherently nonlinear due to the explicit dependency of infection incidence
(βS(t)I(t)/N) on both the susceptible and infective state variables of the system.
However, despite the additional complexity in analysis over linear systems (see
the book by Walter [1982]), the problem of structural identifiability can still be
approached with a number of well documented methods (for a brief review on
general techniques for nonlinear identifiability see the paper by Boubaker and
Fourati [2004]).
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4.2.1 Taylor Series Expansion Approach
The work by Godfrey and Fitch [1984] describes the use of a Taylor series ex-
pansion method on a number of examples in pharmacokinetics. This technique
was first utilised by Pohjanpalo [1978] and is also equally applicable to time vary-
ing and nonlinear systems. The output functions corresponding to two competing
parametrisations, y(t, p) and y(t, p˜), are expanded as a Taylor series about a known
point in time (usually at an initial condition i.e. t = 0+) in the following manner:
y(t, p) = y(0, p) + y˙(0, p)t + y¨(0, p)
t2
2!
+ . . .+ y(k)(0, p)
tk
k!
+ . . . , (4.3)
where y(k)(0, p) =
dky
dtk
∣∣∣∣
t=0
for k = 1, 2, 3, . . . .
The resulting infinite series of successive derivatives, y(k)(0, p), are theoretically
measurable and unique for a particular output expansion. Therefore, if two com-
peting parametrisations are indistinguishable (i.e. yield identical output trajecto-
ries) and hence the considered model structure is unidentifiable, they must have
an identical series of Taylor coefficients. It follows, that in order to perform an
analysis, the Taylor series coefficients for the two parametrisations are found, com-
pared, and algebraically solved to generate a set of conditions for p˜ that give rise
to identical output behaviour [Godfrey and DiStefano III, 1987].
For linear systems it can be shown through the use of the Cayley-Hamilton the-
orem that a maximum of 2n − 1 independent equations (Taylor coefficients) are
required to yield a result (i.e. no further information gained from considering later
coefficients) [Vajda, 1984]. However, for a single output nonlinear system with
rational polynomial transfer coefficients, the upper bound is found to be n+ q+ 1
[Margaria et al., 2001]. In this instance, the full number of coefficients defined
by the upper bound must be evaluated in order to guarantee that further com-
putation does not elicit a reduced result and hence prove a model unidentifiable.
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Consequently, particularly in nonlinear cases, the Taylor series method is more
practically appropriate for proving models that are globally identifiable.
In the case of the basic SIR model, where n = 2 and p = (µ,N, β, v, k, S0, I0), i.e.
q = 7, a total of 10 Taylor coefficients would need to be evaluated given that the
model is shown to be unidentifiable. Implementing this method using a symbolic
manipulation package such as MATHEMATICA (version 7.0.0) [Wolfram, 1999]
or MAPLE (version 13.0) [Heal et al., 1998], it is found that a maximum of only
3 or 4 coefficients are realistically tractable.
4.2.2 Differential Algebra
The application of differential algebra [Ritt, 1950] techniques to identifiability
problems in nonlinear systems has been presented by a number of authors, see
the work by Ljung and Glad [1994], Saccomani et al. [2003], Margaria et al. [2004]
and Yates et al. [2009]. These methods rely on differential algebraic manipulation
to redefine the set of equations that describe a given system into relations that
contain only terms corresponding to the system parameters (p), known inputs (u)
and outputs (y), and their successive derivatives (u(k), y(k)).
The system equations are used as generators for a radical differential ideal, that is
a set of all differential polynomials formed by successive addition, multiplication
and differentiation of the system polynomial equations:
x˙(t, p) − f(x(t, p), p),
y(t, p) − h(x(t, p), p).
(4.4)
This ideal is decomposed and ranked according to a set of criteria that aims to
eliminate the unknown state variables, x(t, p). The process is performed by means
of a computational algorithm (typically Ritt’s algorithm [Ritt, 1950] or the Rosen-
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feld Gro¨bner algorithm [Boulier et al., 2009]), in order to generate either a reduced
set of differential polynomials (known as a characteristic set), or an input-output
map, g(y, u, p), that can be used to determine the identifiability of p.
If it can be shown that the polynomial functions relating to indistinguishable
parameterisations, p, p˜ ∈ Ω, given by:
g(y, . . . , y(k), u, . . . , u(k), p) − g(y, . . . , y(k), u, . . . , u(k), p˜) = 0, (4.5)
are identically zero, i.e. have linearly independent monomials, then their coeffi-
cients can be equated and solved in order to find relationships between p and p˜
with respect to the identifiability problem (see Definition 2).
The method is most commonly implemented in either of two software modules:
DAISY [Bellu et al., 2007] and DiffAlg [Hubert, 2005], that are run in the algebraic
manipulation packages: REDUCE [Hearn, 1995] and MAPLE [Heal et al., 1998],
respectively.
4.2.3 Nonlinear State Transformation
State transformation based methods result in the generation of a set of all possible
models that conform to the same structural properties determined by the postu-
lated model, and have identical input-output behaviour. Linear methods (see the
texts by Godfrey [1983], Godfrey and DiStefano III [1987] and Jacquez [1996])
are based on the use of a similarity transformation (in this case an invertible lin-
ear map T ) of minimal (i.e. controllable and observable) systems represented in
standard vector matrix form:
x˙(t) = Ax(t) +Bu(t), x(0) = x0,
y(t) = Cx(t).
(4.6)
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The transformation, T , therefore relates all equivalent models (i.e. with identical
eigenvalues and input/output kinetics), described by A˜, B˜ and C˜, to the original
model such that:
A˜ = TAT−1,
B˜ = TB,
C˜ = CT−1.
(4.7)
The analysis then reduces to utilising constraints imposed by known physical prop-
erties of the original postulated model on the elements of A, B and C, and the
preceding matrix relationships, to determine the unknown elements of T . If T can
be shown to be unique, i.e. the only solution to (4.7) is T = In, then the system
is found to be structurally globally identifiable. If there are a finite (distinct) set
of possible T then the system is locally identifiable, and an infinite number of
solutions for T implies that the system is unidentifiable.
A common generalisation of this method is the exhaustive modelling approach,
whereby the structure or connectivity (characterised by zero and non-zero ele-
ments) of the original system is not imposed on the set of equivalent systems.
In this instance, the analysis is extended to include all competing model struc-
tures within a defined framework and yields results associated with the problem
of structural indistinguishability.
The similarity transformation approach has subsequently been extended to non-
linear systems by a number of authors including Vajda et al. [1989] through the
use of various forms of nonlinear mapping. The following technique, presented by
Evans et al. [2002], utilises the existence of an infinitely differentiable map, φ(x),
that connects the state trajectories corresponding to indistinguishable parameter
vectors, p ∼ p˜, such that:
φ(x(t, p˜)) = x(t, p). (4.8)
The Lie derivative of h ∈ C∞(M(p)) along the vector field f is the smooth function
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given by:
Lfh(x) =
∂h
∂x
(x)f(x). (4.9)
Let fp = f(·, p) and, for some 1 ≤ l ≤ m, hpl (·) = hl(·, p). For any n smooth
functions u1(x, p), . . . , un(x, p) of the form hj(x, p), for some j, or L
r
fph
p
l (x) (where
Lr denotes successive Lie derivatives), for some l and r, a function H can be
defined by
H(x, p) = (u1(x, p), . . . , un(x, p))
T , (4.10)
where for a particular p ∈ Ω, Hp denotes the vector field H(·, p). The system (4.1)
can be shown to satisfy the Observability Rank Criterion (ORC) [Hermann and
Krener, 1977] at the initial condition x0(p) if a function H, of the form (4.10),
exists such that the Jacobian matrix of Hp, evaluated at x
0(p), is nonsingular.
Theorem 6. [Evans et al., 2002] For the system (4.1), suppose that there exists
a suitable function H for which the ORC is satisfied at the initial condition for a
particular parameter vector p ∈ Ω, then p˜ ∈ Ω is indistinguishable, p˜ ∼ p, provided
a τ > 0, an open neighbourhood Vp˜ of x
0(p˜) and a smooth mapping φ : Vp˜ → φ(Vp˜)
exist, such that
Hp(φ(x)) = Hp˜(x), (4.11)
for all x ∈ Vp˜, and
φ(x0(p˜)) = x0(p), (4.12)
f(φ(x(t, p˜)), p) =
∂φ
∂x
(x(t, p˜))f(x(t, p˜), p˜), (4.13)
h(φ(x(t, p˜)), p) = h(x(t, p˜), p˜), (4.14)
for all t ∈ [0, τ) with x(t, p˜) ∈ Vp˜, where x(t, p˜) is the solution of the system for
parameter vector p˜.
Full proof of Theorem 6 can be found in the work by Evans et al. [2002].
For analysis, provided the system is found to meet the observability rank criterion,
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a smooth mapping, φ(x), is generated according to (4.11), such that (4.14) is also
satisfied, i.e. the first m smooth functions u1(x, p) . . . um(x, p) are chosen to cor-
respond to the m dimensional output function, y(t, p), and um+1(x, p) . . . un(x, p)
are their successive Lie derivatives. In a similar manner to the linear method, the
conditions defined by (4.12) and (4.13) are then used to establish the unknown
elements of φ(x) and elicit any relations between indistinguishable parameter vec-
tors. The intention is to show that φ(x) = In, whereby the system is found to be
structurally globally identifiable.
4.3 Structural Identifiability Analysis of
SIR Framework Models
It has previously been shown by Evans et al. [2005] that a general SIR model
(2.1)-(2.2) with a prevalence observation of infection is unidentifiable given that
the parameters k, N , S0 and I0 (hence β/N) are not uniquely determined by
the output. This indicates that it is inappropriate to use this model and output
structure to estimate the proportion of contacts between infective and susceptible
individuals that result in infection, β/N , without additional knowledge of param-
eter values within the model.
However, this analysis also shows that the individual parameters µ, v and β are
uniquely determined by the output and hence globally identifiable. Therefore, the
model structure can be used to uniquely determine the basic reproduction number,
R0 (2.5), and hence from (2.23) also the proportion of vaccination coverage required
to eradicate the infection and provide herd immunity against future epidemics.
The following section explores the results of a structural identifiability analysis
applied to other fundamental SIR framework models that include epidemiological
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characteristics associated with suboptimal immunity and birth targeted vaccina-
tion. The objective is to find out how processes of reinfection through antigenic
diversity and the implementation of simple public health intervention might affect
the unique determinability of system characteristics from empirical data.
Methods of Analysis
Although a large number of publications suggest that the differential algebra ap-
proach is mathematically rigorous, the exact implementation used in either of the
two available software modules is not easily examinable by the user. Therefore the
analysis in this work is worked and presented using the nonlinear state transfor-
mation approach. This allows for more detailed examination of working, and more
manual manipulation of the computing process to aid in the inference of results
for otherwise intractable problems. The method is also more intuitively extended
to the general problem of structural indistinguishability.
The state transformation method is implemented in MATHEMATICA version
7.0.0; for completeness, all results are also compared to those obtained from DAISY
version 1.5 (using REDUCE version 3.8) and the DiffAlg differential algebra pack-
age within MAPLE version 13. All analyses are computed on a standard desktop
machine with a Pentium D CPU 3.4GHz and 1Gb of RAM.
4.3.1 SIR With Birth Targeted Vaccination
The first model structure to be analysed is that of a general SIR with simple birth
targeted vaccination, as shown in Figure 2.6. The model is reduced to a two state
problem given that R(t) = N−S(t)−I(t), and expressed in the general form shown
in (4.1):
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f(x(t, p), p) =
µN(1−Pv)−βS(t, p)I(t, p)/N−µS(t, p)
βS(t, p)I(t, p)/N−(µ+v)I(t, p)
 ,
h(x(t, p), p) = kI(t, p), (4.15)
x0(p) =
(
S0 I0
)T
,
where x(t, p) = (S(t, p), I(t, p))T ; the output structure, kI(t, p), corresponds to
a prevalence type observation (with unknown gain k) of the infection; S0 and
I0 are the respective initial conditions for the susceptible and infective states;
and p = (µ,N, Pv, β, v, k, S
0, I0)T is a vector of the unknown model parameters
(assumed to be indistinguishable from p˜ = (µ˜, N˜ , P˜v, β˜, v˜, k˜, S˜0, I˜0)
T ).
The first step of the analysis is to ensure that the system is observable, in ac-
cordance with the observability rank criterion detailed by Hermann and Krener
[1977], at x0(p). Let the vector field Hp(x) = (u1(x, p), u2(x, p))
T , where
u1(x, p) = h
p(x) = kI,
u2(x, p) = Lfpu
p
1(x) = kI
[
βS/N − (µ+v)]. (4.16)
It can be seen that the ORC is satisfied given that the Jacobian matrix of Hp(x),
 0 k
kβI/N k
[
βS/N − (µ+v)]
 , (4.17)
has full rank for any p ∈ Ω and for all x ∈ W = {x ∈ Rn : x 6= 0}. Given that
x(t, p) ∈ W for all t ≥ 0 it can be seen from Theorem 6 that if the parameter
vectors p, p˜ ∈ Ω are indistinguishable p˜ ∼ p, the open neighbourhood Vp˜ of x0(p˜)
exists and the smooth mapping φ is a diffeomorphism on Vp˜ onto its range [Evans
et al., 2005].
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The diffeomorphism, φ = H−1p ◦Hp˜ = (φ1, φ2)T , can then be generated according
to (4.11), such that:
φ(x) =
(
N(N˜
[
µ+ v − (µ˜+ v˜)]+ β˜S)
N˜β
,
k˜I
k
)T
, (4.18)
where x = (S, I)T . Since u1(x, p) is chosen to correspond to the output function,
hp(x), it can be seen that φ(x) automatically satisfies (4.14) from Theorem 6 as
well as (4.11).
In order to satisfy (4.13) it is necessary that:
f(φ(x(t, p˜)), p) =
µN(1−Pv)−β φ1 φ2/N−µφ1
φ2(β φ1/N−(µ+v))
 =
∂φ
∂x
(x(t, p˜))f(x(t, p˜), p˜) =
 (Nβ˜/N˜β)(µ˜N˜(1−P˜v)−β˜SI/N˜−µ˜S)
(k˜/k)I(β˜S/N˜−(µ˜+v˜))
 .
(4.19)
Note: for presentation, certain functions in the right hand side of (4.19) have been
abbreviated, for example φ1 = φ1(x(t, p˜)) and S = S(t, p˜).
Subsequently the second row of (4.19) is also automatically equal and the resulting
expression from the first component can be rearranged into the following multi-
variate polynomial form:
q1 + q2S(t, p˜) + q3I(t, p˜) + q4S(t, p˜)I(t, p˜) = 0, (4.20)
where
q1 =
N
[
µ
(
µ˜+v˜−(v+µ) + β(1−Pv)
)−β˜µ˜(1−P˜v)]
β
, q2 =
Nβ˜(µ˜− µ)
N˜β
,
q3 =
k˜(µ˜+ v˜ − (µ+ v))
k
, q4 =
β˜(−k˜N˜β + kNβ˜)
kN˜2β
.
(4.21)
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In order to obtain general conditions from this expression, it is necessary to ensure
that (4.20) is identically zero, i.e. the resulting monomials, Mi(t) for i = 1, . . . , r,
are linearly independent. In many cases this stage can prove to be an entirely
non-trivial task [Bearup et al., 2010]. However, for this specific example, linear
independence can be successfully shown through computation of the Wronski de-
terminant:
WD(M1(t), . . . ,Mr(t)) =
∣∣∣∣∣∣∣∣∣∣∣∣

M1(t) M2(t) . . . Mr(t)
M1(t)
(1) M2(t)
(1) . . . Mr(t)
(1)
...
...
. . .
...
M1(t)
(r−1) M2(t)(r−1) . . . Mr(t)(r−1)

∣∣∣∣∣∣∣∣∣∣∣∣
, (4.22)
where M1(t) = 1, M2(t) = S(t, p˜), M3(t) = I(t, p˜), M4(t) = S(t, p˜)I(t, p˜) ,
and Mi(t)
(j) denotes the jth derivative of Mi(t) with respect to t. If it can be
shown that WD is non-zero for any time point t on some open interval, then the
solutions to the multivariate polynomial are linearly independent (see the work of
Krusemeyer [1988] and the text by Kreyszig [2006]).
Consequently, the only solution to (4.20) is q1 = q2 = q3 = q4 = 0, whereby each of
the four monomial coefficients, qi=0 for i=1, . . . , 4 can then be solved along with
(4.12) to give all possible conditions for p˜ ∼ p:
{
µ˜ = µ, v˜ = v, β˜(1− P˜v) = β(1− Pv),
k˜S˜0 = kS0, k˜I˜0 = kI0,
k˜N˜
β˜
=
kN
β
}
.
(4.23)
Therefore, in this case, the state transformation is found to be an invertible diag-
onal linear map of the form:
φ(x) =
k˜
k
S
I
 , (4.24)
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which is same as that for the unvaccinated SIR, as shown by Evans et al. [2005].
The results show that the parameters µ and v are still globally identifiable, how-
ever, the effective coverage of the applied vaccination, Pv, cannot be uniquely
determined from the output. Further to this, the transmission parameter, β, and
hence the basic reproduction number, R0 (2.5), are no longer uniquely identifiable
following the implementation of a vaccination campaign where Pv > 0. It should
also be noted that only direct knowledge of either β, Pv, or k and N will result
in a structurally globally identifiable system, whereby all other parameters can be
uniquely determined.
4.3.2 SIRS Temporary/Waning Immunity
The SIRS model (2.15)-(2.4), shown in Figure 2.4, is reduced and expressed in the
form given by (4.1), in a similar manner to the previous example, where the output
structure y(t, p) = kI(t, p), initial conditions are given by S0 and I0, and unknown
parameter vector p = (µ,N, ωR, β, v, k, S
0, I0)T (assumed indistinguishable from
p˜ = (µ˜, N˜ , ω˜R, β˜, v˜, k˜, S˜0, I˜0)
T ). It is found that the first stages of the analysis
regarding verification of the ORC and the generation of φ are the same as for the
SIR and SIR with vaccination models discussed in Section 4.3.1. In this instance,
the smooth mapping, φ, given by (4.18), can also be seen to automatically satisfy
conditions (4.11) and (4.14) of Theorem 6 for the SIRS model. However, in order
to satisfy (4.13) it is necessary that:
µN−β φ1 φ2/N−µφ1+ωR(N−φ1−φ2)
φ2(β φ1−(µ+v))
 =
 (Nβ˜/N˜β)(µ˜N˜−β˜SI/N˜−µ˜S+ω˜R(N˜−S−I))
(k˜/k)I(β˜S − N˜(µ˜+ v˜))
.
(4.25)
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Solving (4.25) along with (4.12) yields the following set of necessary and sufficient
conditions for p˜ ∼ p:
{
v˜ = v, µ˜− β˜ = µ− β, ω˜R + µ˜ = ωR + µ,
β˜S˜0
N˜
+ω˜R =
βS0
N
+ωR, k˜I˜0 = kI
0,
k˜N˜
β˜
=
kN
β
}
.
(4.26)
The smooth mapping function can subsequently be reduced to:
φ(x) =
(
N(ω˜R − ωR)
β
+
k˜S
k
,
k˜I
k
)T
, (4.27)
whereby only the recovery rate coefficient, v, is found to be globally identifiable
(except also the combinations µ − β, ωR + β and ωR + µ). The consequence of
this outcome is that neither parameters associated with R0 or the duration of
immunity can be uniquely determined from the model output. This implies that
it is impossible to determine what level of vaccine coverage would be required to
eradicate an infection of this type (2.28), or even if such an outcome were even
possible (2.27).
Following the addition of birth targeted vaccination, the structural identifiability
results are given by:
{
v˜ = v, µ˜+ω˜R = µ+ωR,
k˜N˜
β˜
=
kN
β
,
β˜S˜0
N˜
+ω˜R =
βS0
N
+ωR,
k˜I˜0 = kI0, µ˜β˜P˜v+(µ˜−β˜)(µ˜+ω˜R) = µβPv+(µ−β)(µ+ωR)
}
,
(4.28)
where the smooth map, φ(x), remains the same as (4.27). It can subsequently be
seen that even with prior knowledge of the parameter combination (µ−β), perhaps
from pre-vaccination model fitting, the vaccine efficacy parameter Pv cannot be
globally identified from prevalence data. It should be noted that a minimum of
three parameters are required to be known in order for the model to be structurally
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globally identifiable.
4.3.3 SIR with Partial Immunity
Analysis of the partial immunity model, shown in Figure 2.5, is performed by
first expressing the model equations given by (2.19)-(2.4) in the general form for
a nonlinear two-state system:
f(x(t, p), p) =
 µN−βS(t, p)I(t, p)/N−µS(t, p)[
β
(
S(t, p)+σ
[
N−S(t, p)−I(t, p)])/N−(µ+v)]I(t, p)
 ,
h(x(t, p), p) = kI(t, p), (4.29)
x0(p) =
(
S0 I0
)T
,
and then generating the vector field, Hp(x) = (u1(x, p), u2(x, p))
T , through suc-
cessive Lie derivatives of the output function, h(x(t, p), p), such that:
u1(x, p) = h
p(x) = kI,
u2(x, p) = Lfpu
p
1(x) = kI
[(
S+σ(N−S−I))β/N−(µ+v)]. (4.30)
The ORC is satisfied given that the Jacobian matrix of Hp(x), given by:
 0 k
kβI(1−σ)/N k((β(S(1−σ)−2σI)−N(µ+v−βσ)))/N
 , (4.31)
has full rank for all p ∈ Ω and for all x ∈ W = {x ∈ Rn : x 6= 0}, provided that
σ ∈ [0, 1), i.e. σ 6= 1. It can be noted that the ORC is not met for σ = 1 because
this eventuality corresponds to a reduction of the SIRp model structure into a
single state SIS model. Analysis of the SIS incomplete immunity model would
therefore require consideration of only a single smooth function u1(x, p) = kI.
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Solving (4.11) of Theorem 6 for φ = (φ1, φ2)
T yields the following smooth map:
φ(x) =
(
θ
kN˜β(σ−1) ,
k˜I
k
)T
, (4.32)
where
θ = kN
(
N˜
[
µ˜+v˜ − (µ+v) + βσ−β˜σ˜]+ β˜(σ˜−1)S)+ (kNβ˜σ˜−k˜N˜βσ)I,
which additionally satisfies condition (4.14).
Further satisfying equations (4.13) and (4.12) completes the structural identifia-
bility analysis for an SIR with partial immunity, in which the following relations
between p and p˜ are found:
{
β˜ = β, µ˜ = µ, v˜ = v, σ˜ = σ, k˜S˜0 = kS0, k˜I˜0 = kI0, k˜N˜ = kN
}
. (4.33)
Similar to the general SIR result, the smooth mapping φ(x) can be reduced to
(4.24), and the model parameters associated with the basic reproduction number
(i.e. β, µ, and v) are found to be globally identifiable. In addition, it can be
noted that the reduced susceptibility parameter, σ, is also uniquely determined
by the prevalence output structure. These results indicate that the possibility of
eradication with 100% vaccination coverage (2.29), and the effective proportion of
the population required to be immunised (2.31), are both uniquely determined by
the model output.
Upon inclusion of a birth targeted vaccination programme, the identifiability con-
ditions for the model are found to be:
{
µ˜ = µ, σ˜ = σ, v˜ − β˜σ˜ = v − βσ, k˜S˜0 = kS0,
k˜I˜0 = kI0, β˜(P˜v − 1) = β(Pv − 1), k˜N˜
β˜
=
kN
β
}
,
(4.34)
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where φ(x) is again reducible to that of (4.24), and the actual proportion of vaccine
coverage, Pv, cannot be uniquely determined by the observation. The transmission
parameter, β, recovery rate parameter, v, and hence the basic reproduction num-
ber, R0, become unidentifiable once the intervention has been applied. However,
it should also be noted that σ and µ both remain globally identifiable, and that
if either v, β or kN are known, i.e. from fitting to pre-vaccination data, then R0
and Pv can be uniquely identified.
4.4 Structural Identifiability Analysis of
MSIR Framework Models
The homogeneous time domain MSIR model (3.14)-(3.17), shown in Figure 3.1, is
analysed in order to ascertain whether the model structure suggests that neona-
tal immunity due to maternally acquired antibody has an analytic influence on
the observable behaviour of the system, and consequently if the parameter ωM is
globally identifiable.
The model is considered with a prevalence output structure and defined as a three
state problem given that a closed, constant size population is assumed:
f(x(t, p), p) =

µ
[
N−M(t, p)−S(t, p)−I(t, p)]− ωMM(t, p)
µI(t, p) + ωMM(t, p)− βS(t, p)I(t, p)/N
βS(t, p)I(t, p)/N − (µ+v)I(t, p)
 ,
h(x(t, p), p) = kI(t, p), (4.35)
x0(p) =
(
M0 S0 I0
)T
,
where the state vector, x(t, p) = (M(t, p), S(t, p), I(t, p))T ; M0, S0 and I0 are
the initial conditions for the maternally protected, susceptible and infective states
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respectively; and p = (µ, ωM , N, β, v, k,M
0, S0, I0)T is an unknown parameter
vector (assumed to be indistinguishable from p˜ = (µ˜, ω˜M , N˜ , β˜, v˜, k˜, M˜0, S˜0, I˜0)
T ).
The function, Hp(x) = (u1(x, p), u2(x, p), u3(x, p))
T , is found from successive Lie
derivatives of the output according to (4.10), and corresponds to the following
smooth functions:
u1(x, p) = h
p(x) = kI,
u2(x, p) = Lfpu
p
1(x) = kI
[
βS/N − (µ+v)
]
,
u3(x, p) = Lfpu
p
2(x) = kI
[(
βS/N−(µ+v))2 + β(ωMM−βSI/N+µI)/N].
(4.36)
The Jacobian matrix of Hp(x) is given by:

0 0 k
0
kβI
N
k
(
βS
N
−(µ+v)
)
ωMkβI
N
kIβ
[
β(2S−I)/N−2(v+µ)]
N
k θ
N
 , (4.37)
where
θ = β2S(S − 2I)/N +N(v + µ)2 + β(ωMM − 2S(v+µ) + 2µI),
which is again found to be non-singular for all p ∈ Ω and x ∈ W = {x ∈ Rn : x 6=
0}, thus satisfying the observability rank criterion.
A smooth mapping, of the form φ = (φ1, φ2, φ3)
T , is then generated according to
Theorem 6 (4.11):
φ(x) =
(
θ
kωMN˜β
,
N
(
N˜
[
µ+v − (µ˜+v˜)]+ β˜S)
N˜β
,
k˜I
k
)T
, (4.38)
where
θ = kω˜MNβ˜M +
(
k˜N˜β(v−v˜−µ) + kNβ˜µ+ β˜(k˜β−kNβ˜/N˜)S
)
I,
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and x = (M,S, I)T , which automatically satisfies both (4.11) and (4.14).
In order to satisfy condition (4.13) it is necessary that:

µ(N−φ1−φ2−φ3)− ωMφ1
ωMφ1 + (µ− βφ2/N)φ3
φ3[βφ2/N − (v + µ)]
 =

[µ˜(N˜−M−S−I)− ω˜MM ] θ
(β˜N/βN˜)(µ˜I + ω˜MM − β˜SI/N˜)
(k˜/k)I[β˜S/N˜ − (v˜ + µ˜)]
, (4.39)
where
θ =
k˜β
[
(S + I)β˜ + N˜(v−v˜−µ˜)]+ kNβ˜(ω˜M − [(S + I)β˜]/N˜ + µ˜)
kωMN˜β
.
It can subsequently be seen, from substitution of (4.38) into (4.39), that the second
and third rows are automatically equal. The resulting expression from the first
component of (4.39) can then be rearranged into the form:
q1 + q2M(t, p˜) + q3S(t, p˜) + q4I(t, p˜) + q5M(t, p˜)S(t, p˜)+
q6M(t, p˜)I(t, p˜) + q7S(t, p˜)I(t, p˜) + q8S(t, p˜)
2 + q9I(t, p˜)
2 = 0,
(4.40)
Linear independence of this expression is shown by considering the following fac-
torisation of a general second order multivariate polynomial:
(
z1+z2M(t, p˜)+z3S(t, p˜)+z4I(t, p˜)
)
(
z5+z6M(t, p˜)+z7S(t, p˜)+z8I(t, p˜)
)
= 0.
(4.41)
where computing the Wronski determinant of either factors in (4.41) shows that
zi = 0 for either i=1, . . . , 4 or i=5, . . . , 8, for all t. Therefore, through expanding
(4.41) and comparing equated coefficients from (4.40), the only solution to (4.40)
is qi=0 for i=1, . . . , 9. These coefficients can then be solved along with (4.12) to
give all possible conditions for p˜ ∼ p:
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{
ω˜M = ωM , µ˜ = µ, β˜ = β, v˜ = v,
k˜N˜ = kN, k˜M˜0 = kM0, k˜S˜0 = kS0, k˜I˜0 = kI0
}
,
or{
ω˜M = µ, µ˜ = ωM , v˜ = v, β˜+ω˜M = β+ωM ,
k˜N˜
β˜
=
kN
β
,
k˜M˜0ω˜M = kM
0ωM , S˜0
β˜
N˜
+ω˜M = S
0 β
N
+ωM , k˜I˜0 = kI
0
}
.
(4.42)
It can be seen from the analysis that the system is unidentifiable, i.e. there are an
infinite number of combinations for values for k and N that give rise to the same
observable system behaviour. However, if either k or N are known then the system
becomes locally identifiable given that only two possible parameterisations exist.
In addition, it can be noted that provided the parameters ωM and µ are in practice
clearly distinguishable from their magnitude (i.e. duration of immunity from MAb
is significantly less than average life expectancy), or any of the unidentifiable
parameters are known (in addition to k or N), the model becomes structurally
globally identifiable. In this instance the duration of MAb protection has at least
an analytically unique influence on the output of the system.
4.4.1 MSIR Models with Incomplete Immunity
& Vaccination
Extending the analysis to further variations of the MSIR model yields a series of
results indicating how the addition of secondary infection and basic public health
intervention might impact identifiability issues within the model framework.
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MSIRS with Temporary/Waning Immunity
An MSIRS model structure with temporary/waning immunity can be derived from
the full incomplete immunity system by setting σ = 1, γ = 1 and v1 = v2 = v in
equations (3.20)-(3.26), where for simplification secondary infection characteristics
are considered to be identical to that of primary infection. Susceptible and infective
states can then be combined such that S(t) = S1(t) + S2(t) and I(t) = I1(t) +
I2(t), giving rise to a model structure analogous to that of the SIRS analysed in
Section 4.3.2.
The analysis is performed in order to establish whether the temporary immunity
parameter, ωR, is uniquely determinable from a typical prevalence output struc-
ture, and to establish if the process of repeat infection through antigenic evolution
has an impact on the identifiability of other characteristic parameters within the
model. The procedure follows the same methodology as previous examples and
yields the following set of conditions for indistinguishable parameterisations p˜ ∼ p:
{
ω˜M = ωM , µ˜ = µ, β˜ = β, v˜ = v, ω˜R = ωR,
k˜N˜ = kN, k˜M˜0 = kM0, k˜S˜0 = kS0, k˜I˜0 = kI0
}
,
or{
ω˜M =µ+ωR, µ˜ = ωM−ωR, v˜ = v, ω˜R = ωR, β˜+ω˜M = β+ωM ,
k˜N˜
β˜
=
kN
β
,
k˜M˜0
µ˜
=
kM0
µ
, S˜0
β˜
N˜
+ω˜M = S
0 β
N
+ωM , k˜I˜0 = kI
0
}
.
(4.43)
These conditions reveal that the model is unidentifiable, however, similarily to
the MSIR (4.42), two distinct sets of solutions exist. Interestingly, unlike for the
SIRS results (4.26), the addition of a maternally protected state variable forces
the temporary immunity parameter, ωR, to become globally identifiable. If either
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of the parameters µ, β or ωM are known, then the two solutions become equal and
the basic reproduction number, R0, is then uniquely determined by the output.
MSIR with Maternal & Birth Targeted Immunisation
The implications of both maternal and childhood (birth targeted) vaccine inter-
vention are examined through analysis of the interacting immunisation model pre-
sented in Section 3.3.3. The system equations are reduced by neglecting secondary
infection, i.e. considering only (3.33)-(3.35), and presented as a three state problem
assuming a constant population size:
f(x(t, p), p) =

µ
[
1−(1−ϑ)Pv
][
Ab+(t, p)+PmAb
−(t, p)
]− ωMM(t, p)
µ(1−Pm)(1−Pv)Ab−(t, p) + ωMM(t, p)
− βS(t, p)I(t, p)/N − [µ(1+Pm)]S(t, p)
βS(t, p)I(t, p)/N − [v+µ(1+Pm)]I(t, p)
 ,
h(x(t, p), p) = kI(t, p), (4.44)
x0(p) =
(
M0 S0 I0
)T
.
Inflows Ab+(t, p) = N−M(t, p)−S(t, p)−I(t, p) and Ab−(t, p) = S(t, p)+I(t, p),
describe the birth rates of seropositive and seronegative newborns respectively.
Varying combinations of the two interventions and their potential interaction are
evoked through choice of the parameters Pm, Pv and ϑ.
For a birth targeted only intervention, with a vaccine that does not induce an
active immune response in the presence of protective MAb, Pm = 0 and ϑ = 1. In
this instance a full identifiability analysis yields the following set of conditions:
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{
ω˜M = ωM , µ˜ = µ, β˜ = β, v˜ = v, P˜v = Pv,
k˜N˜ = kN, k˜M˜0 = kM0, k˜S˜0 = kS0, k˜I˜0 = kI0
}
,
or
{
ω˜M = µ, µ˜ = ωM , v˜ = v, µ˜P˜v = µPv,
k˜N˜
β˜
=
kN
β
,
β˜+ω˜M(1+P˜v) = β+ωM(1+Pv), S˜0
β˜
N˜
+ω˜M = S
0 β
N
+ωM ,
k˜ω˜M
(
M˜0 +
µ˜N˜ P˜v
β˜
)
= kωM
(
M0 +
µNPv
β
)
, k˜I˜0 = kI0
}
.
(4.45)
Unlike the SIR model (see conditions in (4.23)), the implementation of birth tar-
geted vaccination to the MSIR system with maternally acquired immunity does not
have a further detrimental effect on structural identifiability. Additional knowl-
edge of only µ, ωM or β, is required for Pv to become uniquely determined by the
output. In addition, if either k or N are also known, then the model becomes
structurally globally identifiable.
Similar sets of conditions are found for the non-interacting vaccine system, where
Pm = 0 and ϑ = 0, and for the maternal immunisation only system, where Pv = 0.
The first local solutions are equivalent to that of the interacting system shown in
(4.45) and marginally more complex parameter combinations for β and M0 exist
in the second solution. However, the conditions for unique determination of all
individual parameters and for global identifiability of the model are found to be
the same.
4.4.2 Age Domain Model Analysis
As discussed in Section 2.4, population-level epidemiological measures of infectious
disease can, in principle, be recorded with respect to both time and age. A struc-
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tural identifiability analysis of age domain model variants is therefore required to
establish whether key parameters within the model are uniquely determined by
corresponding age dependent outputs, or if a combination of both age and time
domain observations might improve system identifiability.
An age domain variant of the fundamental (homogeneous) MSIR model structure
(3.14)-(3.17) can be derived according to Section 3.3.4, see equations (3.45)-(3.45).
The system is considered to be at a constant endemic steady state with respect to
time, and is expressed in the following standard form:
f(x(a, p), p) =

−ωMM(a, p)
ωMM(a, p)− (λ+ µ)S(a, p)
λS(a, p)− (v + µ)I(a, p)
 ,
h(x(a, p), p) = kI(a, p), (4.46)
x0(p) =
(
µ ˆAb+ µ ˆAb− 0
)T
.
The force of infection is therefore given by, λ = βIˆ/N , where Iˆ is the endemic
steady state level of infection (3.54). The recovered/immune state variable, R(a, p),
is omitted from the set of system equations given that it does not influence any
previous states in the natural history of infection and is hence not observable from
a prevalence or incidence output. It should also be noted that if an observation of
incidence is considered, then the model is further reduced to only the maternally
protected and susceptible state variables, M(a, p) and S(a, p). In this instance,
the infective state variable, I(a, p), is also no longer observable via the output
structure, since homogeneous transmission does not permit age dependency within
the force of infection, i.e. Iˆ =
∫ ∞
0
Iˆ(a, p) da is a constant. In addition, the recovery
parameter, v, cannot be estimated unless algebraic expressions for the force of
infection and endemic steady states are substituted into the model.
Provided that constant (annual average) values are taken for λ, i.e. the infective
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population is not included within the force of infection as an age dependent state
variable, the model (4.46) is found to be linear. In this instance, a state transfor-
mation based structural identifiability analysis may be implemented, where φ(x)
is an invertible linear map of the form:
φ(x) =

t11 t12 t13
t21 t22 t23
t31 t32 t33


M
S
I
 . (4.47)
Using condition (4.14) of Theorem 6:
h(φ(x(a, p˜)), p) = k
(
t31M(a, p) + t32S(a,p) + t33I(a, p)
)
= h(x(a, p˜), p˜) = k˜I(a, p),
(4.48)
from which it is seen that t31 = 0, t32 = 0 (given that all parameters, specifically
k and k˜, must be positive), and t33 = k˜/k.
Further satisfying (4.12) and (4.13) yields:
φ(x) =
(
k˜ ω˜M λ˜ M
k ωM
+ t12S + t13I,
k˜
([
v+µ−(v˜+µ˜)]I+λ˜S)
kλ
,
k˜I
k
)T
, (4.49)
where
t12 = 0,
k˜
(
ω˜M − (v˜+µ˜)
)
kλ(v˜+µ˜)
, and t13 = 0,
k˜(v˜−λ˜)(v+µ−ω˜M)
kλ(v˜+µ˜)
. (4.50)
The mapping gives rise to six local sets of solutions for p˜ ∼ p, comprising of
various combinations of ωM , µ, λ and v. It is subsequently found that all model
parameters are unidentifiable, and a minimum of at least three out of the four
inter-compartmental flow coefficients and either k or N are required to be known
for the system to be structurally globally identifiable.
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Substituting steady state expressions for ˆAb+ = Rˆ, ˆAb− = Sˆ + Iˆ and λˆ = βIˆ/N
from (3.54) is seen to further impede the identifiability of p (including the trans-
mission parameter β) for an age domain prevalence output structure. However,
if the resulting conditions for p˜ ∼ p from analysis of an age domain MSIR are
combined with those of the time domain equivalent model (4.42), the following
conditions are obtained:{
ω˜M = ωM , µ˜ = µ, β˜ = β, v˜ = v,
k˜N˜ = kN, k˜M˜0 = kM0, k˜S˜0 = kS0, k˜I˜0 = kI0
}
,
(4.51)
where only k or N are required for the system to be globally structurally iden-
tifiable. Since (4.51) is a subset of (4.42), this suggests that despite the model
parameters appearing to be poorly defined by age domain observations of infec-
tion prevalence, additional information could be elicited if also combined with
equivalent time domain measurements of the same system.
4.5 A Cautionary Note
In all worked examples presented in this chapter, the analysed model structures
have been reduced to either a two or three state system through the omission
of the ‘recovered’ state variable, R(t, p). This simplification is possible provided
there is a constant population size, N , and was initially performed in an effort to
minimise algebraic computation. However, it has since transpired that this model
reduction is in fact a necessary step in order to attain full identifiability results for
compartmental epidemic models.
Considering the SIRS example described in Section 4.3.2, a complete identifiability
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analysis yields the following set of conditions for p˜ ∼ p:
{
v˜ = v, µ˜− β˜ =µ− β, ω˜R + β˜ = ωR + β,
β˜S˜0
N˜
+ω˜R =
βS0
N
+ωR, k˜I˜0 = kI
0,
k˜N˜
β˜
=
kN
β
}
.
Implementing the analysis using the unreduced system equations:
f(x(t, p), p) =

µN + ωRR(t, p)− βS(t, p)I(t, p)/N − µS(t, p)
βS(t, p)I(t, p)/N − (µ+v)I(t, p)
vI(t, p)− (ωR+µ)R(t, p)
 ,
h(x(t, p), p) = kI(t, p), (4.52)
x0(p) =
(
S0 I0 R0
)T
,
where x(t, p) = (S(t, p), I(t, p), R(t, p))T , is a state vector, and S0, I0 and R0 are
the initial conditions for the susceptible, infective and recovered states respectively,
an alternative (incorrect) result can be found:
{
v˜ = v, µ˜ =µ, β˜ = β, ω˜R = ωR,
k˜N˜ = kN, k˜S˜0 = kS0, k˜I˜0 = kI0, k˜R˜0 = kR0
}
.
In this case the parameters µ, β and ωR are incorrectly claimed to be globally
identifiable, where in the full result it can be seen that they are non-uniquely
determined within larger parameter combinations.
The discrepancy between the two analyses occurs due to a lack of linear indepen-
dence in the resulting multivariate polynomials that arise from condition (4.13) of
Theorem 6. This can be shown by considering the additional system equation:
N = S(t, p) + I(t, p) +R(t, p), (4.53)
which is inherently included within the reduced two state model, but remains
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undefined in the full three state model. Analysis of the latter model description
(4.52) ultimately leads to the evaluation of the following multivariate expression:
q1 + q2S(t, p˜) + q3I(t, p˜) + q4R(t, p˜) = 0, (4.54)
where the monomial coefficients are subsequently solved in order to elicit relations
between indistinguishable parameter vectors p and p˜. It is required that the re-
sulting equation (4.54) be identically equal to zero. However, in this instance, it
can be seen that q1=q2=q3=q4=0 is not a unique solution, since, from equation
(4.53), the solution q1=N, q2=q3=q4=−1 also satisfies (4.54). Therefore, if all
state variables are to be included, the expression given by (4.53) must be stated
additionally within the defining set of system equations.
This example emphasises the importance of checking for linear independence dur-
ing structural identifiability analyses and provides an interesting illustration of
how incorrect results may be obtained if this is not satisfactorily fulfilled.
4.6 Indistinguishability in Epidemic
Modelling
The significance of indistinguishability analyses in the area of compartmental epi-
demic modelling is illustrated as a worked example by Evans et al. [2004]. It is
shown that from purely prevalence data, it is not possible to structurally distin-
guish between a simple SIR model with solid lifelong immunity (2.1)-(2.4) and an
SIRS model with temporary/waning immunity (2.15)-(2.4). The consequence of
this result is that from perfect, noise free and continuous output data it is not pos-
sible to determine which postulated model structure best describes the observed
behaviour of the real system, and hence make inferences about the underlying
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biological processes at work (i.e. whether or not immunity wanes over time since
infection). More crucially, depending on which of the two competing model struc-
tures are assumed, there are two possible sets for estimated values of the basic
reproduction number, R0, and thereby the proportion of the population required
to be successfully vaccinated in order to achieve eradication and herd immunity.
Given that the SIR model can be considered as a submodel of the SIRS model,
where the waning immunity parameter, ωR, equals zero, the results of this analysis
can also be extracted from those of an identifiability analysis applied to an SIRS
model, as derived in Section 4.3.2. Setting ωR = 0 in (4.26), hence reducing model
Σ(p) (4.1) to that of a fundamental SIR model (2.1)-(2.4), yields an equivalent
set of algebraic relations between p and p˜ to those found by Evans et al. [2004],
corresponding to structurally indistinguishable systems (Σ(p) ∼ Σ˜(p˜)):
{
v˜ = v, µ˜− β˜ = µ− β, ω˜R + µ˜ = µ,
β˜S˜0
N˜
+ω˜R =
βS0
N
, k˜I˜0 = kI0,
k˜N˜
β˜
=
kN
β
}
.
(4.55)
In the case of the MSIR/MSIRS models it can be seen from (4.43) that the waning
immunity parameter is globally identifiable, therefore setting either ωR or ω˜R to
zero invalidates both sets of conditions, inferring that the two models are struc-
turally distinguishable. The same result can be deduced for a general SIR and an
SIR with partial immunity, where again the former can be considered as a sub-
model of the latter, and the distinguishing parameter σ is found to be globally
identifiable (see the conditions given by (4.33)).
Interestingly, further consideration of the results given by (4.23), indicates that
from a prevalence type output, it is not possible to distinguish between a general
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SIR and one with birth targeted vaccination, provided:
{
µ˜ = µ, v˜ = v, β˜(1− P˜v) = β,
k˜S˜0 = kS0, k˜I˜0 = kI0,
k˜N˜
β˜
=
kN
β
}
.
(4.56)
It should be noted that for competing systems where neither model can be consid-
ered as a submodel of the other, for example SIR framework models with either
temporary or partial immunity, the constraints (4.11)-(4.14) of Theroem 6 are
extended according to Evans et al. [2004].
4.7 Conclusions & Discussion
The key results of this chapter arise from the application of structural identifiabil-
ity/indistinguishability analyses to fundamental SIR and MSIR framework models,
incorporating various processes of sub-optimal immunity and immunisation. It has
been found that the actual vaccination coverage, Pv, achieved after employing a
birth targeted immunisation campaign on any of the discussed SIR framework
models, cannot be uniquely determined from ideal prevalence data. The addition
of vaccination also serves to force important parameters associated with the natu-
ral basic reproduction number and the re-infection threshold to be unidentifiable.
This outcome may prove important given that the proportion of vaccinees that
successfully take an administered vaccine and acquire sufficient protection is often
very difficult to measure directly, and this work suggests that the discussed vacci-
nation models are not appropriate for estimating this effective coverage. It is also
shown, in the case of the SIRS model, that it is not possible to uniquely determine
the potential success of even an ideal birth targeted vaccination programme with
respect to eradication of the infectious agent.
It should be noted that in both the SIR and SIRp cases, if R0 (specifically β)
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or the combination kN is known, perhaps from fitting the unvaccinated model
to pre-vaccination prevalence data, then Pv can be uniquely identified. However,
estimates from pre-intervention data are only appropriate if the parameters β, k
and N can be confidently considered to have remained constant over the period
of time corresponding to pre- and post-vaccination. Confidence in the consistency
of these parameters is limited given the variable nature of population sizes and
the observation gain (notification bias), and the dependency of infection trans-
mission on changing social and environmental trends. The consequence of this is
that assuming the selected model structure remains appropriate for the system,
it cannot be uniquely determined whether an applied vaccination programme has
failed due to an increase in R0 or from an inadequate Pv. It is suggested that these
results may have direct relevance to the current problem of post-vaccine measles
persistence in the UK.
Application of these techniques to both time and age domain MSIR framework
models has suggested that parameters are analytically better defined by time series
observations than by those recorded with respect to age. However, in all presented
time domain examples, the parameter ωM , corresponding to waning protection
from MAb, has been found to be locally identifiable, where two distinct sets of
solutions exist. If a physical distinction between estimated values for ωM and the
birth/mortality rate coefficient, µ, can be made, or the conditions can be combined
with those relating to an age domain analysis, the results are reduced to a single set
of conditions where many important parameters associated with epidemiological
characteristics and intervention become globally identifiable.
Although the models considered in this work are very basic, and would not be
the primary basis for a national public health intervention, extended models with
greater depth of realism and additional complexity are unlikely to reduce the iden-
tifiability problem given increasing degrees of freedom and continued limitations
on the observation of the system. In all the examples presented, the parameters
N and k are found to be unidentifiable, indicating that either the observation gain
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or the population size must be known in order to obtain qualitative estimates of
infection from fitting to prevalence type data.
All worked examples have been presented using the nonlinear state transformation
method detailed in Section 4.2.3, and verified using either the DAISY or DiffAlg
implementations of the differential algebra approach (see Section 4.2.2). Perfor-
mance differences between the two techniques appear to be minimal, hence, there
were no examples of models that could be successfully analysed by one technique
and not the other. Unfortunately, the inclusion of further model complexity aris-
ing from epidemiological characteristics such as altered secondary infections, age
dependency, and alternative observations such as incidence and serology, require a
computational capacity in excess of that available during this work using either of
the two methods. The DAISY software module is potentially more suitable for the
casual user looking to obtain quick results, however, the algebraic manipulation
package, REDUCE, although freely available, is unfortunately no longer supported
by its developers.
Chapter 5
Formal Sensitivity Analysis
The theoretical techniques for structural identifiability and indistinguishability dis-
cussed in Chapter 4 have provided analytic results regarding indeterminacy issues
in compartmental epidemic modelling. However, these methods do not provide
any indication of how well globally identifiable parameters might be determined
by a chosen output structure. There is subsequently no guarantee that estimation
of these parameter values will be robust in the presence of experimental error.
Such aspects of uncertainty and model indeterminacy in the inverse problem are
typically addressed by the strongly related concepts of sensitivity, numerical iden-
tifiability and experimental design [Banks et al., 2007].
In contrast to structural identifiability techniques, sensitivity based methods are
concerned with the quantitative responses of models to the perturbation of in-
puts and parameters, or some variation in structure, connectivity and submodels
[Nestorov, 1999]. In a validation sense these techniques give an indication of con-
fidence in the estimation of a particular model parameter from a given set of
experimental input/output data. In analysis, they also provide an insight into
the potential influence of specific physical processes over the observable behaviour
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of the system. Sensitivity techniques are therefore often used as the basis for
methods concerned with model reduction and experimental design [Banks and
Cintro´n-Arias, 2010].
Parameters that are found to have an insignificant influence on the observable
behaviour of the system may be omitted from a postulated model structure in
order to reduce excessive computation and aid tractable analysis (for examples
see the work by Fink et al. [2007, 2008], Degenring et al. [2004], and Smets et al.
[2002]). Conversely, output structures and sampling intervals that prove to be
highly sensitive with respect to certain parameters of interest may be prioritised
in the design of future experiments, thereby maximising the amount of information
gained from fitting to data (see the work by Kappel et al. [2009], and Ogungbenro
et al. [2009]).
It is the objective of the work in this chapter to explore the implementation of
formal sensitivity methods to compare a number of prospective age and time do-
main output structures, corresponding to observations of infection and serology,
with respect to the MSIR model framework proposed in Chapter 3. The intention
is then to establish how well parameters associated with maternally acquired im-
munity might be determined by various observations of the real system and also
to consider the potential influence of these processes on various aspects of sys-
tem behaviour. The analysis is performed according to the work by Vajda et al.
[1985] on models residing at endemic equilibrium. Analytic results are derived
for systems without seasonal forcing and numerical results obtained for those that
include annual variation with time.
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5.1 Methods & Application
In describing the derivation of parametric sensitivities we consider the standard
nonlinear system:
Σ(p) =

x˙(t, p) = f(x(t, p), p),
y(t, p) = h(x(t, p), p),
x(0, p) = x0(p),
(5.1)
where x(t, p) is an n-dimensional vector of state variables and y(t, p) denotes an
m-dimensional output. It should be noted that both x(t, p) and y(t, p) may be
defined as functions of either time, t, or age, a.
For a given function of time (or age), y(t, p), which is also a differentiable func-
tion of some parameter vector p = (p1, p2, ..., pq)
T , the point or local sensitivities
indicate the rate of change of y(t, p) with respect to p, evaluated at some nominal
point in parameter space, p0 [Jacquez, 1996]. In this case, the sensitivity functions
correspond to partial derivatives of the form:
Si(t, p) =
∂y(t, p)
∂pi
, (5.2)
which are considered as gradients about p0 in a q-dimensional parameter space,
given as a function of time.
In simple examples it may be possible to evaluate sensitivity derivatives analyti-
cally from tractable solutions of the system equations, thus allowing general results
to be obtained. However, in most cases, increasing model complexity inhibits the
direct calculation of these functions and a numerical approach must be adopted
instead. In this instance, parametric sensitivity is estimated from manual manip-
ulation (perturbation) of the individual model parameters and observation of the
resulting deviation in the output (see the book by Tomovic´ [1963]). Subsequently,
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this approach yields only a local analysis about the point p0, whereby an initial
estimate for a nominal set of parameters values is required prior to evaluation.
This may prove problematic in cases where there are high levels of uncertainty in
our prior knowledge of the system.
The generalisation of local analyses over wider regions of parameter space has been
attempted through a number of statistical techniques using Monte Carlo simulation
[Archer et al., 1997; Kleijnen, 1997]. However, numerical based global evaluation
of non-monotonic systems remains a challenging task since adjacent sample points
in p may only coincidently yield similar behaviour of y(t, p). Computation also
becomes increasingly intensive with larger numbers of parameters.
5.1.1 Formal Derivation
The sum of squares deviation of an output function, y(t, p), from some nominal
point, y(t, p0), due to a variation ∆p in p, can be expressed in the form:
Q(p) =
r∑
j=1
[y(tj, p)− y(tj, p0)]2, (5.3)
for the selected time points {t1, t2, ..., tr}. The function Q(p) is an analytic
function of p, which has a Taylor series expansion about the point p0 given by,
Q(p) ≈ Q(p0)+(∆p)TG(p0)+ 1
2
(∆p)TH(p0)∆p, (5.4)
where the variation ∆p is sufficiently small such that terms of O(‖∆p‖3) can be
considered negligible. Since p0 is assumed to minimise Q(p), the gradient vector,
G(p0), defined by [G]i = ∂Q/∂pi, and the term Q(p0) are both equal to zero.
Therefore, the expression given by (5.4) can be further reduced to:
Chapter 5 5.1 Methods & Application 113
Q(p) ≈ 1
2
(∆p)TH(p0)∆p, (5.5)
where [H]ij = ∂
2Q/∂pi∂pj is the Hessian matrix of Q (matrix of second derivatives
with respect to p). The q by r sensitivity matrix, S, where 2S TS ≈ H, can then
be constructed according to the selected time points {t1, t2, ..., tr} in the following
manner:
S =

∂ y(t1, p)
∂ p1
. . .
∂ y(t1, p)
∂ pq
...
. . .
...
∂ y(tr, p)
∂ p1
. . .
∂ y(tr, p)
∂ pq
 . (5.6)
hence allowing (5.5) to be rewritten as:
Q(p) ≈ (∆p)TS TS∆p. (5.7)
Alternatively, following the work of Vajda et al. [1985], a normalised parameter
vector, α, where αi = ln pi for i = 1, 2, . . . , q, may be defined. The resulting
normalised sum of squares deviation of the output function y(t, α), from a nominal
point, y(t, α0), to a change ∆α in α, can then be expressed by:
Q(α) =
r∑
j=1
[
y(tj, α)− y(tj, α0)
y(tj, α0)
]2
, (5.8)
hence replacing the response equation in (5.8). This results in the generation of a
normalised sensitivity matrix of the form:
S =

∂ ln y(t1, p)
∂ ln p1
. . .
∂ ln y(t1, p)
∂ ln pq
...
. . .
...
∂ ln y(tr, p)
∂ ln p1
. . .
∂ ln y(tr, p)
∂ ln pq
 . (5.9)
In cases where analytic solutions to (5.1) are not practically obtainable, the partial
derivatives of the sensitivity matrix are calculated numerically using either finite
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differencing [Chapra and Canale, 2002] or direct differential methods [Rabitz et al.,
1983]. The latter of these techniques involves solving an augmented system of
equations derived by differentiating h(x(t, p), p) in (5.1) with respect to p and
switching the order of differentiation:
dS(t, p)
dt
=
∂h(x(t, p), p)
∂x
S(t, p) +
∂h(x(t, p), p)
∂p
. (5.10)
The state variables, Si(t, p), corresponding to the sensitivity derivatives given by
(5.2), are then found using a suitable ODE integrator such as ode15s in MATLAB.
The other derivative components in (5.10) can be calculated using automatic dif-
ferentiation methods based on repeated application of the chain rule. These can
be implemented using additional MATLAB modules such as myAD [Fink, 2006] or
MAD [Forth and Ketzscher, 2004].
5.1.2 Numerical Identifiability & Model
Reduction
Since sensitivity analyses are largely concerned with assessing the relationships
between model output structure and parameter values, there are strong parallels
with the problems of structural identifiability discussed in Chapter 4. Given that
an observable change in output, ∆y(t, p), is governed by the sensitivity matrix,
S, identifiability can be assessed numerically by considering whether or not the
expression ∆y(t, p) = S∆p can be solved uniquely for a particular ∆p [Batzel
et al., 2009].
Definition 7. For a nominal parametrisation p0 ∈ Ω, a model, Σ(p), is said to be
sensitivity identifiable if the sensitivity matrix, S, has full rank, or equivalently if
and only if the matrix S TS is non-singular (i.e.
∣∣S TS∣∣ 6= 0). If S is shown not to
Chapter 5 5.1 Methods & Application 115
have full rank then the model is found to be unidentifiable at the point p0 [Batzel
et al., 2009].
It should be emphasised that sensitivity identifiability applies only to a single,
nominal point in parameter space and is therefore not indicative of global identi-
fiability. The analysis is also not strictly an a priori technique since it requires an
initial estimation of the model parameters to be made before evaluation.
Additional analysis of the sensitivity matrix can be performed through either QR
factorisation with column pivoting, as in the work by Fink et al. [2007], and Banks
and Cintro´n-Arias [2010], or a principal component analysis (PCA), according to
Vajda et al. [1985], Curtis and Sweetenham [1987], and Degenring et al. [2004].
These techniques allow the ranking of varied model parameters with respect to
their relative importance, for the purpose of model reduction through subset se-
lection.
A PCA can be implemented by means of an eigenvalue-eigenvector decomposition
of the matrix STS = UΛUT , where S is typically the normalised sensitivity matrix
given by (5.9), such that U denotes the matrix of normalised eigenvectors, ui, for
i = 1, 2, . . . ,m, and Λ corresponds to a diagonal matrix of eigenvalues, λi. The
normalised response function, Q(α) ≈ (∆α)TS TS∆α, can then be redefined in
terms of the principal components Ψ = UTα,
Q(Ψ) =
m∑
i=1
λi ‖∆Ψi‖2 , (5.11)
given that ∆Ψi = u
T
i ∆α = (ui,1∆α1 + . . .+ui,m∆αm). Consequently, the function
Q is most sensitive to changes in α along the principal axis corresponding to the
largest eigenvalue and is least sensitive to changes in α along the principal axis
corresponding to the smallest eigenvalue.
If λi is not small, hence the corresponding principal component is a significant one,
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a small value for a particular ‖ui,j‖ indicates that the corresponding parameter αi
contributes little to the component. It is suggested by Vajda et al. [1985] that any
element of ui with magnitude less than 0.2 can be excluded from consideration.
The justification is that they contribute less than 4% to the sum of squares of
relative changes in y(t, α) as the parameters vary in the direction of the principal
component.
5.2 Static Sensitivity Analysis of Time
Domain MSIR Models
The objective of this work is to explore the results of a formal sensitivity anal-
ysis applied to a series of fundamental MSIR framework models, as described in
Sections 3.3 and 3.4. The outcome of a structural identifiability analysis (see the
results from Section 4.4) has shown that the parameter ωM is at least analyti-
cally significant to the output of these systems. However, it does not provide any
quantitative indication of the magnitude of this influence.
It is intended that the analyses in this chapter illustrate how the processes of
reinfection, age structure and the implementation of simple public health inter-
vention conveyed by these models might affect the sensitivity/determinability of
characteristics associated with protective MAb. In the following section a sensi-
tivity analysis is initially performed on time domain MSIR type models residing
at endemic equilibrium, without the inclusion of seasonal forcing.
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5.2.1 Fundamental MSIR Model
The homogeneous, time domain MSIR model is defined by the differential equa-
tions (3.14)-(3.17), and shown as a connectivity diagram in Figure 3.1. Provided
that the basic reproduction number, R0 > 1, it is found in Section 3.3.5 that the
system has the following stable endemic fixed point equilibrium:
Mˆ =
Nvµ(β−(µ+v))
β(µωM+v(µ+ωM))
, Sˆ =
N(µ+v)
β
, Iˆ =
ωM
v
Mˆ, Rˆ =
ωM
µ
Mˆ. (5.12)
Sensitivity functions corresponding to the various epidemiological observations de-
scribed in Section 2.4 can then be found algebraically about this equilibrium by
taking partial derivatives according to (5.2).
For a time domain prevalence observation, where y(t, p) = I(t, p), the magnitude
and normalised sensitivities of the output equilibrium point, yˆ(p) = Iˆ, with respect
to the MAb parameter ωM , are found, respectively, to be given by:
∂ yˆ(p)
∂ ωM
=
Nvµ2(β − (µ+v))
β(µωM + v(µ+ωM))2
,
∂ ln yˆ(p)
∂ lnωM
=
µv
µωM + v(µ+ωM)
. (5.13)
Alternatively, for an incidence observation, where yˆ(p) = βSˆIˆ/N , given that Sˆ is
not a function of ωM , the normalised sensitivity function is identical to that of a
prevalence output and the absolute (non-normalised) sensitivity function is simply
scaled by a factor of βSˆ/N = µ+ v.
Finally, if the output structure corresponds to a serological type observation, where
yˆ(p) = N − Sˆ − Iˆ, since again Sˆ is not a function of ωM , the non-normalised
sensitivity function is the same as for yˆ(p) = −Iˆ (prevalence). The normalised
sensitivity function is then found to be of the form:
∂ ln yˆ(p)
∂ lnωM
=
−µ2ωM
(µ+ ωM)(µv + ωM(µ+ v))
. (5.14)
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If, as in many SIR type infections, v >> µ (i.e. duration of infection is consider-
ably less than average life expectancy), then the following parameter combination,
which is a scaling between the magnitude of the normalised prevalence and sero-
logical sensitivity functions, adheres to the inequality:
µωM
v(µ+ ωM)
< 1. (5.15)
Therefore, the magnitude of the normalised sensitivity values for prevalence and
incidence observations will be greater than that of a serological type observation
by a factor approximately equal to v/µ.
It can also be seen that the normalised sensitivity functions for all three obser-
vation types are only dependent on the parameters µ, v and ωM ; hence they are
independent of the population size, N , and, more interestingly, the transmission
parameter, β. Furthermore, if v >> µ, it is shown, by dividing the second expres-
sion in (5.13) through by v, that the normalised sensitivity functions for incidence
and prevalence type outputs have only a negligible dependence on the rate of
recovery.
Substituting typical values of v = 73 yr−1 (average duration of 5 days) and µ =
0.010, 0.014 and 0.028 yr−1 (life expectancy of 100, 71 and 36 years respectively)
from the set of nominal parameter values for measles (see Table 3.1), the normalised
sensitivity function for an incidence or prevalence type observation can be plotted
against varying ωM (see Figure 5.1). Near identical relations are also found for the
more complicated case where neonatal mortality is included in the model (see the
proportional input structure described by (3.18)).
Subsequently, it can be seen that higher birth/mortality rates (i.e. lower life
expectancy) and a higher duration of maternal immunity (i.e. lower ωM) give rise
to a heightened sensitivity to ωM . This is because the influence of maternally
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Figure 5.1: Static normalised sensitivity functions corresponding to an incidence
or prevalence type observation of a fundamental MSIR system at endemic equilib-
rium; computed for varying ωM and discrete values of µ.
Table 5.1: Normalised sensitivity values for all MSIR model parameters evaluated
at nominal values corresponding to pre-vaccine measles in the UK.
Parameter µ N β v ωM
Prevalence 0.9963 1.0000 0.0588 -1.0586 0.0035
Incidence 0.9965 1.0000 0.0588 -0.0588 0.0035
Serological -0.0020 1.0000 0.0588 -0.0586 −6.7×10−7
acquired immunity on overall infection levels occurs due to a reduction in the
susceptible proportion of the population. The influence is therefore dependent
on the density age profile of the population as a whole, which is governed in the
heterogeneous case by an age dependent mortality function.
For completeness, Table 5.1 contains the normalised sensitivities with respect to
all system parameters in the MSIR model structure, corresponding to each of the
three considered outputs. The values are calculated similarly to those presented
for ωM , i.e. in the second part of (5.13) and (5.14), and are evaluated at the
nominal values for pre-vaccine measles in the UK given in Table 3.1.
It can be seen that ωM is clearly the least sensitive parameter in the model for all
three observation types. In addition, it also appears that the model as a whole
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is least well determined by a serological-type output structure, with respect to
parameter sensitivity.
5.2.2 MSIR Models with Incomplete Immunity
Epidemic systems that include processes of reinfection through antigenic variability
have the potential to support considerably higher levels of endemic infection, and
consequently a significantly lower average age at primary challenge. The steady
state analysis is therefore applied to MSIR framework models with various forms
of incomplete immunity, in order to explore how these processes might impact
output sensitivity with respect to characteristics associated with MAb.
MSIRS with Temporary/Waning Immunity
A basic MSIRS model structure with temporary/waning immunity can be derived
from the full incomplete immunity system described in Section 3.3.1. This is
achieved by setting altered secondary infection parameters, σ = 1, γ = 1 and
v1 = v2 = v in equations (3.20)-(3.26), and then combining primary/secondary
state variables such that S(t) = S1(t) + S2(t) and I(t) = I1(t) + I2(t).
Steady state solutions to the this system at endemic equilibrium, are given by
(3.62), where an observation corresponding to the prevalence of infection is subse-
quently found to be of the form:
yˆ(p) =
ωMN
(
ωR + µ
)(
β − (µ+v))
β
(
ωM(µ+ωR) + v(µ+ωM)
) . (5.16)
The solution for an incidence output may also be deduced by simply multiplying
(5.16) by a factor of (µ+ v). In this instance, the normalised sensitivities for inci-
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dence and prevalence output structures, derived with respect to ωM using equation
(5.6), are both found to be given by,
∂ ln yˆ(p)
∂ lnωM
=
µv
ωM(µ+ωR) + v(µ+ωM)
. (5.17)
Similarly to the fundamental MSIR model, it can be seen that the function is
only dependent on the parameters µ, v, ωM and ωR, and hence not on either the
population size, N , or the transmission parameter, β. Comparing these expressions
with those of the MSIR (complete lifelong immunity i.e. ωR = 0) in equation
(5.13), it can be seen that provided ωR > 0, the normalised sensitivity of yˆ(p) with
respect to ωM is always lower for the SIRS system.
Nominal values of v = 73 yr−1 (average duration of 5 days), µ = 0.014 yr−1 (life
expectancy of 71 years) and ωM = 2, 4 and 12yr
−1 (protective duration of 6, 3 and
1 months respectively), are substituted for comparison with Section 5.2.1, where
the normalised sensitivity functions for an incidence or prevalence observation of
an MSIRS can be plotted against ωR (see Figure 5.2).
Figure 5.2: Normalised sensitivity functions for an incidence or prevalence observa-
tion of a MSIRS system with waning/temporary immunity; computed at endemic
equilibrium, for varying ωR and discrete values of ωM .
Alternatively the model may be parametrised with nominal values corresponding
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to hRSV (Tables 3.2 and 3.3(C)), an infectious disease more commonly observed to
display secondary infection in hosts. However, it has already been noted that the
normalised sensitivity function (5.17) is not dependent on transmission, β, and has
only a negligible dependence on v. Therefore, if the infection is considered within
the UK (i.e. maintaining population parameters µ and N), the relations shown in
Figure 5.2 are found to be the same for both nominal parametrisations.
MSIRS2 with Incomplete Immunity & Secondary Infection
An immediate limitation of the simple MSIRS model is the amalgamated represen-
tation of both primary and secondary (repeat) infection as a single state variable.
In order to distinguish the sensitivity of ωM with respect to primary and sec-
ondary cases, the full MSIRS2 incomplete immunity model (3.20)-(3.26) described
in Section 3.3.1 is analysed accordingly.
Nominal values are substituted for hRSV (Table 3.2), where demographic pa-
rameters such as birth/mortality rates, µ = 0.014 yr−1, and population size,
N = 5.7× 107, remain the same as in previous examples for infection in the
UK. Disease specific parameters such as the rate of recovery from primary and
secondary infection, v1 = 40.56 yr
−1 and v2 = 107.35 yr−1 respectively (average
durations of 9 and 3.4 days), loss of protection from MAb, ωM = 2yr
−1 (protective
duration of 6 months), and the force of infection λˆ = 0.84 (average age at primary
infection of around 14.2 months) are fixed throughout the analysis.
Additional model parameters that do not appear to be as well defined in the
literature, such as ωR (loss of active immunity), σ (partial immunity factor) and
γ (reduced infectivity factor) are varied across their valid ranges. In this instance,
ωR is varied between 0 and∞ yr−1, and the proportions σ and γ are varied within
the interval, [0, 1], where it should be noted that the extreme values of 0 and 1
effectively alter the structure of the model. The unknown transmission parameter,
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β, is continuously adjusted in order to maintain a constant force of infection,
λˆ = 0.84. Subsequently, changes in the three varied parameters (ωR, σ and γ)
generate a shift in the dominance of primary and secondary cases with respect to
overall population infectivity.
The resulting normalised sensitivity functions corresponding to changes in ωM
are illustrated in Figures 5.3 and 5.4, for fixed values of γ = 0.6 (proportional
infectivity of secondary cases) and ωR = 0.67 yr
−1 (average duration of active
immunity of 18 months) respectively.
If the secondary infectivity parameter, γ, is fixed, then the normalised sensitivities
for ωM can be calculated with respect to varying ωR (rate that actively protected
individuals lose immunity and become partially susceptible) for a range of σ ∈ [0, 1]
(proportional degree of partial susceptibility).
Figure 5.3: MSIRS2 model endemic equilibrium normalised sensitivity func-
tions for ωM corresponding to primary (blue) and secondary (black) preva-
lence/incidence of infection. Computed with nominal values for hRSV and
ωM = 2 yr
−1, for varying ωR and contrasting values of σ.
These relations are shown in Figure 5.3, where it can be seen that the processes
of temporary/waning and partial immunity have contrasting effects on the nor-
malised sensitivity of ωM . An increase in ωR (i.e. shortening the duration of
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active immunity) causes a significant reduction in the sensitivity of both primary
and secondary infection, see also the SIRS model results in Figure 5.2. However,
an increase in σ (i.e. a decrease in partial protection afforded by experience of
infection) gives rise to an increase in sensitivity of ωM . This is likely to occur due
to the corresponding effects of these processes on transferable MAb in the wider
population. An increase in ωR has the direct effect of reducing the average period
of time that potentially child bearing individuals experience protective levels of
antibody. Conversely, an increase in σ acts to increase the rate of reinfection,
which subsequently leads to greater levels of population immunity.
Alternatively, for fixed ωR = 0.67 yr
−1 (average duration of active immunity of
18 months), the sensitivity relations corresponding to varying σ ∈ [0, 1] and γ ∈
[0, 1], are evaluated and shown in Figure 5.4. It can be seen from the results
that the normalised sensitivity of ωM is a monotonically increasing function with
respect to both σ and γ. However, for observations of primary infection, the
change in sensitivity due to varying γ is extremely small (note that all plot lines
corresponding to primary infection are overlaid in Figure 5.4).
Figure 5.4: Steady state normalised sensitivity profiles to ωM for a MSIRS2 model
with a prevalence/incidence output and nominal values for hRSV. Plots correspond
to primary (blue) and secondary (black) infection, for varying σ and discrete values
of γ.
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In all analysed examples, the normalised sensitivity of ωM is considerably lower
for observations of primary infection than for secondary infection. This may seem
contrary to the intuitive assumption that maternally acquired immunity has, at
least in the age domain, a greater, more direct degree of interaction with primary
challenge. However, in the absence of age related heterogeneity, influence over
population-wide infection levels arise purely from the proportional removal of po-
tential infectives. In this instance, baseline fluctuations in primary transmission
are often amplified through the reinfection process leading to a greater normalised
change in secondary cases.
5.3 Static Sensitivity Analysis of Age
Domain MSIR Models
At a fixed point (non-seasonally forced) endemic equilibrium, observations of in-
fection and serology are static with respect to time, but still vary with respect to
age. The following section describes a static sensitivity analysis applied to a set
of equivalent (non-heterogeneous) age domain MSIR models (as derived in Sec-
tion 3.3.4), in order to establish parameter sensitivity with respect to age. Homo-
geneous age domain models of this type are linear in form, where output solutions
and corresponding sensitivity relations can be found analytically using symbolic
manipulation software such as MATHEMATICA [Wolfram, 1999] or MAPLE [Heal
et al., 1998].
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5.3.1 Fundamental (Homogeneous) MSIR
Recalling from Section 3.3.4, for a non-seasonally forced MSIR system, residing at
a fixed point endemic equilibrium (in time), a linear, purely age dependent system
of equations can be derived (3.40)-(3.44) with the following analytic solution for
an incidence observation:
y(a, p) =
λˆµe−a(µ+λˆ)
[
ˆAb−(λˆ+µ−ωM) + ωM ˆAb+(ea(λˆ+µ−ωM )−1)
]
λˆ+ µ− ωM
. (5.18)
The seropositive and seronegative populations are assumed to be ˆAb+ = Rˆ and
ˆAb− = Sˆ + Iˆ respectively, where the processes of neonatal fertility and mortality
(i.e. from state M(a)) are removed according to the discussion on proportional
birth rates in Section 3.3. The average force of infection is given by λˆ = βIˆ/N , and
steady state variables by the expressions in (5.12). Sensitivity functions are found
symbolically according to (5.2), for all three observation types, through partial
differentiation of the appropriate output solutions (i.e. (5.18) for incidence) with
respect to p. In this instance, sensitivity functions are found to be age dependent
and, algebraically, considerably more complex than those of the static time domain
examples in Section 5.2.
The normalised sensitivity expressions for ωM are evaluated at the nominal pa-
rameter values corresponding to pre-vaccine measles in the UK (Table 3.1), and
displayed in Figure 5.5 with a prevalence output age profile. Figures 5.6 and 5.7
then illustrate how the three sensitivity curves change with varying basic repro-
duction number (R0 = 8 and R0 = 80), and rate of loss of maternally protected
neonates (ωM = 1 and ωM = 12), respectively.
It can be seen from comparing the relations in Figure 5.6 and Figure 5.5, that
an increase in infectivity (subsequently lowering the average age at primary in-
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Figure 5.5: Age profile normalised sensitivity functions for incidence, prevalence
and serological outputs of a fundamental MSIR system at endemic equilibrium.
Sensitivities are evaluated with respect to ωM at nominal parameter values for
pre-vaccine measles in the UK (i.e. R0 = 18).
fection) reduces the peak age of sensitivity for all three observation types, but
has contrasting effects on their magnitude. For low values of R0, peak sensitivity
for the serological observation is notably larger than that of prevalence and inci-
dence. However, while the latter two output sensitivities increase with higher R0,
serological sensitivity is found to decrease.
Variation in the sensitivity curves between different values of ωM are elicited from
comparison of the plots in Figures 5.5 and 5.7. The results show that the peak
sensitivity for a serological observation varies considerably more than that of the
prevalence and incidence outputs, which remain relatively unchanged at around
0.7. The age at peak sensitivity appears to decrease for all observations with
increasing ωM , which corresponds accordingly to a decrease in the average duration
of acquired protection, ω−1M .
In all five examples there are no noticeable differences between the sensitivity
characteristics of incidence and prevalence outputs. However, it does appear that
the peak sensitivity for a serological type observation occurs consistently later in
age. This result may prove to be significant in cases where there are limitations
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(a) Sensitivity Profiles for R0 = 8 (b) Sensitivity Profiles for R0 = 80
Figure 5.6: Prevalence, incidence and serological output normalised sensitivity
functions corresponding to changes in ωM , for contrasting values of basic repro-
duction. Results computed at time domain endemic equilibrium with nominal
parameter values for pre-vaccine measles in the UK.
(a) Sensitivity Profiles for ωM = 1 (b) Sensitivity Profiles for ωM = 12
Figure 5.7: Age profile normalised sensitivity functions for ωM , evaluated at en-
demic equilibrium with nominal values for pre-vaccine measles in the UK and at
contrasting values for ωM .
on the observation of clinical disease or on the collection of serological samples in
very young infants.
In addition to peak values in sensitivity, it should also be noted that there are
key points in age for all output types where the sensitivity of ωM is equal to
zero. Interestingly, the peak age of sensitivity (0.075 and 0.45 years for incidence
or prevalence and serological outputs respectively, where R0 = 18 and ωM = 4)
appears well below both the average age at primary infection (calculated in this
case to be 3.97 years) and the peak age of infection (0.75 years, see Figure 5.5). It
should also be noted that in all cases, peak normalised sensitivities are found to
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be significantly greater than those recorded for the static time domain examples
in Section 5.2.1.
5.3.2 MSIRS with Temporary/Waning
Immunity
Following the derivation of the linear age domain MSIR in Section 3.3.4, a purely
age dependent system of equations can also be derived for an MSIRS model with
temporary waning immunity. This is performed with the inclusion of an additional
intercompartmental flow representing the process of recovered individuals losing
active immunity and becoming fully susceptible to infection. Normalised sensitiv-
ity functions are again found symbolically from analytical solutions of the three
observation types according to (5.2). The resulting expressions are found to be
considerably more complex than those of the fundamental MSIR (5.18) since the
state variable solutions for S(a) and I(a) become additionally dependent on R(a)
and hence also on I(a).
For comparison with the MSIR model results shown in Figure 5.5, normalised sen-
sitivity functions for the MSIRS model (see Figure 5.8) are evaluated at nominal
parameter values taken from Table 3.1, where the waning active immunity param-
eter, ωR, is set to 0.5, 1.8 and 4yr
−1 (protective duration of 24, 6.67 and 3 months,
respectively).
The profiles in Figure 5.8 show that the initial peak in normalised sensitivity
for prevalence or incidence observations are largely unaffected by variations in the
rate that recovered individuals lose actively acquired immunity. However, for lower
values of ωR (i.e. longer durations of active immunity) a secondary, more variable,
sensitivity peak occurs at around 9-10 months of age. Interestingly, this region
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(a) Sensitivity for Incidence/Prevalence (b) Sensitivity for Serological Observation
Figure 5.8: Normalised sensitivity curves to changes in ωM , for an age domain
incidence/prevalence and serological observations of a MSIRS system; evaluated
at endemic equilibrium, for various values of ωR.
of sensitivity becomes negative in magnitude indicating a positive relationship
between infection prevalence (infective state variable I(a)) and the duration of
maternally acquired immunity, ω−1M , (i.e. a greater duration of protection from
MAb acts to increase infection levels at certain ages).
In contrast to prevalence/incidence outputs, normalised sensitivity functions cor-
responding to serological type outputs are much more variable with respect to
changes in ωR. Shorter durations of actively acquired immunity (i.e. increasing
ωR) give rise to considerably lower sensitivity to changes in ωM , see also Figure 5.5
where ωR = 0.
5.4 Dynamic Sensitivity Analysis of
Seasonally Forced Models
As discussed in Section 2.1.3, many common infections such as measles, mumps
and rubella (MMR), influenza and hRSV tend to display large (seasonal) recurrent
epidemics at endemic equilibrium rather than settling to a constant level of trans-
mission. This limit cycle behaviour is captured by time series data of prevalence,
incidence or serology (see Figure 2.3) and often used for the estimation of epidemic
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model parameters through data fitting (for examples see the work by Weber et al.
[2001], White et al. [2007], and White et al. [2005]).
The following section aims to address the question of parameter sensitivity for
characteristics associated with MAb in this context, through the dynamic analysis
of MSIR framework models that include temporal variation. Since there are no
convenient analytic solutions to the MSIR framework models when system pa-
rameters are allowed to vary dynamically with time, the analysis must resort to
numerical methods, as outlined in Section 5.1.
5.4.1 Fundamental MSIR Model with Seasonal
Forcing
Temporal variation of the transmission function is included in the homogeneous
MSIR model (3.14)-(3.17) as a simple sinusoidal function of time of the form:
β(t) = β0
(
1 + β1 cos
[
2pi(t− φ)]), (5.19)
where β1 defines the magnitude of the annual variation and φ corresponds to
the phase (annual timing). Nominal parameter values are again substituted for
pre-vaccine measles in the UK (Table 3.1), where additionally, β1 = 0.046 and
φ = 0.019.
In order to perform a dynamic sensitivity analysis on the seasonally forced MSIR,
an augmented system of differential equations are derived according to (5.10).
In this instance, the dependent variables correspond to the dynamic sensitivity
functions described by (5.2). The system of sensitivity equations are then solved
numerically, for each of three output structures, using the ode15s ODE integrator,
and the myAD automatic differentiation module [Fink, 2006] in MATLAB version
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R2009b. The computation is performed on an RM desktop machine with a Pen-
tium D 3.4GHz CPU and 1Gb of RAM, using a maximum step size of 0.001 years.
Prior to analysis, the simulation is run for a suitable period of settling time (i.e.
250 years) in order to allow the system solutions to converge satisfactorily close
to their endemic limit cycle. The normalised sensitivity matrix, given by (5.6), is
then generated for all 7 model parameters (i.e. p = (µ,N, β0, β1, φ, v, ωM)
T ), with
sample points taken at uniform time intervals of 0.01 years, for ten complete annual
cycles. Figures 5.9 and 5.10 show the resulting deviation in the sum of squares
function, Q(α), to a unit change in lnωM , i.e. normalised sensitivity squared, for
incidence or prevalence and serological outputs respectively.
Figure 5.9: Sum of squares deviation to a unit change in lnωM (normalised sen-
sitivity squared), for an MSIR model with seasonal forcing and a prevalence or
incidence output; evaluated with nominal parameter values for measles in the UK.
The system is seen to exhibit biennial epidemic behaviour in accordance with
documented observations of pre-vaccine measles in the UK [Keeling and Grenfell,
2002], where the normalised sensitivity of ωM is found also to be periodic with a
time period of 2 years. Near identical results were obtained for both prevalence and
incidence observations, with normalised sensitivity to ωM varying between -0.037
and 0.032 throughout the biennial cycle. In contrast, the normalised sensitivity for
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Figure 5.10: Sum of squares deviation to a unit change in lnωM (normalised
sensitivity squared), for a seasonally forced MSIR model with a serological type
output structure; evaluated with nominal parameter values for measles in the UK.
a serological type observation varies only between −5.26× 10−5 and 2.41× 10−4.
Figures 5.11 and 5.12 show the resulting dynamic sensitivity functions for a preva-
lence/incidence observation where ωM = 1 and 6 yr
−1 respectively (i.e. average
duration of maternally acquired immunity of 12 and 2 months). In this instance
Figure 5.11: Normalised sensitivity (squared) with respect to ωM , for a prevalence
or incidence observation of a seasonally forced MSIR model, computed with the
nominal UK measles parameter set and ωM = 1 yr
−1
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Figure 5.12: Normalised sensitivity (squared) with respect to ωM , for a prevalence
or incidence observation of a seasonally forced MSIR model, computed with the
nominal UK measles parameter set and ωM = 6 yr
−1
the normalised sensitivity functions are found to be amplified with decreasing ωM
(increasing duration of protection). It can be seen from the outputs of the two sim-
ulations that the peak sum of squares deviation to a unit change in lnωM is more
than 10 times greater for an average duration of 12 months than for 2 months.
In all cases the point of maximum (magnitude) normalised sensitivity does not
necessarily align with the biennial peak in the corresponding observation. This is
an interesting result as it suggests, for example, that prevalence or incidence data
collected for validating this particular characteristic of the MSIR model, would
not be optimally sampled around the time of maximum epidemic behaviour. It
can also be seen that there are regions for all output types where the sensitivity
to ωM is positive and negative, and hence two points during each biennial cycle
where the normalised sensitivity of y(t, p) is equal to zero.
Further analysis of the resulting sensitivity matrix for all examples show that it
has full rank (i.e. S TS is non-singular), indicating that the MSIR model is sensi-
tivity identifiable (see Definition 2 in Section 5.1.2) at p0 corresponding to the UK
measles parameter set. This result is consistent with those of a structural iden-
tifiability analysis given in (4.42), see Section 4.4, since the unknown observation
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Table 5.2: Principal component analysis of the normalised sensitivity matrix corre-
sponding to a MSIR model with seasonal forcing. Computed at nominal parameter
values for pre-vaccine measles in the UK and sampled at 0.01 year intervals over
a 10 year period.
No. Eigenvalue µ N β0 β1 φ v ωM
1 561135 0.236 -0.022 0.270 -0.044 -0.927 -0.095 0.002
2 312054 0.560 -0.115 0.710 0.108 0.323 0.230 0.001
3 7952.76 0.366 0.395 -0.009 -0.306 0.174 -0.766 0.003
4 1074.88 0.300 0.594 -0.269 0.672 -0.065 0.170 -0.002
5 32.7887 -0.187 -0.423 0.146 0.662 0.032 -0.567 0.064
6 0.07314 -0.378 0.309 0.357 0.048 0.001 -0.047 -0.794
7 0.00054 0.479 -0.451 -0.450 0.003 -0.000 -0.002 -0.605
gain, k, is neglected i.e. k = 1, and the parameters µ and ωM are distinguishable
from their nominal values.
For completeness, the relative influences of all MSIR model parameters are exam-
ined by means of a singular value decomposition of the normalised S TS matrix,
see Section 5.1.2 and the work by Vajda et al. [1985]. Table 5.2 shows the magni-
tude of the resulting principle components and the relative contributions of each
individual model parameter.
It can be seen that the magnitude of the principal components range between
5.4×10−4 and 5.6×105. The parameter ωM is clearly the least influential parameter
in the model, making significant contributions (i.e. absolute value greater than 0.2
[Vajda et al., 1985]) to only the two smallest components. In this instance an
elemental value of 0.002 corresponds to a 0.0004% contribution to the sum of
squares deviation in y(t, p), in the direction of the largest eigenvalue. It can also
be noted that despite a tenfold increase in the peak sum of squares deviation for
ωM = 1 yr
−1, see Figure 5.12, the resulting PCA reveals no greater contribution to
all but the smallest principal component. In contrast, all other model parameters
appear to be well defined by the chosen outputs, with significant influence over at
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least one of the three major components.
5.4.2 Seasonally Forced Models with Incomplete
Immunity
In order to extend the analysis using nominal values for hRSV, the process of
seasonal forcing is applied to an appropriate epidemic model with incomplete im-
munity. An existing example of a seasonally forced model of this type is the 17
compartment, time domain, ODE based MSEIRS4 model, proposed by Weber
et al. [2001]. It has been developed as a more realistic representation of the epi-
demiological mechanisms associated with reinfection and accumulating acquired
immunity, observed with hRSV.
The model has been chosen for analysis in this work because it is very closely
related to the MSIRS2 model structure proposed in Section 3.3.1 and has also been
previously fitted to four separate sets of empirical data [Weber et al., 2001]. A
formal sensitivity analysis can therefore be performed using fitted nominal values,
in order to study the influence of maternally acquired immunity on observations
of primary infection, and hence, the determinability of ωM . It should be noted
that this is not intended as a critique of the work published by Weber et al. [2001],
given that the flow rate coefficient ωM is not a fitted parameter in their parameter
estimation, and the influence of maternal immunity was not the focus of their
study, or the subject of any inference from the results.
The set of system equations corresponding to the MSEIRS4 model are given in
Appendix A. The first four infections in the natural history of the disease are
distinguished by separate state variables (i.e. Si(t), Ei(t), Ii(t) and Ri(t) for
i = 1, . . . , 4), where Ei(t), for i = 1, . . . , 4, represents a latent incubation period
with an average duration of ζ−1. In this instance, baseline susceptibility decreases
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Table 5.3: MSEIRS4 model parameters for hRSV in Gambia, Florida, Finland &
Singapore [Weber et al., 2001]; values for µ, v, ωM , ωR, & ζ given in yr
−1.
Location µ β0 β1 φ v ωM ωR ζ σ1 σ2 σ3
Gambia 0.041 256 0.20 0.26 36 13 1.8 91 0.50 0.35 0.25
Florida 0.016 268 0.13 0.03 36 13 1.8 91 0.50 0.35 0.25
Finland 0.013 192 0.39 0.19 36 13 1.8 91 0.50 0.35 0.25
Singapore 0.016 260 0.12 0.00 36 13 1.8 91 0.50 0.35 0.25
with successive experience of infection, following a temporary period of full pro-
tection upon recovery from each infection. Therefore, it can be noted that the
MSIRS2 model, given by (3.20)-(3.26), can be derived from the MSEIRS4 model
by neglecting the incubation stages and considering only the first two infections.
The analysis is performed using the nominal set of fitted parameter values, ex-
tracted from the work by Weber et al. [2001], corresponding to hRSV in The
Gambia, see Table 5.3. In a similar manner to the MSIR example, the sensitivity
matrix is generated numerically once the simulation has satisfactorily converged to
a stable endemic limit cycle. Sample points are again taken at uniform 0.01 year
intervals, for 10 complete annual cycles. Figures 5.13 and 5.14 show the resulting
deviation in the sum of squares function, Q(α), due to a unit change in lnωM ,
for primary prevalence or incidence and serological type outputs respectively. The
dynamic sensitivity functions are given with respect to time, and presented against
their corresponding output functions.
It is found that the sensitivity of ωM for all output types is periodic with a time
period of 1 year. Near identical results are obtained for prevalence and incidence
outputs (peak absolute value of 0.078), however, the normalised sensitivity of ωM
for a serological observation is found to be significantly smaller in magnitude (peak
absolute value of 0.005) and peaked at slightly different points in time. There are
again also two points during each epidemic period where the sensitivity of y(t, p)
with respect to ωM is equal to zero. The point of maximum sensitivity for all out-
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Figure 5.13: Resulting sum of squares deviation, Q(α), in a prevalence/incidence
observation of a seasonally forced MSEIRS4 model, to a unit change in lnωM
(normalised sensitivity squared); evaluated at nominal values for hRSV in The
Gambia.
Figure 5.14: Sum of squares deviation to a unit change in lnωM (normalised
sensitivity squared), for a serological observation of a seasonally forced MSEIRS4
model; evaluated with nominal parameter values for hRSV in The Gambia.
puts does not necessarily align with the annual peak in the corresponding obser-
vation, although their position relative to the annual epidemic cycle is comparable
to that of the measles example shown in Figures 5.9 and 5.10.
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It can also be noted that by removing seasonal forcing from the model (i.e. setting
β1 = 0), hence forcing the system to converge to a fixed point endemic equilibrium,
the analysis gives rise to a steady state normalised sensitivity value in the region
of 0.0014 for a prevalence or incidence observation of primary infection. This value
appears to be consistent with the results shown in Figure 5.3, which correspond to
the normalised sensitivity of an unforced MSIRS2 model, at endemic equilibrium,
with nominal values for hRSV in the UK.
The MSEIRS4 system is found to be sensitivity identifiable, i.e. the sensitivity
matrix, S, has full rank for all three observations, however, through a singular
value decomposition of S TS, it is also shown that ωM is again poorly defined by
time series infection dynamics. It can be seen from Table 5.4, which shows the
individual parameter contributions to the resulting principal components of Q(α),
that ωM contributes to only the 5th, 6th, 7th and 8th principal components, which
are between 104 and 108 times smaller than the largest.
Similar results were also obtained for parameter sets estimated using epidemic
data from Finland, Florida and Singapore [Weber et al., 2001], suggesting that
the regional variation in parameter values observed in these cases does not have a
significant impact on sensitivity.
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5.5 Conclusions & Discussion
A formal sensitivity analysis has been applied to a set of contrasting ODE epidemic
models, with various observation structures, for two common viral diseases. The
objective has been to assess the determinability of parameters associated with
passive immunity from MAb, and hence, also estimate the magnitude of their
influence over the static, dynamic and seasonal characteristics of system behaviour.
The analysis has indicated that the corresponding sensitivity of community-wide
transmission levels is potentially increased by processes associated with a greater
duration of protection from MAb, higher fertility rates and partial immunity. It
has also been shown for homogeneous cases that changes in the rate that mater-
nally protected neonates become fully susceptible has a much greater influence on
epidemiological measures recorded with respect to age than with respect to time.
A potential limitation of the analysis in this work has arisen from the consideration
of only homogeneous transmission, immunity and fertility etc. It is possible that
greater output sensitivity may be generated from small perturbations in ωM if, for
example, the peak age of transmission occurs close to that of the average dura-
tion of waning maternal antibody. However, the analysis of heterogeneous PDE
based systems is found to be substantially more challenging using techniques asso-
ciated with automatic differentiation and the accuracy of most numerical methods
do not permit the implementation of finite differencing given that time domain
sensitivities are found to be in the region of 10−3.
Implications for the Estimation of MAb Parameters
All worked examples have consistently shown near identical normalised sensitivity
results, corresponding to changes in ωM , for observations of incidence and preva-
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lence in either domain. This suggests that it is not critical which of the two data
types are used with respect to parameter estimation within these model struc-
tures. In addition, no examples were found where it may be beneficial to utilise a
serological type observation recorded with respect to time.
In all dynamic and static age domain analyses it has been shown that there are
key regions, both in the annual epidemic cycle (i.e. with respect to time) and
in the average age profile, that correspond to peak, and conversely, zero sensi-
tivity to variation in all unknown model parameters. This indicates that the use
of prior experimental design and optimal sampling could be of great benefit in
maximising confidence during parameter estimation and potentially minimising
unnecessary data collection. In the age domain, analysis of the considered models
has shown comparable peak values in normalised sensitivity for serological and
prevalence/incidence outputs. However, these peaks tend not to occur at the same
points in age, and have contrasting dependencies on the basic reproduction number
and nominal value of ωM . Similarly in the time domain, maximal output sensitiv-
ity to ωM appears in all cases not to coincide with the annual or biennial epidemic
peak in infection and differs again between observations of prevalence/incidence
and serology.
A comparison of results corresponding to equilibrium observations of systems with
constant and seasonally varying transmission suggests that changes in ωM can
potentially have a more significant impact on dynamic behaviour than on overall
levels of infection. However, in all dynamic time domain examples the parameter
was still clearly found to be one of the least sensitive in the model. Consequently,
MSIR framework models with time domain output structures are likely to be
inappropriate for estimating characteristics associated with maternally acquired
immunity. Moreover, through the use of techniques such as subset selection, these
models may be acceptably reduced by omitting the immunising effects of MAb if
the purpose of the model is to achieve reasonable estimates for other parameters
such as those associated with transmission.
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More promisingly, analysis has shown that maternally acquired immunity has a
much greater influence on epidemiological observations recorded with respect to
age than with respect to time. However, the results of a structural identifiabil-
ity analysis, described in Chapter 4, have shown that these parameters are not
uniquely determined by age domain output structures. One possible resolution to
this problem might be to simultaneously fit equivalent model structures to both
age and time domain data sets; although this is likely to involve dedicated epidemi-
ological studies beyond those which are typically conducted for the two infections
discussed in this work. In addition, the particularly young age in peak sensitiv-
ity of all age domain observations could be a major hindrance in the selection of
suitably high fidelity sample points in this region.
Chapter 6
Model Analysis & Numerical
Simulation
The role of maternally acquired immunity within the observed characteristics of
many infectious diseases remains largely unclear. Models have been proposed in
Chapter 3 that aim to describe some of the fundamental epidemiological processes
associated with MAb, such that their influence over a broad range of system be-
haviour may be explored. It is the objective of this chapter to provide additional
analysis of these models and present examples of their use in assessing the potential
impact of mass maternal immunisation on systems with differing epidemiological
characteristics.
In the absence of appropriate data, the scope of this work is unable to extend to the
validation of quantitative predictions regarding intervention outcomes for specific
infections. Instead, the aim is to provide a more qualitative analysis using a range
of typical values extracted from the literature (see Section 3.5). It is intended that
the work highlights some of the potential effects of mass maternal immunisation
on static, dynamic and seasonal characteristics of infection, and to encourage the
discussion of how prospective interventions of this type may be more optimally
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implemented in future public health policy. Specific areas of interest include:
• The potential impact of maternally targeted intervention on the incidence of
neonatal infection and the average age of primary contraction.
• Possible outcomes regarding population-wide prevalence of infection.
• How the potential success of maternal immunisation might be subject to:
◦ The force of infection / average age at primary infection.
◦ Processes associated with reinfection, including the distribution/dominance
of primary and secondary infectivity.
◦ Heterogeneity in the population age profile and transmission function.
• The potential interaction of mass maternal immunisation with early child-
hood targeted vaccines.
• The dynamic consequences of system perturbation due to rapid implemen-
tation of an intervention campaign.
• Seasonal targeting of prospective intervention strategies for systems with
temporal forcing.
To address these issues, Section 6.1 presents a continuation of the preliminary
steady state analysis described in Section 3.3.5, where a number of ODE-based time
domain models are used to explore the impact of various combinations of passive
and active intervention effort on the overall prevalence of infection. Relations are
elicited for varying degrees of antibody interaction between vaccines, reinfection
and discrete age dependent fertility/mortality.
A more detailed analysis of potential age specific infection patterns resulting from
maternal immunisation is presented in Section 6.2. The analysis uses various
implementations of the continuous age domain model described in Section 3.4.2,
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with MAb titre distribution characteristics elicited from the literature for hRSV.
Finally, in Section 6.3, a number of the proposed models are used to explore the
consequences of intervention on the time dynamic behaviour of systems with and
without seasonal forcing.
6.1 Time Domain Steady State Analysis
In keeping with the work flow of previous chapters, the following section considers
the characteristics of ODE-based time domain models residing at a fixed point
equilibrium. In this instance, the effects of temporal variation are neglected and
age dependency is included only in the discrete compartmentalised form described
in Section 3.4.1. The analysis is performed in order to gain insight into the poten-
tial dependencies of population-wide infection levels on prospective intervention
strategies.
Analytic solutions are found according to Section 6.2.1 using the symbolic manip-
ulation package MATHEMATICA (version 7.0.0). However, solutions to systems
more complex than those previously considered in the preliminary analysis of Sec-
tion 3.3.5 are typically too expansive to include explicitly. In these cases, key
relations are illustrated graphically using typical parameter values and appropri-
ate intervals of variation.
6.1.1 Fundamental MSIR
The foundation for all prior analyses in this work has been the fundamental MSIR
model shown by Figure 3.1. In this instance, the model is considered with the
addition of maternal (passive) and potentially interacting childhood (active birth
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targeted) immunisation as described in Section 3.3.3. The system equations are
derived from the full incomplete immunity model (3.33)-(3.38) by removing the
state variables corresponding to secondary infection (i.e. S2(t) and I2(t)) and set-
ting the parameter ωR equal to zero. It should be recalled that the proportions Pm
and Pv correspond to the application of maternal and birth targeted immunisation
respectively, which are applied in terms of the net birth rate, µN . The interaction
between neonatal immunity derived from the two intervention types and natural
infection experience of the mother is described by the parameter ϑ.
The system has a single, stable equilibrium point corresponding to either eradica-
tion or endemic persistence of the infectious agent. In the absence of any interven-
tion, these equilibrium points are delineated by the bifurcation point, R0 = 1. For
R0 > 1 and under suboptimal intervention, an endemic level of infection transmis-
sion is observed, which is subsequently dependent on the proportions Pm, Pv and
ϑ. Evaluating this equilibrium using nominal values for pre-vaccine measles in the
UK (Table 3.1), a series of relations between endemic prevalence of infection and
various combinations of intervention effort, with and without antibody interaction,
are elicited and shown in Figure 6.1.
(a) Primary infection profiles for ϑ = 0. (b) Primary infection profiles for ϑ = 1.
Figure 6.1: Endemic prevalence of infection for specific proportions of birth tar-
geted vaccination, Pv, and antibody interaction, ϑ, with respect to maternal immu-
nisation, Pm, and evaluated at nominal parameter values for pre-vaccine measles
in the UK.
It can be seen from the two graphs in Figure 6.1 that the model predicts both
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interventions would have a positive impact on reducing the transmission of the
pathogen. In the absence of antibody interaction, i.e. ϑ = 0, Figure 6.1(a) shows
that in this example it is possible to force the disease free equilibrium to become
stable and eradicate the infectious agent. However, for high values of ϑ, the efficacy
of birth targeted vaccination is significantly reduced. In Figure 6.1(b), high levels
of antibody interaction are seen to prevent the eradication of the infection by
means of the considered intervention strategy.
Following the analysis in Section 2.2.1, an eradication threshold for ϑ can be found,
above which, too few newborns successfully respond to the active vaccine and herd
immunity can no longer be achieved. The system Jacobian matrix is evaluated at
the disease free equilibrium, with maximum maternal and birth targeted immuni-
sation (i.e. Pm, Pv = 1). This gives rise to a set of eigenvalues:
λ1 = −2µ,
λ2 = −(ωM + ϑµ), (6.1)
λ3 = −v − 2µ+ ϑβωM
2(ϑµ+ ωM)
,
which are always negative and real provided the interaction parameter adheres to
the following inequality:
ϑ <
2(v + 2µ)ωM
βωM − 2vµ− 4µ2 . (6.2)
Evaluating (6.2) with respect to the UK measles parameter set (Table 3.1), it is
found that for eradication of the infection to be possible, ϑ < 0.11.
From Figure 6.1(b) it can be seen that for ϑ = 1, the minimum prevalence of infec-
tion that can be achieved is 9675 cases (a reduction of 611 cases or 5.94%). This
limit in efficacy occurs since only newborns born to fully susceptible mothers will
benefit from either of the two immunisations. As population immunity is raised,
the number of successful birth targeted vaccinations quickly diminish, restricting
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the impact of the intervention. If maternal immunisation is successfully applied to
all pregnant women, i.e. Pm = 1, then all newborns will be protected by MAb and
potentially none will respond to the active vaccine. This result emphasizes the ef-
forts of Williams et al. [1995] and Nicoara et al. [1999] who discuss the importance
of targeting childhood vaccination beyond the average duration of MAb.
An expression approximating the average age at primary infection predicted by
the model may be derived similarly to those of the MSIR (3.19) and MSIR with
maternal immunisation only (3.61), and given in the following form:
Av ≈ µˆM
µˆM + µˆS
(ω−1 + λ−1) +
µˆM
µˆM + µˆS
(λ−1), (6.3)
where
µˆM = µ(1−(1−ϑ)Pv)
[
ˆAb++Pm ˆAb−
]
,
µˆS = µ(1−Pv)(1−Pm) ˆAb−.
The function is based on a weighted average of the corresponding proportions of
seropositive (Ab+) and seronegative Ab− newborns, excluding those who success-
fully respond to the active (birth targeted) vaccine and avoid primary infection.
The resulting relations between the average age at primary infection, the two forms
of intervention and their interactions are illustrated by Figure 6.2, which is evalu-
ated again with respect to the UK measles parameter set (Table 3.1). It should be
noted, with respect to Figure 6.2(a), that for values of Pm, Pv and ϑ that result
in the eradication of the infectious agent, an average age at primary infection can
no longer be calculated.
It can be seen from the two graphs in Figure 6.2 that again both interventions have
a positive impact on the average age at primary infection. However, in cases where
there are high levels of antibody interaction the benefits of active immunisation
are substantially limited.
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(a) Average age of infection for ϑ = 0. (b) Average age of infection for ϑ = 1.
Figure 6.2: Average age at primary infection for specific proportions of birth tar-
geted vaccination, Pv, and antibody interaction, ϑ, with respect to maternal im-
munisation, Pm; evaluated at nominal parameter values for pre-vaccine measles in
the UK.
All results in this section suggest that if the detrimental effects of antibody interac-
tion are reduced then active immunisation is by far the most effective intervention
with respect to wider population infection. However, the characteristics that have
been discussed in this section are potentially accentuated by the solid and lifelong
immunity assumed by the MSIR model. In this case, a particularly high propor-
tion of the population is seen to reside in a seropositive state, leading to naturally
high levels of MAb among newborns.
6.1.2 Models with Incomplete Immunity
To explore the outcomes of intervention implemented within systems where active
immunity is incomplete, the analysis is applied to the MSIRS2 model structure
proposed in Section 3.3.3. The model is described by the set of system equations
(3.33)-(3.39), where it can be recalled that the additional state variables S2(t) and
I2(t) correspond to characteristics associated with altered secondary infections.
The parameters ωR, σ and γ describe, respectively, the rate of loss of active immu-
nity, a reduced risk of secondary infection and a reduction in secondary infectivity.
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As discussed in Section 3.3.1, in cases such as hRSV it is often unclear whether the
more significant source of transmission is from primary or secondary infectivity.
In the MSIRS2 model, higher values of σ and γ result in a greater prevalence of
reinfection, which may subsequently dominate the behaviour of the system and
the overall force of infection. In contrast to the MSIR example, rapid waning of
active immunity yields lower numbers of seropositive individuals throughout the
childbearing population, leading also to fewer numbers of children born with pro-
tective levels of MAb. The objective of this analysis is therefore to explore whether
the static influence of maternal immunisation over wider population transmission
is affected by the balance of primary and secondary infection.
The MSIRS2 system is found to have a single, stable equilibrium point correspond-
ing to either eradication or endemic persistence of the infection. Provided that the
invasion threshold is met, an endemic level of transmission is observed, which is
subsequently dependent on the intervention parameters, Pm, Pv and ϑ. The equi-
librium is evaluated at nominal parameter values for hRSV (Table 3.2), where
the secondary infection parameters, ωR, σ and γ, and the transmission parameter,
β, are varied to encompass a spectrum of infectivity biases, whilst maintaining a
constant force of infection.
The resulting relations between the endemic prevalence of primary infection and
various combinations of intervention effort, for primary and reinfection dominated
transmission, with and without antibody interaction, are shown in Figure 6.3. For
Figures 6.3(a) and 6.3(b) the secondary infection parameters are set to: ωR =
1.8 yr−1 (average duration of immunity of 6.67 months), σ = 1 and γ = 1, which
correspond to the upper interval values given by Table 3.3(C). In order to maintain
a typical force of infection for hRSV of λ = 0.84 yr−1, the transmission parameter
is set to β = 152 yr−1.
For comparison, Figures 6.3(c) and 6.3(d) show the relations that result from
parameterising the model such that it emulates an MSIR type structure, where
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only primary infection contributes to the overall force of infection. In this instance,
ωR = 0 yr
−1 (lifelong immunity), σ = 0, γ = 0, and subsequently, β = 2490 yr−1
(see Table 3.3(A)).
(a) Primary infection profiles evaluated at
ωR = 1.8 yr
−1, σ = 1, γ = 1 & ϑ = 0.
(b) Primary infection profiles evaluated at
ωR = 1.8 yr
−1, σ = 1, γ = 1 & ϑ = 1.
(c) Primary infection profiles evaluated at
ωR = 0 yr
−1, σ = 0, γ = 0 & ϑ = 0.
(d) Primary infection profiles evaluated at
ωR = 0 yr
−1, σ = 0, γ = 0 & ϑ = 1.
Figure 6.3: Endemic prevalence of primary infection for specific proportions of
birth targeted vaccination, Pv, and antibody interaction, ϑ, with respect to mater-
nal immunisation, Pm. Evaluated at parameter values corresponding to reinfection-
dominant, (a)-(b), or primary infection-dominant, (c)-(d), transmission.
The results indicate that, when applied independently, both the active and passive
immunisation methods yield a positive impact on the prevalence of primary infec-
tion. For high values of ϑ, the efficacy of the active vaccine is once again inhibited
through its interaction with MAb. However, in the absence of maternal immuni-
sation, i.e. Pm = 0, it can be seen that the childhood vaccine is considerably more
effective within the reinfection system than the MSIR (primary infection) system.
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This is likely to be a result of waning population immunity, which subsequently
leads to a reduction in the number of seropositive newborns. It should also be
noted that since the transmission parameter, β, is reduced in order to maintain
a constant force of infection in the presence of greater secondary infectivity, the
basic reproduction number, R0, is subsequently decreased.
When a combination of the two interventions is applied with high levels of in-
teraction, it can be seen from Figure 6.3(d) that the MSIR-type system displays
qualitatively similar results to that of the measles example shown in Figure 6.1(b).
In this instance, birth targeted vaccination is predominantly limited by naturally
occurring levels of MAb, such that it is still beneficial to implement the passive
vaccine. However, in the reinfection example (Figure 6.3(b)), where natural levels
of MAb are low, maternal immunisation has a significantly detrimental effect on
the efficacy of the active vaccine. This implies that in situations where mater-
nal immunisation is likely to interact with an existing or prospective childhood
vaccine, its application should be considered with caution.
(a) Average age of infection for ϑ = 0. (b) Average age of infection for ϑ = 1.
Figure 6.4: Average age at primary infection for specific proportions of birth tar-
geted vaccination, Pv, and antibody interaction, ϑ, with respect to maternal immu-
nisation, Pm; evaluated at nominal parameter values for hRSV where ωR = 1.8yr
−1,
σ = 1 and γ = 1.
The resulting relations between the average age at primary infection and the ap-
plied interventions are calculated for the reinfection example using equation (6.3)
and shown in Figure 6.4. In contrast to the results shown in Figure 6.3(b), it can
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be seen from Figure 6.4(b) that for ϑ = 1, maternal immunisation has a beneficial
impact on the average age at primary infection at Pv = 0 and Pv = 0.5. Comparing
the two graphs at Pv = 0.5 suggests that the implementation of mass maternal im-
munisation may have a positive influence on the average age at primary infection,
despite raising overall prevalence.
6.2 Static Analysis Age Domain
In order to obtain a more detailed description of infection patterns in neonatal
and young infant age classes, it is necessary to consider the evolution of the sys-
tem state variables continuously with respect to age. Section 3.4.2 describes an
alternatively derived PDE-based MSIR model structure that also includes a more
empirical representation of MAb titres among newborns. The model is therefore
focussed more directly on waning neonatal immunity and infection, rather than
that of the population as a whole. The dependency of the maternally protected
population is decoupled from the dynamics of susceptibility and immunity in the
wider population, and determined purely from static serological observations.
The objective of this section is to demonstrate how the model may be used in order
to explore specifically how the implementation of mass maternal immunisation
might affect the age profile of primary infection incidence and the number of cases
among infants below a target age. Static age profiles are extracted from numerical
simulations generated using typical values and characteristics derived from the
literature, and a number of speculative age varying transmission functions that
emulate potential routes of infection.
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6.2.1 Methods & Application
The model is initially considered as a fundamental MSIR system, without the
additional complexities of sup-optimal immunity and altered secondary infections.
Recalling from Section 3.4.2, the system is defined by the following set of nonlinear
partial differential equations:
∂M(t, a)
∂t
+
∂M(t, a)
∂a
= −Q(t, a)− µd(a)M(t, a), (6.4)
∂S(t, a)
∂t
+
∂S(t, a)
∂a
= Q(t, a)−[λ(t, a)+µd(a)]S(t, a), (6.5)
∂I(t, a)
∂t
+
∂I(t, a)
∂a
= λ(t, a)S(t, a)− [v(a) + µd(a)]I(t, a), (6.6)
∂R(t, a)
∂t
+
∂R(t, a)
∂a
= v(a)I(t, a)− µd(a)R(t, a), (6.7)
where
λ(t, as) =
1
N
∫ ∞
0
β(t, as, ai) I(t, ai) dai. (6.8)
The boundary conditions correspond to the current birth rates of seronegative and
seropositive newborns, given by,
M(t, 0) =
∫ ∞
τ
C(t, Ab) dAb, S(t, 0) =
∫ τ
0
C(t, Ab) dAb, I(t, 0) = 0, (6.9)
where the function C(t, Ab) describes a random distribution of cord log antibody
titres. The rate at which maternally protected newborns become fully susceptible
to infection is then described by the expression:
Q(a) = ωM C(ωMa+τ) e
−∫ a0 µd(α)dα. (6.10)
The work by Williams et al. [1995] suggests the use of a Gaussian distribution as
an appropriate model for population MAb titres in measles and this assumption
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is also adopted in this work. Nominal characteristics for maternally acquired
antibodies are derived according to those observed for hRSV by Cox et al. [1998],
where similar characteristics have also been reported by Ochola et al. [2009]. In
this instance, the static cord titre distribution Cˆ(Ab) has mean, C¯ = 3.0 log AU,
and standard deviation, σC = 0.39, where the rate of MAb decay, ωM , is 3.67 yr
-1,
and the threshold for susceptibility, τ is 1.7 log AU.
Since the dependency of newborn serology is decoupled from that of the child
bearing population, the process of age dependent fertility is not considered and a
constant inflow of births is represented by the integral of Cˆ(Ab) with respect to
Ab. The resulting birth rate coefficient is subsequently assumed to be equal to
that used in previous examples such as for the UK (µ = 0.014) or The Gambia
(µ = 0.041).
An age dependent mortality function, µd(a), is chosen to emulate Type I sur-
vivorship, that is where mortality rates are greatest among older individuals. The
resulting population age distribution, N(a), is generally regarded as a better ap-
proximation to human populations than that of Type II survivorship (where µd(a)
is a constant coefficient), particularly for populations in more developed countries
[Anderson and May, 1991]. For simplicity, this is implemented as a step function
of the form:
µd(a) =
 0 for a ≤ L,∞ for a > L, (6.11)
where L = µ−1 corresponds to the average life expectancy. In the context of
the model, which is focussed predominantly on primary infection in neonatal age
classes, the most significant aspect of this assumption is the resulting neglection
of infant mortality. Again this is reasonable for the consideration of developed
populations, where mortality rates in the first year of life are typically less than
1%, however, it may be less appropriate for communities in developing regions.
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Maternal immunisation is applied to the model according to Section 3.4.3, where
a function VM(Ab) (a random distribution of scalar increases in log AU) is used to
manipulate the initial cord log antibody titre distribution, C(t, Ab), such that,
Cv(t, Ab) = (1− Pm)C(t, Ab) + Pm
∫ Ab
0
C(t, z)VM(Ab/z)
C¯
dz. (6.12)
The distorting function, VM(Ab), is again assumed to be Gaussian, where V¯M and
σVM denote the mean and standard deviation of this distribution, respectively. As
in previous examples, the parameter Pm corresponds to the proportion of pregnant
women who successfully respond to the vaccine. The best documented example of
a candidate vaccine trial of this type for hRSV is that presented by Munoz et al.
[2003]. The study reports a 4 fold increase in the geometric mean concentrations of
hRSV IgG Ab in infants born to vaccine recipients compared to those of mothers
who received a placebo. However, an increase of only 0.5 log 2 AU was observed for
neutralising antibodies. In the model, the immunising effects on the mother are
neglected since in the MSIR example virtually all individuals are already immune
by the time they reach child bearing age.
As continually discussed throughout this work, in reality, pathogen transmission is
often a highly heterogeneous process with potentially complex interdependencies
on social interaction, physiological development and immunological experience of
the host. However, estimation of these functions from empirical observation is
critically impeded by the issues of indeterminacy described in Section 2.4.1. The
most practicable approach to this problem has arisen from the combined works of
Grenfell and Anderson [1985], who present a maximum-likelihood methodology for
estimating age-related changes in the rate of infection, λ(a), from serological data,
and that of May and Anderson [1984], and Schenzle [1984], who impose constraints
on the structure of β(as, ai) such that it may be estimated explicitly.
The technique presented by Grenfell and Anderson [1985] initially involves mod-
elling the average force of infection as an arbitrary degree polynomial of the form:
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λ(a) =

k∑
i=0
bi a
i for M < a ≤ L,
0 for a ≤M,
(6.13)
where L and M denote the upper and lower age limits, respectively, and k is
the order of the expression. The resulting cumulative distribution of seropositive
individuals, given by the function:
F (a) =

1− exp
[
−
k∑
i=0
(
bi
ai+1 −M i+1
i+ 1
)]
for M < a ≤ L,
0 for a ≤M,
(6.14)
is then fitted to empirical age serological profile data, in order to estimate the
polynomial coefficients, bi, for i = 0, . . . , k. In the original work, the method is
applied to a number of datasets corresponding to records of measles incidence in
the UK and USA, for which the estimated rates of infection consistently rise to
a peak at around 10 years of age and decline thereafter [Grenfell and Anderson,
1985]. In addition, the results from a series of further studies for pertussis, measles,
mumps, rubella, chicken pox and scarlet fever are collated in the book by Anderson
and May [1991]. The review reports a striking similarity in the age-specific force
of infection, with a consistent peak in λ(a) occurring between 5-15 years of age
across the range of studied infections.
Unfortunately, the lower age limit, M , is included in functions (6.13) and (6.14)
in order to avoid obscurity due to the presence of maternally acquired antibodies.
It is found that the estimation of λ(a) in this age region is significantly hindered
by ambiguity between genuine seroconversion due to experience of infection and
residual MAb. In this instance, longitudinal serological data, such as that discussed
in the work by Ochola et al. [2009], is required in order to detect increasing Ab
titres that are indicative of an active immune response. However, the inference of
infection rates from analyses of this nature is still limited by restrictions on serum
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sampling frequencies, measurement error and confidence in the interpretation of
results below the limit of quantification. Consequently, in order to further the
analysis in this work, a series of example transmission functions are speculated in
order to characterise potential patterns of infection resulting from common and
vertical age biased social mixing, and decreasing susceptibility due to physiological
development among young infant age classes.
6.2.2 Simulation Results
Simulation of the system is performed in order to give insight into the potential
effects of maternal immunisation on age specific infection patterns among young
infants. Average age profiles of incidence and serology are presented for various
intervention characteristics and age specific transmission functions. The full PDE
model structure, given by (6.4)-(6.9), is solved according to Appendix B using sim-
ple numerical methods based on an explicit 3rd order backwards difference scheme
[Chapra and Canale, 2002]. More sophisticated algorithms have been presented
for problems of this nature, see for example the work by White [2000], however,
the simple approach is adopted in this work for ease of implementation and to
minimise time required for computation. The techniques are considered to be
appropriate since the outcomes of the analysis are largely qualitative in nature.
Constant Transmission Function
The model is first considered in the most simple case with non-seasonal and ho-
mogeneous transmission. The transmission function is therefore assumed to be
constant with respect to time and age, where a nominal value of β = 2490 yr-1 is
chosen to give a typical force of infection, λ = 0.84 yr-1, for hRSV. In the absence
of maternal immunisation, the simulation results are qualitatively comparable to
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the age serological profile data presented by Cox et al. [1998] (Figure 6.5). The
model predicts a peak in the proportion of the population susceptible (nadir in
proportion seropositive) of around 80%, occurring at 0.60 years (7.2 months) of
age, and around 90% of individuals having experienced infection by 3 years of age.
(a) PDE Model Simulation (b) hRSV Age Serological Data
Figure 6.5: Comparison between simulation results for the PDE MSIR model
with non-seasonal and homogeneous transmission, and age serological survey data
presented in the work by Cox et al. [1998], where incidence is presented as a
proportion of the net birth rate, µN .
It can be seen from Figure 6.5(a) that the peak ages for incidence and susceptible
supply occur at around 0.60 years (7.2 months) and 0.35 years (4.3 months) of age,
respectively. Since the distribution Cˆ(Ab) is assumed to be Gaussian, the peak age
of susceptible supply also corresponds to the estimated average duration of pro-
tection afforded by MAb. This prediction is notably higher than that documented
in the original work by Cox et al. [1998], where a simpler first order elimination
model is used to estimate an average duration of around 0.27 years (3.3 months).
The average age at primary infection is calculated using (2.39) and found to be
1.57 years (18.8 months), which is 0.32 years (3.8 months) greater than that pre-
dicted by the ODE models examined in Section 6.1 (Figure 6.4). The proportion
of newborns who become susceptible below a specified age may be found by eval-
uating the integral expression given by (3.94). For the parameter values applied
to the model, it is estimated that only 0.04% of newborns are born immediately
susceptible to infection. However, it is also shown that 91.6% of infants are likely
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to become susceptible before the age of 6 months. In order to protect all individ-
uals at risk of infection in this age region, an immunologically interacting vaccine
would need to invoke an effective response in mothers with antibody titres of at
least 3.54 log AU.
A non-interacting maternal immunisation campaign is applied to the model ac-
cording to Section 6.2.1 and a series of simulations performed in order to examine
the impact of the intervention. Results obtained for a range of values for the
mean vaccine efficacy, V¯M , (with standard deviation, σVM = 0.25) and the effective
vaccination coverage, Pm, are presented in Figure 6.6 and Table 6.1. It should
be noted that since C¯ = 3.0 log AU, mean vaccine efficacies of V¯M = 1.46 and
V¯M = 1.60 correspond roughly to a 4- or 6- fold average increase in antibody titre,
respectively.
(a) Responses to various Pm, at V¯M = 1.46 (b) Responses to various V¯M , at Pm = 0.75
Figure 6.6: Predicted outcomes of mass maternal immunisation applied to a fun-
damental decoupled MSIR model structure with non-seasonal and homogeneous
transmission; evaluated for various values of vaccine coverage and efficacy, where
incidence is presented as a proportion of the net birth rate, µN .
In response to the intervention, the simulations show an upward spreading of the
incidence age profile, leading to a moderate rise in the average age at primary
infection (Figure 6.6). There is also a significant reduction in the proportion of
individuals acquiring infection below 1 year and below 6 months of age, with no-
tably more success in the younger of the two age groups (see Table 6.1). In this
context, the results concur that maternal immunisation is a potentially efficacious
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intervention strategy with respect to reducing neonatal infection. However, it
can also be seen that the predicted distortion in the susceptible age profile con-
sequently leads to a decrease in the peak value. Hence, passive immunisation
may prove detrimental to the task of targeting active childhood vaccination to the
nadir in seropositivity (peak age of susceptibility), thereby increasing the degree
of potential interaction. This effect appears to be more pronounced for midrange
vaccination coverage, where neither the vaccinated or unvaccinated characteristic
curves dominate the resulting age profile.
Table 6.1: Predicted outcomes of mass maternal immunisation applied to a fun-
damental decoupled MSIR model structure with homogeneous transmission; eval-
uated for various values of vaccine coverage and efficacy.
Proportion of Mean Vaccine Average Age at Proportion Infected
Coverage Pm Efficacy V¯M Infection (years) < 6 months < 1 year
0 N/A 1.57 9.4% 39.7%
0.5 1.47 1.78 5.4% 27.6%
0.75 1.47 1.89 3.4% 21.7%
1 1.47 2.00 1.4% 15.8%
0.75 1.23 1.74 5.5% 29.5%
0.75 1.47 1.89 3.4% 21.7%
0.75 1.60 1.98 2.8% 18.0%
The results in Table 6.2 show the effects of differing degrees of variance for the
vaccine response distribution. It can be seen that greater variability in vaccine
response appears to advance the increase in average age at primary infection,
but also leads to less effective prevention of infection among the proportion of
individuals under 6 or 12 months of age.
It should also be noted that the overall prevalence of infection, calculated from the
integral of J(a) with respect to a, remains unchanged following the implementation
of the vaccine. This result is contrary to that predicted by the ODE models in
Section 6.1 (see Figure 6.3), and is a consequence of neglecting the immunising
response of the mother, and of the inclusion of an age-specific mortality function
Chapter 6 6.2 Static Analysis Age Domain 163
Table 6.2: Predicted outcomes of mass maternal immunisation applied to a fun-
damental decoupled MSIR model structure with homogeneous transmission, for
various values of vaccine coverage and variance in efficacy.
Proportion of Standard Deviation Average Age at Proportion Infected
Coverage Pm Vaccine Efficacy σVM Infection (years) < 6 months < 1 year
0 N/A 1.57 9.4% 39.7%
0.25 0.1 1.67 7.1% 33.4%
0.25 0.25 1.682 7.4% 33.7%
0.25 0.5 1.70 7.7% 33.5%
0.75 0.1 1.88 2.6% 20.8%
0.75 0.25 1.89 3.4% 21.7%
0.75 0.5 1.96 4.6% 21.4%
based on simplified Type II survivorship. It indicates that in homogeneous systems
with low infant mortality rates, maternal immunisation does not reduce the overall
prevalence of infection, unless there is significant herd immunity resulting from
vaccination of the mother.
Constant Common Age Transmission Bias
The first heterogeneous transmission profile to be considered is a diagonally sym-
metric, non-decreasing function of age, that is constant with respect to time (see
Figure 6.7(a)). The function corresponds to a situation where the primary route of
transmission is biased towards more frequent mixing between similar aged individ-
uals. Social interactions that potentially spread infection are often more common
between individuals of similar ages due to common social development and the
structure of the education system. Simulation results are shown in Figure 6.7(b),
where mass maternal immunisation is applied with a mean vaccine efficacy of 1.47
(approximately a 4 fold average increase in MAb) and a coverage, Pm = 0.75.
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(a) Transmission Function (b) Incidence Age Profile
Figure 6.7: Simulation results comparing pre- and post-mass maternal immuni-
sation incidence age profiles obtained using a decoupled MSIR model structure
with common age biased transmission; evaluated for V¯M = 1.47, σVM = 0.25 and
Pm = 0.75, where incidence is presented as a proportion of the net birth rate, µN .
The model suggests that if transmission is higher among similar aged individuals,
then raising the average age of infection among vaccinated individuals subsequently
reduces the force of infection acting on unvaccinated individuals at younger ages
and increases it at later ages. This leads to a lower incidence of infection in
younger (unvaccinated) age classes, subsequently raising the average age of infec-
tion. Therefore, in this instance it can be noted that maternal immunisation is
potentially beneficial for the infant population as a whole, including those that are
not directly immunised by the vaccine. The overall prevalence of infection is again
found to be unaffected by the intervention.
Vertical Age Transmission Bias
In the second example, the transmission function is biased such that the primary
source of infection for relatively well protected neonates and very young children is
from older age groups, for example through interaction with elder siblings residing
in a higher risk (school or preschool) age class. The resulting transmission profile
(shown in Figure 6.8(a)) is diagonally symmetric, constant in time, but increasing
with respect to age. Simulation results corresponding to the static system response
to immunisation are displayed in Figure 6.8.
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(a) Transmission Function (b) Incidence Age Profile
Figure 6.8: Simulation results comparing pre- and post-mass maternal immuni-
sation incidence age profiles obtained using a decoupled MSIR model structure
with vertical age biased transmission; evaluated for V¯M = 1.47, σVM = 0.25 and
Pm = 0.75, where incidence is presented as a proportion of the net birth rate, µN .
In this case, the force of infection applied to younger unvaccinated infants may be
increased as a result of increasing the average age of infection in the vaccinated
proportion. The simulation results shown in Figure 6.8 suggest that the imple-
mentation of a maternal immunisation campaign to a system of this type may in
fact prove detrimental to those individuals who do not directly receive the vaccine,
consequently reducing their average age at primary infection. The total proportion
of individuals ultimately infected for pre- and post-vaccine implementations are
compared as previously described and again suggest no significant impact from
the intervention.
Non Symmetrical Decreasing Transmission Bias
The final heterogeneous transmission example corresponds to a situation where the
susceptibility of the infant decreases with increasing age. This relation could be the
result of some aspect of physiological development, for example, larger and more
robust airways. The transmission function, shown in Figure 6.9(a), is therefore
assumed to be non-diagonally symmetric and represents an age specific change in
the host rather than social mixing patterns. Simulation results for the vaccinated
and unvaccinated age profiles of primary incidence are shown in Figure 6.9(b).
Chapter 6 6.3 Times Series Analysis of Dynamic & Seasonal Responses 166
(a) Transmission Function (b) Incidence Age Profile
Figure 6.9: Simulation results comparing pre- and post-mass maternal immunisa-
tion incidence age profiles obtained using a decoupled MSIR model structure with
non-symmetrical decreasing transmission; evaluated for V¯M = 1.47, σVM = 0.25
and Pm = 0.75, where incidence is presented as a proportion of the net birth rate,
µN .
The simulation suggests there is little difference in the risk experienced by pre-
and post-vaccine unvaccinated individuals. However, the total proportion of in-
dividuals infected in the post-vaccine system (area under incidence age profile) is
found to be 0.74, which is notably lower than the pre-vaccine proportion of 0.87.
This indicates that maternal immunisation may result in reduced prevalence of in-
fection in this type of system. However, in practical terms the decrease in β(as, ai)
must originate from an initial value high enough to facilitate a very low average
age at primary infection, to a final value low enough to sufficiently reduce basic
reproduction, and within relatively close proximity of the region between pre- and
post-vaccine average duration of MAb.
6.3 Times Series Analysis of Dynamic &
Seasonal Responses
The static based analyses reported in the previous sections of this chapter have
indicated that maternal immunisation is unlikely to notably affect long term pop-
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ulation infection levels unless there exists some specific pattern of heterogeneity
within neonatal and young infant age classes. However, interventions of this type
do have a direct influence over the rate of susceptible supply, which is a key factor
in the observed dynamic behaviour of epidemic systems. The two main objectives
of this section are to demonstrate how MSIR framework models may be used to
establish, firstly, whether stimulating greater neonatal immunity through maternal
immunisation has the potential to significantly perturb stable endemic systems,
and secondly, whether interventions of this type may benefit from seasonal target-
ing in cases where recurrent epidemic behaviour is driven by temporal forcing.
Time dynamic behaviour is simulated using the MSIRS2 ODE model with maternal
immunisation (3.27)-(3.32) and the decoupled PDE system (3.81)-(3.85), which is
extended to also include additional state variables corresponding to secondary
infection. As in previous examples, the MSIRS2 model is solved using the ode45
algorithm in MATLAB and the PDE model according to Section 6.2.1 where state
variable solutions are integrated with respect to age in order to isolate population
wide time series dynamics. Parameter values are set corresponding to those elicited
in Section 3.5 for hRSV with varying degrees of reinfection. In the PDE model
the transmission function, β(t, as, ai), is considered to be constant with respect to
age and mortality is assumed to follow the Type I survivorship function given by
(6.11). The cord log antibody titre distribution, Cˆ(Ab), and the vaccine response
function, VM(Ab), are parameterised as in Section 6.2.1, such that they emulate
the observations of Cox et al. [1998], and Munoz et al. [2003].
6.3.1 Dynamic Consequences of Intervention
Recalling from Section 2.1.2, it is discussed that unforced epidemic systems, partic-
ularly those with a short duration of infection and relatively slow rate of susceptible
supply, have a strong propensity to oscillate following perturbation away from a
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stable endemic steady state [Anderson and May, 1991]. In this instance, rapid
implementation of public health interventions that lead to an appreciable reduc-
tion in population susceptibility have the potential to evoke significant epidemic
behaviour while the system converges back to endemic equilibrium [Scherer and
McLean, 2002].
In the absence of infant mortality, the total inflow of susceptible individuals is
found to converge to that of the population net birth rate, µN . Assuming that
the implementation of a mass maternal immunisation campaign yields a positive
distortion of the cord antibody titre distribution, the intervention will result in
an increase in the average duration of immunity between unvaccinated and vacci-
nated generations of newborns. This leads to a temporary decrease in susceptible
supply, with magnitude and duration dependent on the efficacy of the vaccine
and the proportion of pregnant mothers to which it is applied. Since maternally
acquired immunity is passive and ultimately wanes with age, any reduction in
susceptible supply invoked by higher MAb titres is unsustainable and will quickly
return to its pre-vaccine rate. The resulting characteristic disturbance is illus-
trated in Figure 6.10(a), where simulation results are obtained for both the ODE
and PDE versions of the MSIRS2 model evaluated at parameter values correspond-
ing to hRSV with intermediate secondary infection (Tables 3.2 and 3.3(D)) and
Pm = 0.75.
It can be seen from Figure 6.10(a) that both models predict a significant decrease
in the rate of susceptible supply as a direct result of the immunisation. This leads
to a reduction in the incidence of infection, which, when the rate of susceptible
supply returns to its original value, allows for a rapid increase in the number of
available susceptibles. This in turn triggers a series of epidemics as shown in
Figure 6.10(b). In the ODE based system the rate at which maternally protected
neonates become fully susceptible to infection is governed by simple first order
elimination kinetics. This incurs an immediate response to the intervention that
Chapter 6 6.3 Times Series Analysis of Dynamic & Seasonal Responses 169
(a) Perturbation of Susceptible Supply (b) Predicted Dynamic Response
Figure 6.10: MSIRS2 ODE (coupled) and PDE (empirical/decoupled) model pre-
dictions for the dynamic response to perturbation from rapid implementation of
a maternally targeted vaccine at t = 0.5 years. Susceptible supply and primary
infection prevalence presented as a proportion of their steady state values.
converges exponentially back to its pre-vaccine rate (Figure 6.10(a)). In contrast,
the PDE model prediction is determined by the resulting distortion of the cord
titre distribution and the manner in which MAb wanes with age. This gives rise
to a more gradual response curve with a notable delay in peak reduction caused
by the propagation of seropositive individuals born prior to the intervention.
The epidemic oscillations observed following the implementation of the vaccine
(Figure 6.10(b)) are the result of complex endemic steady state eigenvalues, as
discussed in Section 2.1.2. Further investigation reveals that the observed differ-
ences in dynamics predicted by the two models result largely from the neglection
of immunity acquired by the mother in the PDE model, rather than from decou-
pling the dependency of passive neonatal immunity on the wider population. The
implications of this assumption also account for the offset in final value infection
prevalence observed between the two models. This reiterates the suggestion that
in homogeneous systems only the active response of the mother is likely to reduce
overall population infection through herd immunity.
For comparison, Figure 6.11 shows the resulting dynamic response of the two
models with parameter values corresponding to hRSV with varying infectivity
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bias (see Table 3.3(B) and (C)). It can be seen from Figure 6.11(b) that increasing
reinfection tends to reduce the highly oscillatory behaviour observed with more
primary infection dominant systems, such as that shown in Figure 6.11(a). This
illustrates that there is likely to be less risk of rebound epidemics associated with
the rapid implementation of mass maternal immunisation in systems that display
frequent reinfection of the host.
(a) Primary infection dynamics evaluated at
β0 = 2490yr
−1, ωR = 1.8yr−1, σ = 1, γ = 0.
(b) Primary infection dynamics evaluated at
β0 = 152 yr
−1, ωR = 1.8 yr−1, σ = 1, γ = 1.
Figure 6.11: MSIRS2 ODE and PDE system responses to perturbation by mass
maternal immunisation at t = 0.5 years, presented as a proportion of pre-vaccine
steady state values. Evaluated at parameter values corresponding to primary
infection dominant, (a), or reinfection dominant, (b), transmission.
It should be noted that these characteristics may be evaluated in more detail
through an eigenvalue analysis of the endemic steady state as described in Sec-
tions 2.1.2 and 3.3.5. It is also important to note that in cases where long term
population infection levels are largely unaffected by the intervention, any subse-
quent oscillatory behaviour will result in epidemic peaks of infection that exceed
pre-vaccination endemic levels.
6.3.2 Seasonality
Recalling from Section 2.1.3, many common infections tend to display large sea-
sonal epidemics at endemic equilibrium, which are presumed to be sustained by
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some form of temporal variation within the transmission function, β(t) [Altizer
et al., 2006]. In many cases such as measles and polio, pulse vaccination strategies
are employed, whereby a vaccine is repeatedly administered independently of age
and over very short periods of time [Nokes and Swinton, 1995]. Consequently,
work such as that by Grassly and Fraser [2006] has sought to optimise the timing
of periodic interventions with respect to the seasonal epidemic cycle, in order to
maximise the impact of the vaccine.
Since maternal immunisation has been shown to directly influence the supply of
susceptible individuals, it seems intuitive that there may be some notable ad-
vantage to seasonal targeting of the intervention in the context of systems with
periodic temporal forcing. This is additionally supported given that the average
duration of maternally acquired immunity is short with respect to typical epidemic
time periods. Individuals who are immunised at such a time that their natural
MAb titre would have waned shortly following an annual epidemic are unlikely
to benefit from the vaccine if they are not significantly exposed to infection again
until the following year. In this case it is hypothesised that immunisation should
be targeted to those individuals who are likely to experience their first annual
epidemic at around the time that low MAb titres wane to a susceptible level.
In order to assess the implications of alternative, seasonally targeted maternal
immunisation strategies, the ODE MSIRS2 model, given by (3.27)-(3.32), is ex-
tended such that the proportional application of the intervention, Pm(t), becomes
a function of time. In the simplest case, maternal immunisation is administered
during a single fixed period within each epidemic cycle. The relative timing of the
immunisation pulse is then varied with respect to the epidemic interval in order to
optimise the efficacy of the intervention. Temporal variation in the transmission of
infection is included within the model as in previous examples using the sinusoidal
function given by (2.14). The model is also further extended into a number of
discrete age classes according to Section 3.4.1, such that the number of primary
infections below a specific target age may be evaluated.
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Simulation results are obtained using a two age class model structure, where the
ageing parameter, k1 = 2yr
−1, is set such that primary infection prevalence may be
estimated among children under 6 months of age. For simplicity, all other model
parameters are assumed to be the same for both age classes and are set according to
Tables 3.2 and 3.3(C) for hRSV with high levels of reinfection. Simulation results
corresponding to an ideal (Pm(t) = 1) annual maternal immunisation campaign
with a duration of 3 months are shown in Figure 6.12(a).
(a) Primary infection prevalence under 6 months of age with optimal maternal immunisation.
(b) Proportion of pre-vaccine primary infection level with respect to intervention timing.
Figure 6.12: Simulation results for a seasonally forced MSIRS2 model with variably
timed 3 month pulse maternal immunisation. Evaluated at parameter values for
hRSV with highly prevalent reinfection.
It can be seen from Figure 6.12(b) that the reduction in primary infection preva-
lence achieved varies between 0.8% and 20.5% depending on the timing of the
intervention with respect to the epidemic cycle. This compares to a maximum
reduction of 29.1%, which may be obtained with an untargeted intervention strat-
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egy applied constantly throughout the year. The results suggest that the optimal
implementation of a three month pulse strategy is during the period immediately
prior to the annual epidemic peak of primary infection. This also coincides with
the peak in population susceptibility, which additionally minimises the interaction
between the vaccine and active immunity of the mother acquired from natural in-
fection. It should be noted from Figure 6.12(b) that the impact of this particular
intervention decreases rapidly either side of the optimum and that in practice, the
epidemic peak of infection may be difficult to accurately predict three months in
advance.
The analysis suggests that the potential benefit of seasonal targeting for a partic-
ular system is dependent on the ratio between the resulting increase in average
duration of maternally acquired immunity and the inter-epidemic time period. For
example, in cases such as hRSV infection in Finland, where seasonal epidemics are
biennial, a significant reduction in vaccine effort may be achieved through pulse
implementation. However, for infections where the inter-epidemic time period is
similar or less than the potential increase in duration of MAb, the prospective
benefits in efficacy are likely to be reduced.
Simulation results have clearly shown that there are likely to be potential bene-
fits to pulse implementation of maternally targeted vaccines in seasonal systems.
However, addition complexities such as the physical delay between vaccine admin-
istration to the mother and the birth of her offspring are required to be included
in forthcoming versions of the model in order to facilitate more accurate predic-
tions of optimal timing. In addition, it should be noted that the specificity of a
particular strategy may also be diminished by variability in factors such as cord
antibody titre and vaccine response distributions, consistency in the timing of epi-
demic peaks and again the duration of time between vaccine administration and
full term.
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6.4 Conclusions & Discussion
A series of MSIR framework models have been proposed for the study of population-
level epidemiological processes associated with maternally acquired immunity. A
preliminary analysis of this framework has been performed in order to gain insight
into the potential outcomes and consequences of mass maternal immunisation, and
to illustrate the importance of the subject. The discussed models have been shown
to qualitatively repeat empirical observations of unvaccinated epidemic systems
and their applicability in studying the wider implications of maternally targeted
intervention has been demonstrated. It is hoped that the framework will ulti-
mately contribute to the assessment and optimal implementation of future public
health policy within this context.
Simulation of the models using nominal parameterisations have concurred that
maternally targeted vaccines have the potential to appreciably reduce the inci-
dence of infection among neonatal age classes. In cases such as hRSV, where a
particularly low average age at primary infection is typically observed, interven-
tions of this nature may prove invaluable to efforts aimed at alleviating the burden
of disease within these age groups. However, it is anticipated that the potential
consequences of mass maternal immunisation for the wider population are more
variable and depend on a number of epidemiological factors such as age specific
transmission characteristics and reinfection.
Population Level Outcomes
A series of static analyses have suggested that overall population infection levels
may only be notably reduced by maternal immunisation if susceptibility, infectivity
or survivorship decreases significantly between the pre- and post-vaccine average
durations of maternally acquired immunity. In all static simulation examples,
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the average age at primary infection and the prevalence of infection in younger
ages for the vaccinated proportion of newborns showed improvements. However,
the indirect consequences of immunisation to unvaccinated individuals appears to
vary depending on the characteristic heterogeneity of the transmission function.
Example transmission patterns have been illustrated that give rise to both ben-
eficial and detrimental influences on infection among the remaining unvaccinated
neonatal population.
Time series-based analyses have demonstrated that mass maternal immunisation
has a direct impact on the rate that maternally protected infants become sus-
ceptible to infection. Simulation results suggest that any subsequent decrease in
susceptibility arising from the intervention is ultimately only temporary. However,
rapid implementation of a maternally targeted vaccine does have the potential to
cause significant perturbations in susceptible supply that may notably alter the
time course of the infection. Since a considerable decrease in long term prevalence
is unlikely, any rebound epidemics that occur are likely to exceed endemic pre-
intervention infection levels, posing an additional risk to newborns who remain
unvaccinated.
The work has also provided evidence contributing to the question of whether mater-
nally acquired immunity is a prominent driving force on seasonal epidemic cycles.
For hRSV, studies such as those by Saux et al. [2003] and Stensballe et al. [2009]
have reported significant seasonal variations in maternally derived antibody titres
in newborns, and a strong correlation between neutralising MAb and seasonality of
infection among infants under 6 months of age. This suggests that if variations in
hRSV-neutralising MAb are reflective of those throughout the wider population, a
coupled cyclic dependency between neonatal and population wide immunity may
play an important role in the seasonality of hRSV in temperate climates [Stens-
balle et al., 2009]. However, simple comparisons between coupled and decoupled
model structures in this work suggest, at least in the homogeneous case, that the
dependency of immunity among newborns on that of the wider population does
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not have a significant impact on dynamics. This is an interesting result since it
indicates that for the presented examples, temporal variation in MAb may not
have a significant influence on population wide patterns of infection.
The outcome is additionally supported in Section 6.3.2 for systems with high levels
of reinfection, where minimal changes in seasonal epidemic behaviour are observed
despite repeated variation in the maternally protected population induced by pulse
maternal immunisation. However, the application of maternal immunisation to
seasonally forced MSIR models, without processes of reinfection, has frequently
given rise highly aberrant and possibly chaotic patterns of infection. Dramatic
changes in the periodicity of epidemic cycles have been empirically observed fol-
lowing active intervention in cases such as measles [Bolker and Grenfell, 1996] and
simple compartmental based models have been shown to qualitatively repeat these
observations in work such as that by Earn et al. [2000]. However, due to the in-
herently complex and nonlinear nature of these processes, it is not certain that the
transitions between regular and irregular dynamics are correctly described by the
models presented in this work. Subsequently, the apparent suggestion that ma-
ternal immunisation has the potential to destabilise long term recurrent epidemic
cycles of childhood diseases remains inconclusive without more formal validation.
Interaction and Optimisation
The study has highlighted the potential significance of antibody interaction with
respect to the success of combined (maternally and childhood targeted) interven-
tion strategies. For many childhood infections circulating within developed popu-
lations there is a sufficient window of opportunity to implement mass age targeted
(childhood) vaccination campaigns that both avoid interaction with MAb and
succeed in preventing a significant amount of susceptibility to natural infection.
However, in more developing settings, where transmission rates among pre-school
children are often much higher, and with more virulent infections such as hRSV,
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it is not always possible to delay vaccination beyond the complete duration of
MAb. In situations such as these, the upward distortion in susceptible age pro-
file resulting from the implementation of mass maternal immunisation, may prove
additionally detrimental to the success of childhood vaccines targeted at the peak
age of susceptibility.
The analysis of intervention strategies applied to models with seasonal forcing has
illustrated the potential merit for pulsed implementation of maternally adminis-
tered vaccines. This study has found that the likely benefit for seasonal targeting
is dependent on the ratio between the resulting increase in average duration of pas-
sively acquired immunity and the inter-epidemic time period. It has been shown
through simulation of the model that the optimal time for intervention is immedi-
ately prior to the annual epidemic peak of infection. However, additional factors
including the duration of time to full term and variability in determinants such as
cord antibody titre, vaccine response and epidemic timing must also be considered
in order to achieve a fully optimal strategy.
Chapter 7
Final Discussion & Future
Research
The objective of this work has been to consider the population level influences
of maternally acquired immunity and the potential outcomes and consequences of
mass maternal immunisation. A series of lumped system models have been pro-
posed as part of a general mathematical model framework for studying a number
of distinct problems within this context. The analysis and simulations presented
in Chapter 6 have demonstrated the applicability of these models to real world sce-
narios and raised a number of pertinent questions regarding the safe and optimal
implementation of maternally targeted interventions. The work has also consid-
ered the impact of maternally acquired immunity on aspects of model validation
through the application of formal methods such as structural identifiability, indis-
tinguishability and sensitivity analysis. It is found in Chapters 4 and 5 that the
confident estimation of model parameters through fitting to real data is likely to
be a markedly non-trivial task.
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Maternal Immunisation
A qualitative analysis of the proposed models has shown that maternally tar-
geted vaccination has the potential to appreciably reduce the incidence of infection
among neonatal and young infant age classes. In all static simulation examples the
models have predicted notable improvements in both the average age at primary
infection and the prevalence of infection among infants under 6 months of age. In
cases such as hRSV, where a particularly low average age at primary infection is
typically observed, these results may prove invaluable to efforts aimed at alleviat-
ing the burden of disease among the very young. The efficacy of the intervention is
found to be dependent on successful seroconversion of the mother, sufficient trans-
fer of antibodies before birth and the duration of maternally acquired antibodies
within the newborn. Variability in these characteristics is currently included within
the model, however, an intuitive progression from this work would be to consider
variation in the neutralising characteristics of MAb.
Low levels of neutralising MAb are likely to result in partial immunity, similar to
that described in altered secondary infection models [White et al., 2007], which
could have significant implications on the outcome of neonatal infection. The
problem may also be extended to consider the effects of cross reaction between
multiple strain variants as described in the work by White et al. [1998]. A common
epidemiological observation of hRSV are complex patterns of homologous and
heterologous infection and a seasonal alternation between two dominant genotypes
[White et al., 2005]. It is hypothesised in the review by Cane [2001] that these
observed patterns may in fact be governed by high levels of maternal antibody
present after an epidemic of a particular strain. An interesting subject of further
research may be to explore these interactions using compartmental based models
and to consider the implications of control by maternally targeted vaccines.
A static analysis of age dependent model structures with heterogeneous trans-
mission functions has been used to highlight characteristic examples where the
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implementation of mass maternal immunisation may have beneficial or detrimen-
tal consequences to unvaccinated newborns and to the population as a whole. It is
suggested by the model that a substantial change in social interaction, physiolog-
ical development or survivorship is required within the region of 3 to 9 months of
age in order to induce a significant impact on long term infection characteristics.
A valuable route of future research may therefore be towards better characteri-
sation of neonatal and young infant transmission patterns, perhaps through the
identification of key factors such as the start of nursery or the typical composition
of households, i.e. mixing with elder siblings etc.
Time series-based simulations suggest that the greatest risks associated with mass
maternal immunisation reside in the form of short term dynamics resulting from
rapid implementation of the vaccine and the potential interaction with childhood
targeted interventions. It is found that maternal immunisation has a temporary
but direct impact on the rate of susceptible supply, where significant perturbations
may notably alter the time course of the infection. In cases where the long term
population wide prevalence of infection remains largely unchanged, any rebound
epidemics are likely to exceed pre-intervention endemic levels. The work dictates
that sufficient care must be taken to ensure that interventions are not aggressively
implemented within highly oscillatory systems.
It is also strongly suggested that the potential interactions between maternally
and childhood targeted vaccines are exhaustively considered. The subsequent dis-
tortion in the susceptible age profile resulting from the implementation of mass
maternal immunisation may prove detrimental to the success of childhood vaccines
targeted at the peak age of susceptibility. This could be particularly problematic
in cases where there is a narrow window of opportunity between the duration of
MAb and the average age at primary infection. A potential opportunity for fu-
ture application of the proposed models may be in the optimisation of combined
intervention strategies, where, for example, the benefits of seasonally pulsed ad-
ministration could be further utilised to minimise interaction between vaccines.
Chapter 7 7.0 181
Model Validation
The proposed model framework has been shown to qualitatively repeat empirical
observations of unvaccinated epidemic systems, however, further validation of these
models, and particularly those including processes of intervention, is a markedly
non-trivial task. A structural identifiability analysis of fundamental ODE models
within the proposed framework has shown that key parameters are not uniquely
determined by age domain observations of infection. Furthermore, it has been
shown that homogeneous time-series models are highly insensitive to processes
associated with maternally acquired immunity and that the addition of vaccination
tends to have an additionally detrimental effect on parameter identifiability. It is
suggested that further validation of these models through fitting to population
data will require very specific longitudinal based studies that provide both age
and time domain records of infection and serology. The outcome of a formal
sensitivity analysis has also highlighted the necessity for optimal sampling during
the collection of such data. It is hoped that the outcome of this work may be of
use in guiding the design of future studies in order to maximise the amount of
information gained from parameter estimation.
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Appendix A
MSEIRS4 Model Equations
System of ordinary differential equations describing the MSEIRS4 model derived
and evaluated for hRSV in the work by Weber et al. [2001].
M˙(t) = µAb+(t)− (ωM + µ)M(t),
S˙1(t) = µAb
−(t) + ωMM(t)− µS1(t)− λ1(t)S1(t),
E˙i(t) = λi(t)Si(t)− (ζ + µ)Ei(t), i = 1, . . . , 4,
I˙i(t) = ζEi(t)− (ν + µ)Ii(t), i = 1, . . . , 4,
R˙i(t) = νIi(t)− (ωR + µ)Ri(t), i = 1, . . . , 4,
S˙j(t) = ωRRj−1(t)− µSj(t)− λj(t)Sj(t), j = 2, 3,
S˙4(t) = ωR(R3(t) +R4(t))− µS4(t)− λ4(t)S4(t),
where
Ab+(t) =
4∑
i=1
Ri(t), Ab
−(t) = 1−Ab+(t), I(t) =
4∑
i=1
Ii(t),
λ1(t) = β0(1+β1 cos(2pit+φ))I(t), λ2(t) = σ1 λ1(t)
λ3(t) = σ2 λ1(t), λ4(t) = σ3 λ1(t),
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Simulation Techniques for PDE
Model Structures
Simulation of the PDE system in Chapter 6 is performed using simple numerical
methods based on finite differencing. The domain space is divided into a uniform
mesh with a constant step size, h, and boundary conditions determined by the
model. The internal grid points are then estimated incrementally, for each age
profile at increasing steps in time, using an explicit backwards difference scheme.
Since time series dynamics are seen to evolve much more rapidly than average age
profiles, a higher degree of accuracy is applied to calculations in the time domain.
Therefore, partial derivatives with respect to age and time are substituted by 2nd
and 3rd order finite differences, respectively, according to the following expressions:
dX(t, a)
dt
=
11Xi,j − 18Xi−1,j + 9Xi−2,j − 2Xi−3,j
6h
+ O(h3), (B.1)
dX(t, a)
da
=
3Xi,j − 4Xi,j−1 +Xi,j−2
2h
+ O(h2), (B.2)
where Xi,j = X(ti, aj).
In practice, additional complexities arise in the solving of epidemic PDE systems
since the force of infection is directly dependent on the integral of the infective
age profile, denoted I(t). This means that mesh points for certain state variables
cannot be solved explicitly since they are effectively dependent on their own solu-
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tion. Therefore, for each increment in time, an estimate of λ(t, a) is extrapolated
from previous time points using a 2nd order Lagrange interpolating polynomial of
the form:
L(ti) =
k∑
i=0
yi`i(t) `i(t) =
k∏
j=0, j 6=i
(t− tj)
(ti − tj) . (B.3)
Since the simulation time steps are uniformly spaced, the function can be reduced
to the following expression:
I(ti) = I(ti−3) − 3 I(ti−2) + 3 I(ti−1) . (B.4)
More sophisticated numerical methods have been presented to address this prob-
lem, for example in the work by White [2000], where a further iterative process,
nested into the main routine, is executed at each increment in time in order to
allow convergence to a solution for λ(t, a). The simple extrapolation approach is
adopted in this work for ease of implementation and to minimise time required for
computation.
Integration of the state variable solutions, for example over an integer number of
complete annual cycles to find an average age profile, is performed using Romberg
integration; a Newton-Cotes type method based on repeated application of Richard-
son extrapolation to the trapezoidal rule (for more information see the book by
Chapra and Canale [2002]).
Let J
(h)
0 , J
(2h)
0 and J
(4h)
0 denote the integrals computed using the trapezoidal rule
with step sizes h, 2h and 4h respectively, such that:
J
(h)
0 = J + c1h
2 + c2h
4 + c3h
6 + . . . , (B.5)
J
(2h)
0 = J + c1(2h)
2 + c2(2h)
4 + c3(2h)
6 + . . . , (B.6)
J
(4h)
0 = J + c1(4h)
2 + c2(4h)
4 + c3(4h)
6 + . . . , (B.7)
where J is the exact solution and the later terms correspond to the resulting error.
More accurate integral estimates can then be obtained by combining (B.5)-(B.7)
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such that subsequent error terms are eliminated according to the following process:
J
(h)
1 =
4J
(h)
0 − J (2h)0
3
= J − 4c2h4 − 20c3h6 + . . . , (B.8)
J
(2h)
1 =
4J
(2h)
0 − J (4h)0
3
= J − 64c2h4 − 1280c3h6 + . . . , (B.9)
J
(h)
2 =
16J
(h)
1 − J (2h)1
15
= J + 64c3h
6 + . . . . (B.10)
It can be seen from the final estimate (B.10) that the magnitude of the truncation
error is significantly reduced with relatively little computational effort.
Error Estimation
An estimation of the error in the numerical solution is found by comparing sim-
ulation results corresponding to a homogeneous MSIR model to those generated
from equivalent ODE-based systems with more computationally tractable solu-
tions. A suitable test model is derived from the general MSIR system equations
(3.3)-(3.7) by setting all model parameters to constant values and ensuring that
µb = µd = µ, such that equivalent time and age domain models are given by (3.14)-
(3.17) and (3.45)-(3.48), respectively. The system of partial differential equations
is then solved using the described methods with parameter values corresponding
to hRSV without secondary infection (Tables 3.2 and 3.3(A)), and a step size of
0.0026 years.
In the absence of seasonal forcing, the steady state prevalence of infection esti-
mated by the simulation is compared to the analytic solution given by (3.54).
The resulting normalised error is found to be 3.9 × 10−4 for the PDE model and
4.3× 10−8 for the ODE system obtained using the ode45 algorithm in MATLAB.
In the age domain, the steady state average age profile predicted by the PDE
model simulation is compared to an analytic solution derived from the equivalent
age domain model (3.45)-(3.48), as shown in Section 3.3.4. The resulting error
functions are displayed in Figure B.1. It can be seen from Figure B.1(b) that the
peak normalised error has a magnitude of 0.096 and occurs directly after the first
simulation step. The location of the maximum error coincides with the greatest
rate of change in I(a) and is also likely to be a result of there being only one
previous age point on which to base the finite difference estimate. Following its
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peak, the magnitude of the normalised error curve quickly decreases to a more
reasonable level, where an average value of 6.3× 10−4 is recorded over the first 12
months of age.
(a) Absolute Error (b) Normalised Error
Figure B.1: Variation in absolute and normalised error of the numerical solution
to a homogeneous MSIR PDE model found using a 2nd/3rd order backwards
difference scheme.
Finally, the resulting times series prediction generated by the addition of seasonal
forcing is compared to that obtained by solving the ODE system (3.14)-(3.17)
using a fourth order Runge-Kutta algorithm (MATLAB ode45) with a maximum
step size of 0.001 years. The variation in normalised error over a complete annual
cycle is shown in Figure B.2. It is found that the maximum normalised error is
0.0081, which occurs at the beginning of each annual epidemic, and the average
error across one complete annual cycle is 0.0039.
(a) Simulation Output (b) Normalised Error
Figure B.2: Time series variation in normalised error between numerical solutions
of the homogeneous PDE and ODE MSIR models, using 2nd/3rd order backwards
differencing and 4th order Runge-Kutta, respectively.
It should be noted that the estimated error is considered to be acceptable in the
context of this work given that the outcomes of the analysis are largely qualitative
in nature.
